These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ý
|
Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 [Fee Required]
|
|
¨
|
Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 [No Fee Required]
|
|
Delaware
|
|
63-1261433
|
|
(State of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
100 Brookwood Place,
Birmingham, AL
|
|
35209
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
Title of Each Class
|
|
Name of Each Exchange On Which Registered
|
|
Common Stock, par value $0.01 per share
|
|
New York Stock Exchange
|
|
Large accelerated filer
|
|
ý
|
|
Accelerated filer
|
|
¨
|
|
Non-accelerated filer
|
|
¨
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
¨
|
|
Emerging growth company
|
|
¨
|
|
|
|
|
|
(i)
|
The definitive proxy statement for the
2019
Annual Meeting of the Stockholders of ProAssurance Corporation (File No. 001-16533) is incorporated by reference into Part III of this report.
|
|
Term
|
Meaning
|
|
ACA
|
The Affordable Care Act
|
|
ALAE
|
Allocated loss adjustment expense
|
|
AOCI
|
Accumulated other comprehensive income (loss)
|
|
ASU
|
Accounting Standards Update
|
|
BEAT
|
Base erosion anti-abuse tax
|
|
Board
|
Board of Directors of ProAssurance Corporation
|
|
BOLI
|
Business owned life insurance
|
|
CIMA
|
Cayman Islands Monetary Authority
|
|
Council of Lloyd's
|
The governing body for Lloyd's of London
|
|
CODM
|
Chief Operating Decision Maker
|
|
COSO
|
Committee of Sponsoring Organizations of the Treadway Commission
|
|
Commutation
|
An agreement between a ceding insurer and the reinsurer that provides for the valuation, payment, and complete discharge of all obligations between the parties under a particular reinsurance contract
|
|
DDR
|
Death, disability and retirement
|
|
Dodd-Frank Act
|
The Dodd-Frank Wall Street Reform and Consumer Protection Act
|
|
DPAC
|
Deferred policy acquisition costs
|
|
Eastern Re
|
Eastern Re, LTD, S.P.C.
|
|
EBUB
|
Earned but unbilled premium
|
|
EEA
|
European Economic Area
|
|
ERM
|
Enterprise Risk Management
|
|
FAL
|
Funds at Lloyd's
|
|
FASB
|
Financial Accounting Standards Board
|
|
FHLB
|
Federal Home Loan Bank
|
|
FHLMC
|
Federal Home Loan Mortgage Corporation
|
|
FIO
|
Federal Insurance Office
|
|
FNMA
|
Federal National Mortgage Association
|
|
GAAP
|
Generally accepted accounting principles in the United States of America
|
|
GDPR
|
General Data Protection Regulation
|
|
GILTI
|
Global intangible low-taxed income
|
|
GNMA
|
Government National Mortgage Association
|
|
HCPL
|
Healthcare professional liability
|
|
IBNR
|
Incurred but not reported
|
|
Inova Re
|
Inova Re, LTD, S.P.C.
|
|
IRS
|
Internal Revenue Service
|
|
LAE
|
Loss adjustment expense
|
|
LIBOR
|
London Interbank Offered Rate
|
|
LLC
|
Limited liability company
|
|
Lloyd's
|
Lloyd's of London market
|
|
LP
|
Limited partnership
|
|
LPT
|
Loss portfolio transfer
|
|
Medical technology liability
|
Medical technology and life sciences products liability
|
|
Model Holding Co. Law
|
Model Insurance and Holding Company System Regulatory Act and Regulation
|
|
Term
|
Meaning
|
|
NAIC
|
National Association of Insurance Commissioners
|
|
NAV
|
Net asset value
|
|
NFIP
|
National Flood Insurance Program
|
|
NOL
|
Net operating loss
|
|
NRSRO
|
Nationally recognized statistical rating organization
|
|
NYDFS
|
New York Department of Financial Services
|
|
NYSE
|
New York Stock Exchange
|
|
OCI
|
Other comprehensive income (loss)
|
|
ORSA
|
Risk Management and Own Risk and Solvency Assessment Model Act
|
|
OTTI
|
Other-than-temporary impairment
|
|
PCAOB
|
Public Company Accounting Oversight Board
|
|
PICA
|
Podiatry Insurance Company of America
|
|
ProAssurance Plan
|
Non-qualified deferred compensation plan
|
|
ProAssurance Savings Plan
|
Defined contribution savings and retirement plan
|
|
Revolving Credit Agreement
|
ProAssurance's $250 million revolving credit agreement
|
|
ROE
|
Return on equity
|
|
SAB
|
Staff Accounting Bulletin, which reflects the SEC staff's views regarding accounting-related disclosure practices
|
|
SAP
|
Statutory accounting principles
|
|
SEC
|
Securities and Exchange Commission
|
|
SPA
|
Special Purpose Arrangement
|
|
SPC
|
Segregated portfolio cell
|
|
Specialty P&C
|
Specialty Property and Casualty
|
|
Syndicate 1729
|
Lloyd's of London Syndicate 1729
|
|
Syndicate 6131
|
Lloyd's of London Syndicate 6131, a Special Purpose Arrangement with Lloyd's of London Syndicate 1729
|
|
Syndicate Credit Agreement
|
Unconditional revolving credit agreement with the Premium Trust Fund of Syndicate 1729
|
|
TCJA
|
Tax Cuts and Jobs Act H.R.1 of 2017
|
|
TRIA
|
Federal Terrorism Risk Insurance Act
|
|
U.K.
|
United Kingdom of Great Britain and Northern Ireland
|
|
ULAE
|
Unallocated loss adjustment expense
|
|
VIE
|
Variable interest entity
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
changes in general economic conditions, including the impact of inflation or deflation and unemployment;
|
|
|
our ability to maintain our dividend payments;
|
|
|
regulatory, legislative and judicial actions or decisions that could affect our business plans or operations, including the impact of Brexit;
|
|
|
the enactment or repeal of tort reforms;
|
|
|
formation or dissolution of state-sponsored insurance entities providing coverages now offered by ProAssurance which could remove or add sizable numbers of insureds from or to the private insurance market;
|
|
|
changes in the interest and tax rate environment;
|
|
|
resolution of uncertain tax matters and changes in tax laws, including the impact of the TCJA;
|
|
|
changes in laws or government regulations regarding financial markets or market activity that may affect our business;
|
|
|
changes in the ability of the U.S. government to meet its obligations that may affect the U.S. economy and our business;
|
|
|
performance of financial markets affecting the fair value of our investments or making it difficult to determine the value of our investments;
|
|
|
changes in requirements or accounting policies and practices that may be adopted by our regulatory agencies, the FASB, the SEC, the PCAOB or the NYSE that may affect our business;
|
|
|
changes in laws or government regulations affecting the financial services industry, the property and casualty insurance industry or particular insurance lines underwritten by our subsidiaries;
|
|
|
the effect on our insureds, particularly the insurance needs of our insureds, and our loss costs, of changes in the healthcare delivery system and/or changes in the U.S. political climate that may affect healthcare policy or our business;
|
|
|
consolidation of our insureds into or under larger entities which may be insured by competitors, or may not have a risk profile that meets our underwriting criteria or which may not use external providers for insuring or otherwise managing substantial portions of their liability risk;
|
|
|
uncertainties inherent in the estimate of our loss and loss adjustment expense reserve and reinsurance recoverable;
|
|
|
changes in the availability, cost, quality or collectability of insurance/reinsurance;
|
|
|
the results of litigation, including pre- or post-trial motions, trials and/or appeals we undertake;
|
|
|
effects on our claims costs from mass tort litigation that are different from that anticipated by us;
|
|
|
allegations of bad faith which may arise from our handling of any particular claim, including failure to settle;
|
|
|
loss or consolidation of independent agents, agencies, brokers or brokerage firms;
|
|
|
changes in our organization, compensation and benefit plans;
|
|
|
changes in the business or competitive environment may limit the effectiveness of our business strategy and impact our revenues;
|
|
|
our ability to retain and recruit senior management;
|
|
|
the availability, integrity and security of our technology infrastructure or that of our third-party providers of technology infrastructure, including any susceptibility to cyber-attacks which might result in a loss of information or operating capability;
|
|
|
the impact of a catastrophic event, as it relates to both our operations and our insured risks;
|
|
|
the impact of acts of terrorism and acts of war;
|
|
|
the effects of terrorism-related insurance legislation and laws;
|
|
|
guaranty funds and other state assessments;
|
|
|
our ability to achieve continued growth through expansion into new markets or through acquisitions or business combinations;
|
|
|
changes to the ratings assigned by rating agencies to our insurance subsidiaries, individually or as a group;
|
|
|
provisions in our charter documents, Delaware law and state insurance laws may impede attempts to replace or remove management or may impede a takeover;
|
|
|
state insurance restrictions may prohibit assets held by our insurance subsidiaries, including cash and investment securities, from being used for general corporate purposes;
|
|
|
taxing authorities can take exception to our tax positions and cause us to incur significant amounts of legal and accounting costs and, if our defense is not successful, additional tax costs, including interest and penalties; and
|
|
|
expected benefits from completed and proposed acquisitions may not be achieved or may be delayed longer than expected due to business disruption; loss of customers, employees or key agents; increased operating costs or inability to achieve cost savings; and assumption of greater than expected liabilities, among other reasons.
|
|
Additional risks, assumptions and uncertainties that could arise from our membership in the Lloyd's market and our participation in Lloyd's Syndicates include, but are not limited to, the following:
|
|
|
|
members of Lloyd's are subject to levies by the Council of Lloyd's based on a percentage of the member's underwriting capacity, currently a maximum of 3%, but can be increased by Lloyd's;
|
|
|
Syndicate operating results can be affected by decisions made by the Council of Lloyd's which the management of Syndicate 1729 and Syndicate 6131 have little ability to control, such as a decision to not approve the business plan of Syndicate 1729 or Syndicate 6131, or a decision to increase the capital required to continue operations, and by our obligation to pay levies to Lloyd's;
|
|
|
Lloyd's insurance and reinsurance relationships and distribution channels could be disrupted or Lloyd's trading licenses could be revoked, making it more difficult for a Lloyd's Syndicate to distribute and market its products;
|
|
|
rating agencies could downgrade their ratings of Lloyd's as a whole; and
|
|
|
Syndicate 1729 and Syndicate 6131 operations are dependent on a small, specialized management team and the loss of their services could adversely affect the Syndicate’s business. The inability to identify, hire and retain other highly qualified personnel in the future could adversely affect the quality and profitability of Syndicate 1729’s or Syndicate 6131's business.
|
|
•
|
Provide specialized healthcare-centric expertise to meet evolving demands in the healthcare marketplace
. Through our focus on healthcare, we provide traditional liability insurance products to healthcare providers. We also leverage our reach, expertise and financial strength to provide innovative and customized products to meet the risk management needs of larger healthcare organizations or groups.
|
|
•
|
Provide superior workers' compensation products and services.
We provide workers' compensation products and services that focus on increasing an organization's productivity while reducing costs. We do this by providing
|
|
•
|
Provide superior customer service.
Our mission statement, "We exist to Protect Others," goes hand-in-hand with our corporate brand promise, "Treated Fairly." Our employees demonstrate our core values of integrity, leadership, relationships and enthusiasm every day and are focused on meeting the needs of our customers.
|
|
•
|
Effectively manage capital.
We carefully monitor use of our capital and consider various options for capital deployment, such as business expansion by our existing subsidiaries, opportunities that arise for mergers or acquisitions, share repurchases and payment of dividends.
|
|
•
|
Pursue profitable underwriting opportunities.
We emphasize profitability, not market share. Key elements of our approach are prudent risk selection using established underwriting guidelines, appropriate pricing, and adjusting our business mix as appropriate to effectively utilize capital and achieve market synergies.
|
|
•
|
Emphasize risk management.
We actively manage our enterprise risk by maintaining strong internal controls. We also emphasize the importance of risk management to our insureds and offer them training in the use of risk reduction tools and techniques.
|
|
•
|
Manage claims effectively.
Our experienced claims teams have industry and insurance expertise that, with our extensive local knowledge, allows us to resolve claims in an effective manner, considering the circumstances of each claim. When practicable, we utilize formalized claims management processes and protocols as a means of reducing claim costs.
|
|
•
|
Maintain a conservative investment strategy.
We believe that we follow a conservative investment strategy designed to emphasize the preservation of our capital and provide adequate liquidity for the prompt payment of claims. Our investment portfolio consists primarily of investment-grade, fixed-maturity securities of short-to medium-term duration.
|
|
•
|
Maintain financial stability
. We are committed to maintaining financial strength and adequate capital.
|
|
•
|
Specialty P&C
- This segment includes our professional liability business and medical technology liability business. Professional liability insurance is primarily offered to healthcare providers and institutions and to attorneys and their firms. Medical technology liability insurance is offered to medical technology and life sciences companies that manufacture or distribute products including entities conducting human clinical trials. The underwriting results of SPCs that assume healthcare professional liability business were previously reported in this segment and are now reported in our Segregated Portfolio Cell Reinsurance segment.
|
|
•
|
Workers' Compensation Insurance
- This segment includes our workers' compensation insurance business which is provided primarily to employers with 1,000 or fewer employees. Our workers' compensation products include guaranteed cost policies, policyholder dividend policies, retrospectively-rated policies, deductible policies and alternative market solutions. The underwriting results of SPCs that assume workers’ compensation business were previously reported in this segment and are now reported in our Segregated Portfolio Cell Reinsurance segment.
|
|
•
|
Segregated Portfolio Cell Reinsurance
- This segment reflects the operating results (underwriting profit or loss, plus investment results) of SPCs at Eastern Re and Inova Re, our Cayman Islands SPC operations. The SPCs assume workers' compensation insurance, healthcare professional liability insurance or a combination of the two from either our Workers' Compensation Insurance or Specialty P&C segments.
|
|
•
|
Lloyd's Syndicates
- This segment includes the operating results from our participation in Lloyd's of London Syndicates 1729 and 6131. Syndicate 6131 is a SPA that began writing business effective January 1, 2018. The results of this segment are normally reported on a quarter delay, except when information is available that is material to the current period. Syndicate 1729 underwrites risks over a wide range of property and casualty insurance and reinsurance lines in both the U.S. and international markets while Syndicate 6131 focuses on contingency and specialty property business, also within the U.S. and international markets.
|
|
•
|
Corporate
- This segment includes our investment operations, interest expense and U.S. income taxes, all of which are managed at the corporate level with the exception of investment assets solely allocated to either SPC operations or
Lloyd's
Syndicate operations. The results of investment assets solely allocated to SPC operations were previously reported in this segment and are now reported in our Segregated Portfolio Cell Reinsurance segment. This segment also includes non-premium revenues generated outside of our insurance entities and corporate expenses.
|
|
|
Year Ended December 31
|
||||||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
2016
|
||||||||||||
|
Specialty P&C
(1)
|
$
|
577,196
|
|
60
|
%
|
|
$
|
549,323
|
|
63
|
%
|
|
$
|
535,725
|
|
64
|
%
|
|
Workers' Compensation Insurance
|
293,230
|
|
31
|
%
|
|
264,048
|
|
30
|
%
|
|
248,875
|
|
30
|
%
|
|||
|
Segregated Portfolio Cell Reinsurance
(2)
|
85,086
|
|
9
|
%
|
|
77,675
|
|
9
|
%
|
|
72,221
|
|
9
|
%
|
|||
|
Lloyd's Syndicates
(3)
|
88,746
|
|
9
|
%
|
|
70,224
|
|
8
|
%
|
|
65,157
|
|
8
|
%
|
|||
|
Inter-segment revenues
(2)(3)
|
(86,947
|
)
|
(9
|
%)
|
|
(86,394
|
)
|
(10
|
%)
|
|
(86,964
|
)
|
(11
|
%)
|
|||
|
Total
|
$
|
957,311
|
|
100
|
%
|
|
$
|
874,876
|
|
100
|
%
|
|
$
|
835,014
|
|
100
|
%
|
|
(3)
|
Our written premium includes our participation in Syndicates 1729 and 6131, including casualty premium assumed by
Syndicate 1729
from our
Specialty P&C
segment through a quota share reinsurance agreement.
Syndicate 1729
did not renew the quota share reinsurance agreement with our Specialty P&C segment on January 1, 2018; however, gross premiums written for the year ended
December 31, 2018
included one quarter of cession due to the previously mentioned quarter delay. We eliminate this inter-segment revenue.
|
|
•
|
Traditional workers' compensation insurance coverages provided to employers, generally those with 1,000 employees or less. Types of policies offered include guaranteed cost policies, policyholder dividend policies, retrospectively-rated policies and deductible policies.
|
|
•
|
Alternative market workers' compensation solutions provided to individual companies, groups and associations whereby the workers' compensation premium written is 100% ceded to either the
SPC
s at
Eastern Re
or
Inova Re
, which are reported in our Segregated Portfolio Cell Reinsurance segment, or, to a limited extent, unaffiliated
|
|
•
|
for reported claims, the nature of the claim and the jurisdiction in which the claim occurred;
|
|
•
|
trends in paid and incurred loss development;
|
|
•
|
trends in claim frequency and severity;
|
|
•
|
emerging economic and social trends;
|
|
•
|
trends in healthcare costs for claims involving bodily injury;
|
|
•
|
inflation and levels of employment; and
|
|
•
|
changes in the regulatory, legal and political environment.
|
|
|
|
Rating Agency
(1)
|
||||
|
|
|
A.M. Best
(www.ambest.com) |
|
Fitch
(www.fitchratings.com) |
|
Moody’s
(www.moodys.com) |
|
ProAssurance Indemnity Company, Inc.
|
|
A+ (Superior)
|
|
A (Strong)
|
|
A2
|
|
ProAssurance Casualty Company
|
|
A+ (Superior)
|
|
A (Strong)
|
|
A2
|
|
ProAssurance Specialty Insurance Company, Inc.
|
|
A+ (Superior)
|
|
A (Strong)
|
|
NR
|
|
Podiatry Insurance Company of America
|
|
A+ (Superior)
|
|
A (Strong)
|
|
A2
|
|
PACO Assurance Company, Inc.
|
|
A- (Excellent)
|
|
A (Strong)
|
|
NR
|
|
Noetic Specialty Insurance Company
|
|
A+ (Superior)
|
|
A (Strong)
|
|
NR
|
|
Medmarc Casualty Insurance Company
|
|
A+ (Superior)
|
|
A (Strong)
|
|
NR
|
|
Lloyd's Syndicate 1729 and Syndicate 6131
(2)
|
|
A (Excellent)
|
|
AA- (Strong)
|
|
NR
|
|
Eastern Alliance Insurance Company
|
|
A (Excellent)
|
|
A (Strong)
|
|
A3
|
|
Allied Eastern Indemnity Company
|
|
A (Excellent)
|
|
A (Strong)
|
|
A3
|
|
Eastern Advantage Assurance Company
|
|
A (Excellent)
|
|
A (Strong)
|
|
NR
|
|
Eastern Re Ltd., SPC
|
|
A (Excellent)
|
|
NR
|
|
NR
|
|
Inova Re Ltd., SPC
|
|
NR
|
|
NR
|
|
NR
|
|
(1)
NR indicates that the subsidiary has not been rated by the listed rating agency.
|
|
|
||||
|
(2)
Rating provided is the rating applicable to all Lloyd's syndicates.
|
|
|
||||
|
•
|
reliance on insurance and reinsurance brokers and distribution channels to distribute and market products;
|
|
•
|
obligation to pay levies to
Lloyd's
;
|
|
•
|
obligations to maintain funds to support underwriting activities and risk-based capital requirements that are assessed periodically by
Lloyd's
and subject to variation;
|
|
•
|
ability to maintain liquidity to fund claims payments, when due;
|
|
•
|
ability to obtain reinsurance and retrocessional coverage to protect against adverse loss activity;
|
|
•
|
reliance on ongoing approvals from
Lloyd's
and various regulators to conduct business, including a requirement that Annual Business Plans be approved by
Lloyd's
before the start of underwriting for each account year;
|
|
•
|
financial strength ratings are derived from the rating assigned to
Lloyd's
, although they have limited ability to directly affect the overall
Lloyd's
rating; and
|
|
•
|
reliance on
Lloyd's
trading licenses in order to underwrite business outside the
U.K.
|
|
•
|
licensing requirements;
|
|
•
|
trade practices;
|
|
•
|
capital and surplus requirements;
|
|
•
|
investment practices; and
|
|
•
|
rates charged to insurance customers.
|
|
ITEM 1B.
|
UNRESOLVED STAFF COMMENTS.
|
|
ITEM 2.
|
PROPERTIES.
|
|
|
|
Square Footage of Properties
|
|||||||
|
Property Location
|
|
Occupied by
ProAssurance |
|
Leased or Available
for Lease |
|
Total
|
|||
|
Birmingham, AL*
|
|
120,000
|
|
|
45,000
|
|
|
165,000
|
|
|
Franklin, TN
|
|
52,000
|
|
|
51,000
|
|
|
103,000
|
|
|
Okemos, MI
|
|
53,000
|
|
|
—
|
|
|
53,000
|
|
|
* Corporate Headquarters
|
|
|
|
|
|
|
|||
|
ITEM 3.
|
LEGAL PROCEEDINGS.
|
|
W. Stancil Starnes
|
|
Mr. Starnes was appointed as Chief Executive Officer in 2007 and has served as the Chairman of the Board since 2008. Mr. Starnes served as President of ProAssurance from 2012 to December 2018. Mr. Starnes previously served as President, Corporate Planning and Administration of Brasfield & Gorrie, Inc., a large national commercial contractor. Prior to 2006, Mr. Starnes served as the Senior and Managing Partner of the law firm of Starnes & Atchison, LLP, where he was extensively involved with ProAssurance and its predecessors in the defense of healthcare professional liability claims for over 25 years. Mr. Starnes served as a director of Infinity Property and Casualty Corporation, a public insurance holding company, from 2008 to May 2017 where he served on the Audit and Investment Committees. Mr. Starnes currently serves on the Board of Trustees for the University of Alabama. He also serves on the Board of Directors of National Commerce Corporation, located in Birmingham, Alabama, where he serves as Chairman of the Nominating and Corporate Governance Committee, Chairman of the Pricing Committee and is a member of the Compensation Committee. (Age 70)
|
|
|
|
|
|
Edward L. Rand, Jr.
|
|
Mr. Rand was appointed as Chief Operating Officer and President of ProAssurance in 2018. Mr. Rand was appointed as an Executive Vice President in 2014. Mr. Rand also has served as President of our Medmarc subsidiary since 2016. Mr. Rand has previously served as Chief Financial Officer and Senior Vice President of Finance. Prior to joining ProAssurance, Mr. Rand was the Chief Accounting Officer and Head of Corporate Finance for PartnerRe Ltd. Prior to that time Mr. Rand served as the Chief Financial Officer of Atlantic American Corporation. (Age 52)
|
|
|
|
|
|
Howard H. Friedman
|
|
Mr. Friedman was appointed as President of our Healthcare Professional Liability Group in 2014, and is also our Chief Underwriting Officer and Chief Actuary. Mr. Friedman has previously served as a Co-President of our Professional Liability Group, Chief Financial Officer, Corporate Secretary, and as the Senior Vice President of Corporate Development. Mr. Friedman joined our predecessor in 1996. Mr. Friedman is an Associate of the Casualty Actuarial Society and a member of the American Academy of Actuaries. (Age 60)
|
|
|
|
|
|
Dana S. Hendricks
|
|
Ms. Hendricks was appointed as our Chief Financial Officer in 2018. Ms. Hendricks has previously served as Senior Vice President of Business Operations for our PICA subsidiary. Prior to that time, Ms. Hendricks served PICA as Vice President of Finance and Corporate Controller. Prior to joining PICA in 2001, Ms. Hendricks held various finance and data analysis positions with American General Life & Accident Insurance Company. Ms. Hendricks is a Certified Public Accountant. (Age 51)
|
|
|
|
|
|
Jeffrey P. Lisenby
|
|
Mr. Lisenby was appointed as an Executive Vice President in 2014 and is also our General Counsel, Corporate Secretary and head of the corporate Legal Department. Mr. Lisenby has previously served as Senior Vice President. Prior to joining ProAssurance, Mr. Lisenby practiced law privately in Birmingham, Alabama. Mr. Lisenby is a member of the Alabama State Bar and the United States Supreme Court Bar and is a Chartered Property Casualty Underwriter. (Age 50)
|
|
|
|
|
|
Frank B. O’Neil
|
|
Mr. O’Neil was appointed as our Senior Vice President and Chief Communications Officer in 2001. Mr. O’Neil has previously served as our Senior Vice President of Corporate Communications, having joined our predecessor in 1987. (Age 65)
|
|
|
|
|
|
Michael L. Boguski
|
|
Mr. Boguski is President of our Eastern subsidiary. Prior to the acquisition of Eastern, Mr. Boguski served as President and Chief Executive Officer of Eastern, and first joined Eastern in 1997. (Age 56)
|
|
|
|
|
|
Ross E. Taubman
|
|
Dr. Taubman is President and Chief Medical Officer of our PICA subsidiary. Prior to joining PICA, Dr. Taubman practiced podiatry for 26 years. During that time, Dr. Taubman served as Treasurer, Vice-President and President of the Maryland Podiatric Medical Association. Dr. Taubman also served as President of The American Podiatric Medical Association (APMA) from 2008 through 2009, and served in a number of executive leadership positions for the APMA. Dr. Taubman is a diplomate in the American Board of Podiatric Surgery. (Age 61)
|
|
|
|
2018
|
|
2017
|
||||||||||||||||
|
Quarter
|
|
High
|
|
Low
|
|
High
|
|
Low
|
||||||||||||
|
First
|
|
$
|
56.00
|
|
|
|
$
|
47.35
|
|
|
|
$
|
61.85
|
|
|
|
$
|
53.90
|
|
|
|
Second
|
|
$
|
48.20
|
|
|
|
$
|
35.35
|
|
|
|
$
|
62.45
|
|
|
|
$
|
57.80
|
|
|
|
Third
|
|
$
|
49.40
|
|
|
|
$
|
35.50
|
|
|
|
$
|
61.80
|
|
|
|
$
|
51.30
|
|
|
|
Fourth
|
|
$
|
46.28
|
|
|
|
$
|
37.18
|
|
|
|
$
|
63.00
|
|
|
|
$
|
55.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
Dividends Declared
|
|
Dividends Paid
|
||||||||||||||||
|
Quarter
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||||||
|
First
|
|
$
|
0.31
|
|
|
|
$
|
0.31
|
|
|
|
$
|
5.00
|
|
|
|
$
|
5.00
|
|
|
|
Second
|
|
$
|
0.31
|
|
|
|
$
|
0.31
|
|
|
|
$
|
0.31
|
|
|
|
$
|
0.31
|
|
|
|
Third
|
|
$
|
0.31
|
|
|
|
$
|
0.31
|
|
|
|
$
|
0.31
|
|
|
|
$
|
0.31
|
|
|
|
Fourth*
|
|
$
|
0.81
|
|
|
|
$
|
5.00
|
|
|
|
$
|
0.31
|
|
|
|
$
|
0.31
|
|
|
|
Plan Category
|
|
Number of securities to be
issued upon exercise of outstanding options, warrants and rights |
|
Weighted-average
exercise price of outstanding options, warrants and rights |
|
Number of securities
remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) |
|
|
|
(a)
|
|
(b)
|
|
(c)
|
|
Equity compensation plans approved by security holders
|
|
582,409
|
|
$—
|
*
|
1,976,325
|
|
Equity compensation plans not approved by security holders
|
|
—
|
|
—
|
|
—
|
|
Period
|
|
Total Number of
Shares Purchased |
|
Average
Price Paid per Share |
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
|
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs* (In thousands)
|
|
October 1 - 31, 2018
|
|
—
|
|
N/A
|
|
—
|
|
$109,643
|
|
November 1 - 30, 2018
|
|
—
|
|
N/A
|
|
—
|
|
$109,643
|
|
December 1 - 31, 2018
|
|
—
|
|
N/A
|
|
—
|
|
$109,643
|
|
Total
|
|
—
|
|
$—
|
|
—
|
|
|
|
|
|
Year Ended December 31
|
||||||||||||||||||
|
($ in thousands, except per share data)
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
||||||||||
|
Selected Financial Data
|
|
|
||||||||||||||||||
|
Gross premiums written
|
|
$
|
957,311
|
|
|
$
|
874,876
|
|
|
$
|
835,014
|
|
|
$
|
812,218
|
|
|
$
|
779,609
|
|
|
Net premiums earned
|
|
$
|
818,853
|
|
|
$
|
738,531
|
|
|
$
|
733,281
|
|
|
$
|
694,149
|
|
|
$
|
699,731
|
|
|
Net investment income
|
|
$
|
91,884
|
|
|
$
|
95,662
|
|
|
$
|
100,012
|
|
|
$
|
108,660
|
|
|
$
|
125,557
|
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
|
$
|
8,948
|
|
|
$
|
8,033
|
|
|
$
|
(5,762
|
)
|
|
$
|
3,682
|
|
|
$
|
3,986
|
|
|
Net realized investment gains (losses)
|
|
$
|
(43,488
|
)
|
|
$
|
16,409
|
|
|
$
|
34,875
|
|
|
$
|
(41,639
|
)
|
|
$
|
14,654
|
|
|
Other income
|
|
$
|
9,833
|
|
|
$
|
7,514
|
|
|
$
|
7,808
|
|
|
$
|
7,227
|
|
|
$
|
8,398
|
|
|
Total revenues
|
|
$
|
886,030
|
|
|
$
|
866,149
|
|
|
$
|
870,214
|
|
|
$
|
772,079
|
|
|
$
|
852,326
|
|
|
Net losses and loss adjustment expenses
|
|
$
|
593,210
|
|
|
$
|
469,158
|
|
|
$
|
443,229
|
|
|
$
|
410,711
|
|
|
$
|
363,084
|
|
|
Net income
|
|
$
|
47,057
|
|
|
$
|
107,264
|
|
|
$
|
151,081
|
|
|
$
|
116,197
|
|
|
$
|
196,565
|
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Basic
|
|
$
|
0.88
|
|
|
$
|
2.01
|
|
|
$
|
2.84
|
|
|
$
|
2.12
|
|
|
$
|
3.32
|
|
|
Diluted
|
|
$
|
0.88
|
|
|
$
|
2.00
|
|
|
$
|
2.83
|
|
|
$
|
2.11
|
|
|
$
|
3.30
|
|
|
Weighted average shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Basic
|
|
53,598
|
|
|
53,393
|
|
|
53,216
|
|
|
54,795
|
|
|
59,285
|
|
|||||
|
Diluted
|
|
53,749
|
|
|
53,611
|
|
|
53,448
|
|
|
55,017
|
|
|
59,525
|
|
|||||
|
Balance Sheet Data, as of December 31
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Total investments
|
|
$
|
3,349,382
|
|
|
$
|
3,686,528
|
|
|
$
|
3,925,696
|
|
|
$
|
3,650,130
|
|
|
$
|
4,009,707
|
|
|
Total assets
(1)
|
|
$
|
4,600,726
|
|
|
$
|
4,929,197
|
|
|
$
|
5,065,181
|
|
|
$
|
4,906,021
|
|
|
$
|
5,167,375
|
|
|
Reserve for losses and loss adjustment expenses
|
|
$
|
2,119,847
|
|
|
$
|
2,048,381
|
|
|
$
|
1,993,428
|
|
|
$
|
2,005,326
|
|
|
$
|
2,058,266
|
|
|
Debt less debt issuance costs
(1)
|
|
$
|
287,757
|
|
|
$
|
411,811
|
|
|
$
|
448,202
|
|
|
$
|
347,858
|
|
|
$
|
248,215
|
|
|
Total liabilities
(1)
|
|
$
|
3,077,724
|
|
|
$
|
3,334,402
|
|
|
$
|
3,266,479
|
|
|
$
|
2,947,667
|
|
|
$
|
3,009,431
|
|
|
Total capital
|
|
$
|
1,523,002
|
|
|
$
|
1,594,795
|
|
|
$
|
1,798,702
|
|
|
$
|
1,958,354
|
|
|
$
|
2,157,944
|
|
|
Total capital per share of common stock outstanding
|
|
$
|
28.39
|
|
|
$
|
29.83
|
|
|
$
|
33.78
|
|
|
$
|
36.88
|
|
|
$
|
38.17
|
|
|
Common stock outstanding, period end
|
|
53,637
|
|
|
53,457
|
|
|
53,251
|
|
|
53,101
|
|
|
56,534
|
|
|||||
|
•
|
Specialty P&C
- This segment includes our professional liability business and medical technology liability business. Professional liability insurance is primarily offered to healthcare providers and institutions and, to a lesser extent, to attorneys and their firms. Medical technology liability insurance is offered to medical technology and life sciences companies that manufacture or distribute products including entities conducting human clinical trials. The underwriting results of SPCs that assume healthcare professional liability business were previously reported in this segment and are now reported in our Segregated Portfolio Cell Reinsurance segment.
|
|
•
|
Workers' Compensation Insurance
- This segment includes our workers' compensation insurance business which is provided primarily to employers with 1,000 or fewer employees. Our workers' compensation products include guaranteed cost, policyholder dividend policies, retrospectively-rated policies, deductible policies and alternative market solutions. The underwriting results of SPCs that assume workers’ compensation business were previously reported in this segment and are now reported in our Segregated Portfolio Cell Reinsurance segment.
|
|
•
|
Segregated Portfolio Cell Reinsurance
- This segment reflects the operating results (underwriting profit or loss, plus investment results) of
SPC
s at
Eastern Re
and
Inova Re
, our Cayman Islands
SPC
operations. The
SPC
s assume workers' compensation insurance, healthcare professional liability insurance or a combination of the two from our Workers' Compensation Insurance and
Specialty P&C
segments.
|
|
•
|
Lloyd's
Syndicates
- This segment includes the operating results from our participation (
62%
for 2018) in
Lloyd's
of London
Syndicate 1729
and our
100%
participation in
Syndicate 6131
, which is a SPA that began writing business effective January 1, 2018. For the
2019
underwriting year, we slightly decreased our participation in the operating results of
Syndicate 1729
from
62%
to
61%
. The results of this segment are normally reported on a quarter delay, except when information is available that is material to the current period.
Syndicate 1729
underwrites risks over a wide range of property and casualty insurance and reinsurance lines in both the U.S. and international markets while
Syndicate 6131
focuses on contingency and specialty property business, also within the U.S. and international markets.
|
|
•
|
Corporate
- This segment includes our investment operations, other than those reported in our Segregated Portfolio Cell Reinsurance and Lloyd's Syndicates segments, interest expense and U.S. income taxes. The results of investment assets solely allocated to
SPC
operations were previously reported in this segment and are now reported in our Segregated Portfolio Cell Reinsurance segment. This segment also includes non-premium revenues generated outside of our insurance entities and corporate expenses.
|
|
•
|
The
net loss ratio
which is calculated as net losses incurred divided by net premiums earned and is a component of underwriting profitability.
|
|
•
|
The
underwriting expense ratio
which is calculated as underwriting, policy acquisition and operating expenses incurred divided by net premiums earned and is a component of underwriting profitability.
|
|
•
|
The
combined ratio
which is the sum of the net loss ratio and the underwriting expense ratio and measures underwriting profitability.
|
|
•
|
The
investment income ratio
which is calculated as net investment income divided by net premiums earned and measures the contribution investment earnings provide to our overall profitability.
|
|
•
|
The
operating ratio
which is the combined ratio, less the investment income ratio. This ratio provides the combined effect of underwriting profitability and investment income.
|
|
•
|
The
tax ratio
which is calculated as total income tax expense divided by income (loss) before income taxes and measures our effective tax rate.
|
|
•
|
ROE
which is calculated as net income divided by the average of beginning and ending shareholders’ equity. This ratio measures our overall after-tax profitability and shows how efficiently capital is being used.
|
|
•
|
Book value per share
which is calculated as total shareholders’ equity at the balance sheet date divided by the total number of common shares outstanding. This ratio measures the net worth of the company to shareholders on a per-share basis. The declaration of dividends decreases book value per share. Growth in book value per share, adjusted for dividends declared, is an indicator of overall profitability.
|
|
•
|
Bornhuetter-Ferguson (Paid and Reported) Method
|
|
•
|
Paid Development Method
|
|
•
|
Reported Development Method
|
|
•
|
Average Paid Value Method
|
|
•
|
Average Reported Value Method
|
|
•
|
Backward Recursive Development Method
|
|
•
|
The Adjusted Reported and the Adjusted Paid Methods
|
|
($ in thousands)
|
|
|
2018
|
|
2017
|
|
2016
|
|||||||||||||||||
|
Accident Years
|
Estimated Ultimate Losses, Net of Reinsurance, December 31, 2018
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|||||||||||
|
2018
|
$
|
447,267
|
|
|
N/A
|
|
|
18.0
|
%
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
|||
|
2017
|
$
|
403,256
|
|
|
$
|
13,637
|
|
|
46.4
|
%
|
|
N/A
|
|
|
20.4
|
%
|
|
N/A
|
|
|
N/A
|
|
||
|
2016
|
$
|
403,185
|
|
|
$
|
10,648
|
|
|
66.4
|
%
|
|
$
|
3,413
|
|
|
48.2
|
%
|
|
N/A
|
|
|
17.6
|
%
|
|
|
2015
|
$
|
395,158
|
|
|
$
|
(1,268
|
)
|
|
80.8
|
%
|
|
$
|
1,510
|
|
|
68.7
|
%
|
|
$
|
304
|
|
|
47.5
|
%
|
|
2014
|
$
|
352,845
|
|
|
$
|
(16,627
|
)
|
|
89.4
|
%
|
|
$
|
(15,782
|
)
|
|
82.3
|
%
|
|
$
|
(11,358
|
)
|
|
71.8
|
%
|
|
2013
|
$
|
371,888
|
|
|
$
|
(20,398
|
)
|
|
94.7
|
%
|
|
$
|
(23,164
|
)
|
|
90.4
|
%
|
|
$
|
(10,501
|
)
|
|
83.4
|
%
|
|
2012
|
$
|
388,945
|
|
|
$
|
(13,403
|
)
|
|
97.4
|
%
|
|
$
|
(17,187
|
)
|
|
95.3
|
%
|
|
$
|
(24,988
|
)
|
|
92.0
|
%
|
|
2011
|
$
|
377,782
|
|
|
$
|
(13,940
|
)
|
|
97.8
|
%
|
|
$
|
(18,277
|
)
|
|
96.4
|
%
|
|
$
|
(15,977
|
)
|
|
94.0
|
%
|
|
2010
|
$
|
380,469
|
|
|
$
|
(4,268
|
)
|
|
99.1
|
%
|
|
$
|
(17,224
|
)
|
|
98.7
|
%
|
|
$
|
(14,532
|
)
|
|
97.6
|
%
|
|
2009
|
$
|
335,851
|
|
|
$
|
(5,558
|
)
|
|
99.5
|
%
|
|
$
|
(8,380
|
)
|
|
99.0
|
%
|
|
$
|
(19,920
|
)
|
|
98.4
|
%
|
|
Prior to 2009
|
$
|
7,209,070
|
|
|
$
|
(12,616
|
)
|
|
|
|
$
|
(14,128
|
)
|
|
|
|
$
|
(28,674
|
)
|
|
|
|||
|
($ in millions)
|
2018
|
|
2017
|
|
2016
|
||||||
|
Prior accident years
|
2015-2017
|
|
2014-2016
|
|
2013-2015
|
||||||
|
Net favorable (unfavorable) development recognized for the specified years
|
$
|
(23.0
|
)
|
|
$
|
10.9
|
|
|
$
|
21.6
|
|
|
Development as a % of established ultimates, prior calendar year end
|
(2.0
|
%)
|
|
0.9
|
%
|
|
2.3
|
%
|
|||
|
($ in thousands)
|
|
|
2018
|
|
2017
|
|
2016
|
|||||||||||||||||
|
Accident Years
|
Estimated Ultimate Losses, Net of Reinsurance, December 31, 2018
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|||||||||||
|
2018
|
$
|
14,105
|
|
|
N/A
|
|
|
52.4
|
%
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
|||
|
2017
|
$
|
14,228
|
|
|
$
|
(695
|
)
|
|
72.2
|
%
|
|
N/A
|
|
|
42.2
|
%
|
|
N/A
|
|
|
N/A
|
|
||
|
2016
|
$
|
12,473
|
|
|
$
|
(1,114
|
)
|
|
62.8
|
%
|
|
$
|
(537
|
)
|
|
53.3
|
%
|
|
N/A
|
|
|
26.4
|
%
|
|
|
2015
|
$
|
10,832
|
|
|
$
|
(1,511
|
)
|
|
64.6
|
%
|
|
$
|
(1,755
|
)
|
|
79.5
|
%
|
|
$
|
(440
|
)
|
|
60.0
|
%
|
|
2014
|
$
|
11,971
|
|
|
$
|
(1,526
|
)
|
|
93.2
|
%
|
|
$
|
(187
|
)
|
|
92.5
|
%
|
|
$
|
(845
|
)
|
|
81.7
|
%
|
|
2013
|
$
|
5,312
|
|
|
$
|
(1,526
|
)
|
|
98.7
|
%
|
|
$
|
(2,622
|
)
|
|
96.4
|
%
|
|
$
|
(2,400
|
)
|
|
87.7
|
%
|
|
2012
|
$
|
9,867
|
|
|
$
|
585
|
|
|
98.8
|
%
|
|
$
|
(1,251
|
)
|
|
96.9
|
%
|
|
$
|
(1,826
|
)
|
|
90.5
|
%
|
|
2011
|
$
|
9,608
|
|
|
$
|
(5,273
|
)
|
|
99.8
|
%
|
|
$
|
92
|
|
|
73.9
|
%
|
|
$
|
(1,591
|
)
|
|
72.0
|
%
|
|
2010
|
$
|
24,330
|
|
|
$
|
1,449
|
|
|
99.6
|
%
|
|
$
|
(1,385
|
)
|
|
96.3
|
%
|
|
$
|
(800
|
)
|
|
90.6
|
%
|
|
2009
|
$
|
20,876
|
|
|
$
|
(753
|
)
|
|
99.7
|
%
|
|
$
|
(1,178
|
)
|
|
95.7
|
%
|
|
$
|
(1,382
|
)
|
|
92.2
|
%
|
|
Prior to 2009
|
$
|
534,144
|
|
|
$
|
(2,927
|
)
|
|
|
|
$
|
(1,250
|
)
|
|
|
|
$
|
(2,229
|
)
|
|
|
|||
|
($ in thousands)
|
|
|
2018
|
|
2017
|
|
2016
|
||||||||||||||||
|
Accident Years
|
Estimated Ultimate Losses, Net of Reinsurance, December 31, 2017
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|
Reserve Development (favorable) unfavorable
|
% of Known Claims Closed
|
|||||||||||
|
2018
|
$
|
139,426
|
|
|
N/A
|
|
|
40.0
|
%
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
N/A
|
|
|||
|
2017
|
$
|
138,468
|
|
|
$
|
(4,203
|
)
|
|
80.8
|
%
|
|
N/A
|
|
|
37.0
|
%
|
|
N/A
|
|
N/A
|
|
||
|
2016
|
$
|
123,146
|
|
|
$
|
(8,257
|
)
|
|
91.8
|
%
|
|
$
|
(7,546
|
)
|
|
82.5
|
%
|
|
N/A
|
|
41.3
|
%
|
|
|
2015
|
$
|
125,202
|
|
|
$
|
(1,998
|
)
|
|
95.3
|
%
|
|
$
|
(5,773
|
)
|
|
92.4
|
%
|
|
$
|
(3,452
|
)
|
82.6
|
%
|
|
2014
|
$
|
121,310
|
|
|
$
|
(92
|
)
|
|
98.4
|
%
|
|
$
|
(1,428
|
)
|
|
97.0
|
%
|
|
$
|
77
|
|
92.5
|
%
|
|
2013
|
$
|
113,293
|
|
|
$
|
(227
|
)
|
|
99.2
|
%
|
|
$
|
441
|
|
|
98.3
|
%
|
|
$
|
944
|
|
97.1
|
%
|
|
2012
|
$
|
94,875
|
|
|
$
|
(565
|
)
|
|
99.5
|
%
|
|
$
|
(308
|
)
|
|
99.3
|
%
|
|
$
|
(577
|
)
|
98.4
|
%
|
|
2011
|
$
|
91,101
|
|
|
$
|
(60
|
)
|
|
99.3
|
%
|
|
$
|
241
|
|
|
99.0
|
%
|
|
$
|
156
|
|
98.9
|
%
|
|
2010
|
$
|
71,824
|
|
|
$
|
(54
|
)
|
|
99.4
|
%
|
|
$
|
(42
|
)
|
|
99.4
|
%
|
|
$
|
(820
|
)
|
99.3
|
%
|
|
Prior to 2010
|
$
|
401,859
|
|
|
$
|
(11
|
)
|
|
|
|
$
|
1,710
|
|
|
|
|
$
|
(782
|
)
|
|
|||
|
|
Low End Point
|
|
Carried Net Reserve
|
|
High End Point
|
|
80% Confidence Level
|
$1.392 billion
|
|
$1.776 billion
|
|
$2.227 billion
|
|
60% Confidence Level
|
$1.497 billion
|
|
$1.776 billion
|
|
$2.030 billion
|
|
|
Distribution by GAAP Fair Value Hierarchy
|
|
|
|
|
||||
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Not Categorized
|
|
Total
Investments |
|
Investments recorded at:
|
|
|
|
|
|
|
|
|
|
|
Fair value
|
20%
|
|
65%
|
|
1%
|
|
9%
|
|
95%
|
|
Other valuations
|
|
|
|
|
|
|
|
|
5%
|
|
Total Investments
|
|
|
|
|
|
|
|
|
100%
|
|
(In millions)
|
Carrying Value
|
|
GAAP Measurement Method
|
||
|
Other investments:
|
|
|
|
||
|
Other, principally FHLB capital stock
|
$
|
2.9
|
|
|
Principally Cost
|
|
Investment in unconsolidated subsidiaries:
|
|
|
|
||
|
Investments in tax credit partnerships
|
69.4
|
|
|
Equity
|
|
|
Equity method investments, primarily LPs/LLCs
|
29.9
|
|
|
Equity
|
|
|
|
99.3
|
|
|
|
|
|
BOLI
|
64.1
|
|
|
Cash surrender value
|
|
|
Total investments - Other valuation methodologies
|
$
|
166.3
|
|
|
|
|
•
|
if there is intent to sell the security;
|
|
•
|
if it is more likely than not that the security will be required to be sold before full recovery of its amortized cost basis; or
|
|
•
|
if the entire amortized basis of the security is not expected to be recovered.
|
|
•
|
third-party research and credit rating reports;
|
|
•
|
the current credit standing of the issuer, including credit rating downgrades, whether before or after the balance sheet date;
|
|
•
|
the extent to which the decline in fair value is attributable to credit risk specifically associated with the security or its issuer;
|
|
•
|
internal assessments and the assessments of external portfolio managers regarding specific circumstances surrounding an investment, which indicate the investment is more or less likely to recover its amortized cost than other investments with a similar structure;
|
|
•
|
for asset-backed securities, the origination date of the underlying loans, the remaining average life, the probability that credit performance of the underlying loans will deteriorate in the future, and our assessment of the quality of the collateral underlying the loan;
|
|
•
|
failure of the issuer of the security to make scheduled interest or principal payments;
|
|
•
|
any changes to the rating of the security by a rating agency; and
|
|
•
|
recoveries or additional declines in fair value subsequent to the balance sheet date.
|
|
•
|
our ability and intent to hold the investment until the recovery of its carrying value; and
|
|
•
|
in situations where there was not a previous
OTTI
for the investment, whether the current expected cash flows from the investment, primarily tax benefits, are less than those expected at the time the investment was acquired due to various factors, such as a change in the statutory tax rate; or
|
|
•
|
in situations where there was a previous
OTTI
for the investment, whether the expected cash flows from the investment at the time of the
OTTI
, primarily tax benefits, are less than its current carrying value.
|
|
|
Year Ended December 31
|
||||||||||
|
(In thousands)
|
2018
|
|
2017
|
|
Change
|
||||||
|
Net cash provided (used) by:
|
|
|
|
|
|
||||||
|
Operating activities
|
$
|
177,265
|
|
|
$
|
173,388
|
|
|
$
|
3,877
|
|
|
Investing activities
|
214,897
|
|
|
200,275
|
|
|
14,622
|
|
|||
|
Financing activities
|
(446,186
|
)
|
|
(356,515
|
)
|
|
(89,671
|
)
|
|||
|
Increase (decrease) in cash and cash equivalents
|
$
|
(54,024
|
)
|
|
$
|
17,148
|
|
|
$
|
(71,172
|
)
|
|
|
Year Ended December 31
|
||||||||||
|
(In thousands)
|
2017
|
|
2016
|
|
Change
|
||||||
|
Net cash provided (used) by:
|
|
|
|
|
|
||||||
|
Operating activities
|
$
|
173,388
|
|
|
$
|
178,983
|
|
|
$
|
(5,595
|
)
|
|
Investing activities
|
200,275
|
|
|
(288,802
|
)
|
|
489,077
|
|
|||
|
Financing activities
|
(356,515
|
)
|
|
(13,934
|
)
|
|
(342,581
|
)
|
|||
|
Increase (decrease) in cash and cash equivalents
|
$
|
17,148
|
|
|
$
|
(123,753
|
)
|
|
$
|
140,901
|
|
|
|
Year Ended December 31
|
||||||||||
|
(In thousands)
|
2016
|
|
2015
|
|
Change
|
||||||
|
Net cash provided (used) by:
|
|
|
|
|
|
||||||
|
Operating activities
|
$
|
178,983
|
|
|
$
|
139,141
|
|
|
$
|
39,842
|
|
|
Investing activities
|
(288,802
|
)
|
|
199,770
|
|
|
(488,572
|
)
|
|||
|
Financing activities
|
(13,934
|
)
|
|
(294,851
|
)
|
|
280,917
|
|
|||
|
Increase (decrease) in cash and cash equivalents
|
$
|
(123,753
|
)
|
|
$
|
44,060
|
|
|
$
|
(167,813
|
)
|
|
•
|
The line entitled “Reserve for losses, undiscounted and net of reinsurance recoverables” reflects our reserve for losses and loss adjustment expense, less the receivables from reinsurers, each as reported in our consolidated financial statements at the end of each year (the Balance Sheet Reserves).
|
|
•
|
The section entitled “Cumulative net paid, as of” reflects the cumulative amounts paid as of the end of each succeeding year with respect to the previously recorded Balance Sheet Reserves.
|
|
•
|
The section entitled “Re-estimated net liability as of” reflects the re-estimated amount of the liability previously recorded as Balance Sheet Reserves that includes the cumulative amounts paid and an estimate of the remaining net liability based upon claims experience as of the end of each succeeding year (the Net Re-estimated Liability).
|
|
•
|
The line entitled “Net cumulative redundancy (deficiency)” reflects the difference between the previously recorded Balance Sheet Reserve for each applicable year and the Net Re-estimated Liability relating thereto as of the end of the most recent fiscal year.
|
|
Analysis of Reserve Development
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
December 31
|
||||||||||||||||||||||||||||||||||||||||||
|
(In thousands)
|
2008
|
|
2009
|
|
2010
|
|
2011
|
|
2012
|
|
2013
|
|
2014
|
|
2015
|
|
2016
|
|
2017
|
|
2018
|
||||||||||||||||||||||
|
Reserve for losses, undiscounted and net of reinsurance recoverables
|
$
|
2,111,112
|
|
|
$
|
2,159,571
|
|
|
$
|
2,136,664
|
|
|
$
|
2,000,114
|
|
|
$
|
1,860,076
|
|
|
$
|
1,825,304
|
|
|
$
|
1,820,300
|
|
|
$
|
1,755,976
|
|
|
$
|
1,719,953
|
|
|
$
|
1,712,796
|
|
|
$
|
1,776,027
|
|
|
Cumulative net paid, as of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
|
One Year Later
|
278,655
|
|
|
291,654
|
|
|
264,597
|
|
|
300,703
|
|
|
311,835
|
|
|
343,197
|
|
|
390,849
|
|
|
383,062
|
|
|
369,682
|
|
|
412,711
|
|
|
|
||||||||||||
|
Two Years Later
|
468,277
|
|
|
476,682
|
|
|
491,657
|
|
|
526,903
|
|
|
563,805
|
|
|
571,690
|
|
|
646,878
|
|
|
633,246
|
|
|
644,422
|
|
|
|
|
|
|||||||||||||
|
Three Years Later
|
584,410
|
|
|
614,369
|
|
|
639,220
|
|
|
682,576
|
|
|
704,795
|
|
|
732,892
|
|
|
804,624
|
|
|
818,102
|
|
|
|
|
|
|
|
||||||||||||||
|
Four Years Later
|
666,105
|
|
|
706,091
|
|
|
737,253
|
|
|
763,703
|
|
|
800,189
|
|
|
826,384
|
|
|
917,236
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
Five Years Later
|
724,377
|
|
|
761,659
|
|
|
789,965
|
|
|
821,742
|
|
|
852,873
|
|
|
891,615
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Six Years Later
|
758,863
|
|
|
793,528
|
|
|
828,043
|
|
|
852,119
|
|
|
893,529
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Seven Years Later
|
778,795
|
|
|
811,333
|
|
|
844,810
|
|
|
876,840
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Eight Years Later
|
790,950
|
|
|
821,435
|
|
|
859,561
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
|
Nine Years Later
|
796,125
|
|
|
829,217
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
Ten Years Later
|
798,022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Re-estimated net liability as of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
|
End of Year
|
2,111,112
|
|
|
2,159,571
|
|
|
2,136,664
|
|
|
2,000,114
|
|
|
1,860,076
|
|
|
1,825,304
|
|
|
1,820,300
|
|
|
1,755,976
|
|
|
1,719,953
|
|
|
1,712,796
|
|
|
|
||||||||||||
|
One Year Later
|
1,903,812
|
|
|
1,925,581
|
|
|
1,810,799
|
|
|
1,728,076
|
|
|
1,644,203
|
|
|
1,644,516
|
|
|
1,659,120
|
|
|
1,612,198
|
|
|
1,612,198
|
|
|
1,620,680
|
|
|
|
||||||||||||
|
Two Years Later
|
1,665,832
|
|
|
1,615,603
|
|
|
1,543,650
|
|
|
1,498,158
|
|
|
1,472,259
|
|
|
1,483,378
|
|
|
1,519,078
|
|
|
1,485,357
|
|
|
1,481,292
|
|
|
|
|
|
|||||||||||||
|
Three Years Later
|
1,383,189
|
|
|
1,362,538
|
|
|
1,324,906
|
|
|
1,342,996
|
|
|
1,331,828
|
|
|
1,358,560
|
|
|
1,396,130
|
|
|
1,380,687
|
|
|
|
|
|
|
|
||||||||||||||
|
Four Years Later
|
1,154,552
|
|
|
1,172,091
|
|
|
1,205,737
|
|
|
1,224,597
|
|
|
1,231,337
|
|
|
1,252,605
|
|
|
1,296,074
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
Five Years Later
|
1,019,407
|
|
|
1,086,027
|
|
|
1,111,591
|
|
|
1,148,793
|
|
|
1,157,493
|
|
|
1,173,975
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Six Years Later
|
961,808
|
|
|
1,012,597
|
|
|
1,050,549
|
|
|
1,091,646
|
|
|
1,108,716
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Seven Years Later
|
915,935
|
|
|
961,987
|
|
|
1,010,802
|
|
|
1,056,053
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Eight Years Later
|
885,698
|
|
|
940,035
|
|
|
988,980
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
|
Nine Years Later
|
871,466
|
|
|
919,089
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
Ten Years Later
|
855,145
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
|
Net cumulative redundancy (deficiency)
|
$
|
1,255,967
|
|
|
$
|
1,240,482
|
|
|
$
|
1,147,684
|
|
|
$
|
944,061
|
|
|
$
|
751,360
|
|
|
$
|
651,329
|
|
|
$
|
524,226
|
|
|
$
|
375,289
|
|
|
$
|
238,661
|
|
|
$
|
92,116
|
|
|
|
||
|
Original gross liability - end of year
|
$
|
2,379,468
|
|
|
$
|
2,422,230
|
|
|
$
|
2,414,100
|
|
|
$
|
2,247,772
|
|
|
$
|
2,051,428
|
|
|
$
|
2,072,822
|
|
|
$
|
2,058,266
|
|
|
$
|
2,005,326
|
|
|
$
|
1,993,428
|
|
|
$
|
2,048,381
|
|
|
|
||
|
Reinsurance recoverables
|
(268,356
|
)
|
|
(262,659
|
)
|
|
(277,436
|
)
|
|
(247,658
|
)
|
|
(191,352
|
)
|
|
(247,518
|
)
|
|
(237,966
|
)
|
|
(249,350
|
)
|
|
(273,475
|
)
|
|
(335,585
|
)
|
|
|
||||||||||||
|
Original net liability - end of year
|
$
|
2,111,112
|
|
|
$
|
2,159,571
|
|
|
$
|
2,136,664
|
|
|
$
|
2,000,114
|
|
|
$
|
1,860,076
|
|
|
$
|
1,825,304
|
|
|
$
|
1,820,300
|
|
|
$
|
1,755,976
|
|
|
$
|
1,719,953
|
|
|
$
|
1,712,796
|
|
|
|
||
|
Gross re-estimated liability - latest
|
$
|
1,002,251
|
|
|
$
|
1,049,576
|
|
|
$
|
1,122,573
|
|
|
$
|
1,195,275
|
|
|
$
|
1,245,263
|
|
|
$
|
1,338,250
|
|
|
$
|
1,483,540
|
|
|
$
|
1,598,594
|
|
|
$
|
1,730,277
|
|
|
$
|
1,937,847
|
|
|
|
||
|
Re-estimated reinsurance recoverables
|
(147,106
|
)
|
|
(130,487
|
)
|
|
(133,593
|
)
|
|
(139,222
|
)
|
|
(136,547
|
)
|
|
(164,275
|
)
|
|
(187,466
|
)
|
|
(217,907
|
)
|
|
(248,985
|
)
|
|
(317,167
|
)
|
|
|
||||||||||||
|
Net re-estimated liability - latest
|
$
|
855,145
|
|
|
$
|
919,089
|
|
|
$
|
988,980
|
|
|
$
|
1,056,053
|
|
|
$
|
1,108,716
|
|
|
$
|
1,173,975
|
|
|
$
|
1,296,074
|
|
|
$
|
1,380,687
|
|
|
$
|
1,481,292
|
|
|
$
|
1,620,680
|
|
|
|
||
|
Gross cumulative redundancy (deficiency)
|
$
|
1,377,217
|
|
|
$
|
1,372,654
|
|
|
$
|
1,291,527
|
|
|
$
|
1,052,497
|
|
|
$
|
806,165
|
|
|
$
|
734,572
|
|
|
$
|
574,726
|
|
|
$
|
406,732
|
|
|
$
|
263,151
|
|
|
$
|
110,534
|
|
|
|
||
|
•
|
Reserves for 2009 and thereafter include gross and net reserves acquired in 2009 business combinations of
$169.4 million
and
$163.9 million
, respectively.
|
|
•
|
Reserves for 2010 and thereafter include gross and net reserves acquired in 2010 business combinations of
$88.1 million
and
$82.2 million
, respectively.
|
|
•
|
Reserves for 2012 and thereafter include gross and net reserves acquired in 2012 business combinations of
$21.8 million
and
$19.2 million
, respectively, which considers reductions of
$3.6 million
and
$3.3 million
, respectively, recorded in 2013 due to the re-estimation of the fair value of the acquired reserves.
|
|
•
|
Reserves for 2013 include gross and net reserves acquired in 2013 business combinations of
$201.1 million
and
$126.0 million
, respectively.
|
|
•
|
Reserves for 2014 include gross and net reserves acquired in 2014 business combinations of
$153.2 million
and
$139.5 million
, respectively.
|
|
•
|
The
HCPL
legal environment deteriorated in the late 1990’s and severity began to increase at a greater pace than anticipated in our rates and reserve estimates. We addressed the adverse severity trends through increased rates, stricter underwriting and modifications to claims handling procedures, and reflected this adverse severity trend when we established our initial reserves for subsequent years.
|
|
•
|
These adverse severity trends later moderated, with that moderation becoming more pronounced beginning in 2009. We have been cautious in giving full recognition to indications that the pace of severity increase had slowed, however we have given measured recognition of the improved trend in our reserve estimates, as discussed more fully under the heading “Reserve for Losses and Loss Adjustment Expenses" in the Critical Accounting Estimates section (reserve for losses or reserve). The favorable development was most pronounced for years 2004 to 2008, as the initial reserves for these accident years were established prior to substantial indication that severity trends were moderating. We have given stronger recognition to the lower severity trend as time has elapsed and a greater percentage of claims have closed.
|
|
•
|
A general decline in claim frequency has also been a contributor to favorable loss development. A significant portion of our policies through 2003 were issued on an occurrence basis, and a smaller portion of our ongoing business results from the issuance of extended reporting endorsements which have occurrence-like exposure. As claim frequency declined, the number of reported claims related to these coverages was less than originally expected.
|
|
•
|
In 2017, we became concerned again around potential higher severity trends in HCPL business and began to reflect this concern in our case reserve estimates for both 2017 and 2018. This concern was also reflected in more conservative estimates of ultimate losses for open claims for earlier accident years. Furthermore, we are responding to these initial loss indications by seeking rate increases where we believe appropriate and maintaining our underwriting discipline.
|
|
|
Year Ended December 31
|
||||||||||
|
(In thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
|
Balance, beginning of year
|
$
|
2,048,381
|
|
|
$
|
1,993,428
|
|
|
$
|
2,005,326
|
|
|
Less reinsurance recoverables on unpaid losses and loss adjustment expenses
|
335,585
|
|
|
273,475
|
|
|
249,350
|
|
|||
|
Net balance, beginning of year
|
1,712,796
|
|
|
1,719,953
|
|
|
1,755,976
|
|
|||
|
Net losses:
|
|
|
|
|
|
||||||
|
Current year
|
685,326
|
|
|
603,518
|
|
|
587,007
|
|
|||
|
Favorable development of reserves established in prior years, net
|
(92,116
|
)
|
|
(134,360
|
)
|
|
(143,778
|
)
|
|||
|
Total
|
593,210
|
|
|
469,158
|
|
|
443,229
|
|
|||
|
Paid related to:
|
|
|
|
|
|
||||||
|
Current year
|
(117,268
|
)
|
|
(106,633
|
)
|
|
(96,190
|
)
|
|||
|
Prior years
|
(412,711
|
)
|
|
(369,682
|
)
|
|
(383,062
|
)
|
|||
|
Total paid
|
(529,979
|
)
|
|
(476,315
|
)
|
|
(479,252
|
)
|
|||
|
Net balance, end of year
|
1,776,027
|
|
|
1,712,796
|
|
|
1,719,953
|
|
|||
|
Plus reinsurance recoverables on unpaid losses and loss adjustment expenses
|
343,820
|
|
|
335,585
|
|
|
273,475
|
|
|||
|
Balance, end of year
|
$
|
2,119,847
|
|
|
$
|
2,048,381
|
|
|
$
|
1,993,428
|
|
|
|
Healthcare
Professional Liability
|
|
Medical Technology &
Life Sciences Products
|
|
Workers'
Compensation - Traditional
|
|
Per Occurrence Coverage
|
|
Aggregate Coverage
(1)
|
|
•
|
Reinsurance is utilized on a per risk basis for the property insurance and casualty coverages in order to mitigate risk volatility.
|
|
•
|
Catastrophic protection is utilized on both our property insurance and casualty coverages to protect against losses in excess of policy limits as well as natural catastrophes.
|
|
•
|
Both quota share reinsurance and excess of loss reinsurance are utilized to manage the net loss exposure on our property reinsurance coverages.
|
|
•
|
Property umbrella excess of loss reinsurance is utilized for peak catastrophe and frequency of catastrophe exposures.
|
|
•
|
External excess of loss reinsurance is utilized by
Syndicate 1729
to manage the net loss exposure on the specialty property and contingency coverages ceded to
Syndicate 6131
(see further discussion in Segment Operating Results - Lloyd’s Syndicates section that follows).
|
|
|
December 31, 2018
|
|
December 31, 2017
|
||||||||
|
($ in thousands)
|
Carrying
Value |
% of Total Investment
|
|
Carrying
Value |
% of Total Investment
|
||||||
|
Fixed maturities, available for sale:
|
|
|
|
|
|
||||||
|
U.S. Treasury obligations
|
$
|
120,201
|
|
4
|
%
|
|
$
|
133,627
|
|
4
|
%
|
|
U.S. Government-sponsored enterprise obligations
|
35,354
|
|
1
|
%
|
|
20,956
|
|
1
|
%
|
||
|
State and municipal bonds
|
293,772
|
|
9
|
%
|
|
632,243
|
|
17
|
%
|
||
|
Corporate debt
|
1,223,475
|
|
37
|
%
|
|
1,167,158
|
|
31
|
%
|
||
|
Residential mortgage-backed securities
|
181,238
|
|
5
|
%
|
|
197,844
|
|
5
|
%
|
||
|
Commercial mortgage-backed securities
|
44,101
|
|
1
|
%
|
|
26,703
|
|
1
|
%
|
||
|
Other asset-backed securities
|
195,657
|
|
6
|
%
|
|
101,711
|
|
3
|
%
|
||
|
Total fixed maturities, available for sale
|
2,093,798
|
|
63
|
%
|
|
2,280,242
|
|
62
|
%
|
||
|
Fixed maturities, trading
|
38,188
|
|
1
|
%
|
|
—
|
|
—
|
%
|
||
|
Total fixed maturities
|
2,131,986
|
|
64
|
%
|
|
2,280,242
|
|
62
|
%
|
||
|
|
|
|
|
|
|
||||||
|
Equity investments
|
442,937
|
|
13
|
%
|
|
470,609
|
|
13
|
%
|
||
|
Short-term investments
|
308,319
|
|
9
|
%
|
|
432,126
|
|
12
|
%
|
||
|
BOLI
|
64,096
|
|
1
|
%
|
|
62,113
|
|
1
|
%
|
||
|
Investment in unconsolidated subsidiaries
|
367,757
|
|
11
|
%
|
|
330,591
|
|
9
|
%
|
||
|
Other investments
|
34,287
|
|
2
|
%
|
|
110,847
|
|
3
|
%
|
||
|
Total investments
|
$
|
3,349,382
|
|
100
|
%
|
|
$
|
3,686,528
|
|
100
|
%
|
|
|
December 31, 2018
|
|
December 31, 2017
|
||||||||
|
($ in thousands)
|
Carrying
Value |
% of Total Investment
|
|
Carrying
Value |
% of Total Investment
|
||||||
|
Rating*
|
|
|
|
|
|
||||||
|
AAA
|
$
|
645,300
|
|
31
|
%
|
|
$
|
617,091
|
|
27
|
%
|
|
AA+
|
101,328
|
|
5
|
%
|
|
183,221
|
|
8
|
%
|
||
|
AA
|
120,801
|
|
6
|
%
|
|
173,488
|
|
8
|
%
|
||
|
AA-
|
155,352
|
|
7
|
%
|
|
195,110
|
|
9
|
%
|
||
|
A+
|
190,595
|
|
9
|
%
|
|
210,263
|
|
9
|
%
|
||
|
A
|
311,036
|
|
15
|
%
|
|
296,852
|
|
13
|
%
|
||
|
A-
|
146,721
|
|
7
|
%
|
|
202,581
|
|
9
|
%
|
||
|
BBB+
|
133,199
|
|
6
|
%
|
|
103,023
|
|
4
|
%
|
||
|
BBB
|
118,864
|
|
6
|
%
|
|
100,025
|
|
4
|
%
|
||
|
BBB-
|
50,466
|
|
2
|
%
|
|
48,207
|
|
2
|
%
|
||
|
Below investment grade
|
100,447
|
|
5
|
%
|
|
119,310
|
|
6
|
%
|
||
|
Not rated
|
19,689
|
|
1
|
%
|
|
31,071
|
|
1
|
%
|
||
|
Total
|
$
|
2,093,798
|
|
100
|
%
|
|
$
|
2,280,242
|
|
100
|
%
|
|
*Average of three NRSRO sources, presented as an S&P equivalent. Source: S&P, Copyright ©2018, S&P Global Market Intelligence
|
|||||||||||
|
|
Carrying Value
|
|
December 31, 2018
|
||||||||
|
($ in thousands, except expected funding period)
|
December 31, 2018
|
December 31, 2017
|
|
Unfunded Commitment
|
Expected funding period in years
|
||||||
|
Qualified affordable housing project tax credit partnerships
(1)
|
$
|
65,677
|
|
$
|
84,607
|
|
|
$
|
960
|
|
6
|
|
Historic tax credit partnerships
(2)
|
3,757
|
|
6,118
|
|
|
276
|
|
1
|
|||
|
All other investments, primarily investment fund LPs/LLCs
|
298,323
|
|
294,924
|
|
|
221,612
|
|
5
|
|||
|
Total
|
$
|
367,757
|
|
$
|
385,649
|
|
|
$
|
222,848
|
|
|
|
(1)
The carrying value reflects our total commitments (both funded and unfunded) to the partnerships, less any amortization, since our initial investment. We fund these investments based on funding schedules maintained by the partnerships.
|
|||||||||||
|
(2)
The carrying value reflects our funded commitments less any amortization.
|
|||||||||||
|
(In thousands)
|
2018
|
|
2017
|
|
2016
|
|||
|
Treasury shares at the beginning of the period
|
9,368
|
|
|
9,409
|
|
|
9,403
|
|
|
Shares reacquired, at cost of $2 million for 2016
|
—
|
|
|
—
|
|
|
44
|
|
|
Shares reissued, primarily those reissued pursuant to the ProAssurance 2011 Employee Stock Ownership Plan, had a fair value of approximately $1 million in 2018 and approximately $2 million in both 2017 and 2016
|
(16
|
)
|
|
(41
|
)
|
|
(38
|
)
|
|
Treasury shares at the end of the period
|
9,352
|
|
|
9,368
|
|
|
9,409
|
|
|
|
|
Quarterly Cash Dividends Declared, per Share
|
||||||||||
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
First Quarter
|
|
$
|
0.31
|
|
|
$
|
0.31
|
|
|
$
|
0.31
|
|
|
Second Quarter
|
|
$
|
0.31
|
|
|
$
|
0.31
|
|
|
$
|
0.31
|
|
|
Third Quarter
|
|
$
|
0.31
|
|
|
$
|
0.31
|
|
|
$
|
0.31
|
|
|
Fourth Quarter
|
|
$
|
0.31
|
|
|
$
|
0.31
|
|
|
$
|
0.31
|
|
|
Fourth Quarter - Special dividend
|
|
$
|
0.50
|
|
|
$
|
4.69
|
|
|
$
|
4.69
|
|
|
|
|
Payments due by period
|
||||||||||||||||||
|
(In thousands)
|
|
Total
|
|
Less than
1 year
|
|
1-3 years
|
|
3-5 years
|
|
More than
5 years
|
||||||||||
|
Losses and loss adjustment expenses
|
|
$
|
2,119,847
|
|
|
$
|
580,902
|
|
|
$
|
815,498
|
|
|
$
|
381,397
|
|
|
$
|
342,050
|
|
|
Debt obligations including interest and fees
|
|
366,010
|
|
|
19,640
|
|
|
32,684
|
|
|
60,678
|
|
|
253,008
|
|
|||||
|
Operating lease obligations
|
|
27,124
|
|
|
4,829
|
|
|
7,577
|
|
|
4,506
|
|
|
10,212
|
|
|||||
|
Funding commitments primarily related to non-public investment entities
|
|
231,942
|
|
|
107,585
|
|
|
87,914
|
|
|
36,325
|
|
|
118
|
|
|||||
|
Total
|
|
$
|
2,744,923
|
|
|
$
|
712,956
|
|
|
$
|
943,673
|
|
|
$
|
482,906
|
|
|
$
|
605,388
|
|
|
|
Year Ended December 31
|
|||||||||||
|
($ in thousands, except per share data)
|
2018
|
|
2017
|
|
Change
|
|||||||
|
Revenues:
|
|
|
|
|
|
|
||||||
|
Net premiums written
|
$
|
834,914
|
|
|
$
|
764,018
|
|
|
$
|
70,896
|
|
|
|
Net premiums earned
|
$
|
818,853
|
|
|
$
|
738,531
|
|
|
$
|
80,322
|
|
|
|
Net investment result
|
100,832
|
|
|
103,695
|
|
|
(2,863
|
)
|
|
|||
|
Net realized investment gains (losses)
|
(43,488
|
)
|
|
16,409
|
|
|
(59,897
|
)
|
|
|||
|
Other income
|
9,833
|
|
|
7,514
|
|
|
2,319
|
|
|
|||
|
Total revenues
|
886,030
|
|
|
866,149
|
|
|
19,881
|
|
|
|||
|
|
|
|
|
|
|
|
||||||
|
Expenses:
|
|
|
|
|
|
|
||||||
|
Net losses and loss adjustment expenses
|
593,210
|
|
|
469,158
|
|
|
124,052
|
|
|
|||
|
Underwriting, policy acquisition and operating expenses
|
238,556
|
|
|
235,753
|
|
|
2,803
|
|
|
|||
|
Segregated portfolio cells dividend expense (income)
|
9,122
|
|
|
15,771
|
|
|
(6,649
|
)
|
|
|||
|
Interest expense
|
16,117
|
|
|
16,844
|
|
|
(727
|
)
|
|
|||
|
Total expenses
|
857,005
|
|
|
737,526
|
|
|
119,479
|
|
|
|||
|
Income before income taxes
|
29,025
|
|
|
128,623
|
|
|
(99,598
|
)
|
|
|||
|
Income tax expense (benefit)
|
(18,032
|
)
|
|
21,359
|
|
|
(39,391
|
)
|
|
|||
|
Net income
|
$
|
47,057
|
|
|
$
|
107,264
|
|
|
$
|
(60,207
|
)
|
|
|
Non-GAAP operating income
|
$
|
79,527
|
|
|
$
|
108,538
|
|
|
$
|
(29,011
|
)
|
|
|
Earnings per share:
|
|
|
|
|
|
|
||||||
|
Basic
|
$
|
0.88
|
|
|
$
|
2.01
|
|
|
$
|
(1.13
|
)
|
|
|
Diluted
|
$
|
0.88
|
|
|
$
|
2.00
|
|
|
$
|
(1.12
|
)
|
|
|
Non-GAAP operating earnings per share:
|
|
|
|
|
|
|
||||||
|
Basic
|
$
|
1.48
|
|
|
$
|
2.03
|
|
|
$
|
(0.55
|
)
|
|
|
Diluted
|
$
|
1.48
|
|
|
$
|
2.02
|
|
|
$
|
(0.54
|
)
|
|
|
Net loss ratio
|
72.4
|
%
|
|
63.5
|
%
|
|
8.9
|
|
pts
|
|||
|
Underwriting expense ratio
|
29.1
|
%
|
|
31.9
|
%
|
|
(2.8
|
)
|
pts
|
|||
|
Combined ratio
|
101.5
|
%
|
|
95.4
|
%
|
|
6.1
|
|
pts
|
|||
|
Operating ratio
|
90.3
|
%
|
|
82.4
|
%
|
|
7.9
|
|
pts
|
|||
|
Effective tax rate
|
(62.1
|
%)
|
|
16.6
|
%
|
|
(78.7
|
)
|
pts
|
|||
|
Return on equity
|
3.0
|
%
|
|
6.3
|
%
|
|
(3.3
|
)
|
pts
|
|||
|
In all tables that follow, the abbreviation "
nm
" indicates that the information or the percentage change is not meaningful.
|
||||||||||||
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Net Premiums Earned
|
|
|
|
|
|
|
|
|||||||
|
Specialty P&C
|
$
|
491,787
|
|
|
$
|
449,823
|
|
|
$
|
41,964
|
|
|
9.3
|
%
|
|
Workers' Compensation Insurance
|
186,079
|
|
|
163,309
|
|
|
22,770
|
|
|
13.9
|
%
|
|||
|
Segregated Portfolio Cell Reinsurance
|
73,940
|
|
|
68,197
|
|
|
5,743
|
|
|
8.4
|
%
|
|||
|
Lloyd's Syndicates
|
67,047
|
|
|
57,202
|
|
|
9,845
|
|
|
17.2
|
%
|
|||
|
Consolidated total
|
$
|
818,853
|
|
|
$
|
738,531
|
|
|
$
|
80,322
|
|
|
10.9
|
%
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Net investment income
|
$
|
91,884
|
|
|
$
|
95,662
|
|
|
$
|
(3,778
|
)
|
|
(3.9
|
%)
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
8,948
|
|
|
8,033
|
|
|
915
|
|
|
11.4
|
%
|
|||
|
Net investment result
|
$
|
100,832
|
|
|
$
|
103,695
|
|
|
$
|
(2,863
|
)
|
|
(2.8
|
%)
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Net impairment losses recognized in earnings
|
$
|
(490
|
)
|
|
$
|
(12,952
|
)
|
|
$
|
12,462
|
|
|
96.2
|
%
|
|
Other net realized investment gains (losses)
|
(42,998
|
)
|
|
29,361
|
|
|
(72,359
|
)
|
|
(246.4
|
%)
|
|||
|
Net realized investment gains (losses)
|
$
|
(43,488
|
)
|
|
$
|
16,409
|
|
|
$
|
(59,897
|
)
|
|
(365.0
|
%)
|
|
|
Year Ended December 31
|
|||||||||||
|
($ in millions)
|
2018
|
|
2017
|
|
Change
|
|||||||
|
Current accident year net loss ratio
|
|
|
|
|
|
|
||||||
|
Consolidated ratio
|
83.7
|
%
|
|
81.7
|
%
|
|
2.0
|
|
pts
|
|||
|
Specialty P&C
|
93.8
|
%
|
|
89.9
|
%
|
|
3.9
|
|
pts
|
|||
|
Workers' Compensation Insurance
|
68.0
|
%
|
|
66.1
|
%
|
|
1.9
|
|
pts
|
|||
|
Segregated Portfolio Cell Reinsurance
|
64.5
|
%
|
|
67.4
|
%
|
|
(2.9
|
)
|
pts
|
|||
|
Lloyd's Syndicates
|
74.0
|
%
|
|
78.7
|
%
|
|
(4.7
|
)
|
pts
|
|||
|
|
|
|
|
|
|
|
||||||
|
Calendar year net loss ratio
|
|
|
|
|
|
|
||||||
|
Consolidated ratio
|
72.4
|
%
|
|
63.5
|
%
|
|
8.9
|
|
pts
|
|||
|
Specialty P&C
|
78.2
|
%
|
|
63.4
|
%
|
|
14.8
|
|
pts
|
|||
|
Workers' Compensation Insurance
|
63.7
|
%
|
|
62.6
|
%
|
|
1.1
|
|
pts
|
|||
|
Segregated Portfolio Cell Reinsurance
|
52.4
|
%
|
|
54.9
|
%
|
|
(2.5
|
)
|
pts
|
|||
|
Lloyd's Syndicates
|
76.9
|
%
|
|
77.3
|
%
|
|
(0.4
|
)
|
pts
|
|||
|
|
|
|
|
|
|
|
||||||
|
Favorable (unfavorable) net loss development, prior accident years
|
|
|
|
|
|
|
||||||
|
Consolidated
|
$
|
92.1
|
|
|
$
|
134.4
|
|
|
$
|
(42.3
|
)
|
|
|
Specialty P&C
|
$
|
77.0
|
|
|
$
|
119.4
|
|
|
$
|
(42.4
|
)
|
|
|
Workers' Compensation Insurance
|
$
|
8.1
|
|
|
$
|
5.7
|
|
|
$
|
2.4
|
|
|
|
Segregated Portfolio Cell Reinsurance
|
$
|
9.0
|
|
|
$
|
8.5
|
|
|
$
|
0.5
|
|
|
|
Lloyd's Syndicates
|
$
|
(2.0
|
)
|
|
$
|
0.8
|
|
|
$
|
(2.8
|
)
|
|
|
|
Year Ended December 31
|
||||||||
|
|
2018
|
|
2017
|
|
Change
|
||||
|
Underwriting Expense Ratio
|
|
|
|
|
|
|
|||
|
Consolidated
|
29.1
|
%
|
|
31.9
|
%
|
|
(2.8
|
)
|
pts
|
|
Specialty P&C
|
22.9
|
%
|
|
24.0
|
%
|
|
(1.1
|
)
|
pts
|
|
Workers' Compensation Insurance
|
29.9
|
%
|
|
32.2
|
%
|
|
(2.3
|
)
|
pts
|
|
Segregated Portfolio Cell Reinsurance
|
30.3
|
%
|
|
30.4
|
%
|
|
(0.1
|
)
|
pts
|
|
Lloyd's Syndicates
|
47.3
|
%
|
|
47.1
|
%
|
|
0.2
|
|
pts
|
|
Corporate*
|
2.3
|
%
|
|
4.0
|
%
|
|
(1.7
|
)
|
pts
|
|
*There are no net premiums earned associated with the Corporate segment. Ratios shown are the contribution of the Corporate segment to the consolidated ratio (Corporate operating expenses divided by consolidated net premium earned).
|
|||||||||
|
|
Year Ended December 31
|
|||||
|
|
2018
|
2017
|
Change
|
|||
|
Operating ratio
|
90.3
|
%
|
82.4
|
%
|
7.9
|
pts
|
|
|
Year Ended December 31
|
||||||
|
|
2018
|
2017
|
Change
|
||||
|
ROE
|
3.0
|
%
|
6.3
|
%
|
(3.3
|
)
|
pts
|
|
|
Book Value Per Share
|
||
|
Book Value Per Share at December 31, 2017
|
$
|
29.83
|
|
|
Increase (decrease) to book value per share during the year ended December 31, 2018 attributable to:
|
|
||
|
Dividends declared
|
(1.74
|
)
|
|
|
Net income
|
0.88
|
|
|
|
OCI
|
(0.66
|
)
|
|
|
Other *
|
0.08
|
|
|
|
Book Value Per Share at December 31, 2018
|
$
|
28.39
|
|
|
* Includes the impact of cumulative effect adjustments related to ASUs adopted during 2018.
|
|||
|
|
Year Ended December 31
|
||||||
|
(In thousands, except per share data)
|
2018
|
|
2017
|
||||
|
Net income
|
$
|
47,057
|
|
|
$
|
107,264
|
|
|
Items excluded in the calculation of Non-GAAP operating income:
|
|
|
|
||||
|
Net realized investment (gains) losses
|
43,488
|
|
|
(16,409
|
)
|
||
|
Net realized gains (losses) attributable to SPCs which no profit/loss is retained
(1)
|
(2,535
|
)
|
|
3,083
|
|
||
|
Guaranty fund assessments (recoupments)
|
148
|
|
|
(157
|
)
|
||
|
Pre-tax effect of exclusions
|
41,101
|
|
|
(13,483
|
)
|
||
|
Tax effect
(2)
|
(8,631
|
)
|
|
4,719
|
|
||
|
After-tax effect of exclusions
|
32,470
|
|
|
(8,764
|
)
|
||
|
Non-GAAP operating income, before tax reform adjustments
|
79,527
|
|
|
98,500
|
|
||
|
Tax reform adjustments on our deferred tax balances excluded in the calculation of Non-GAAP operating income:
|
|
|
|
||||
|
Adjustment of deferred taxes upon the change in corporate tax rate
(3)
|
—
|
|
|
6,541
|
|
||
|
Adjustment of deferred taxes upon the change in limitation of future deductibility of certain executive compensation
(3)
|
—
|
|
|
3,497
|
|
||
|
Non-GAAP operating income
|
$
|
79,527
|
|
|
$
|
108,538
|
|
|
Per diluted common share:
|
|
|
|
||||
|
Net income
|
$
|
0.88
|
|
|
$
|
2.00
|
|
|
Effect of exclusions
|
0.60
|
|
|
0.02
|
|
||
|
Non-GAAP operating income per diluted common share
|
$
|
1.48
|
|
|
$
|
2.02
|
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Net premiums written
|
$
|
494,148
|
|
|
$
|
466,621
|
|
|
$
|
27,527
|
|
|
5.9
|
%
|
|
|
|
|
|
|
|
|
|
|||||||
|
Net premiums earned
|
$
|
491,787
|
|
|
$
|
449,823
|
|
|
$
|
41,964
|
|
|
9.3
|
%
|
|
Other income
|
5,844
|
|
|
5,688
|
|
|
156
|
|
|
2.7
|
%
|
|||
|
Net losses and loss adjustment expenses
|
(384,431
|
)
|
|
(285,250
|
)
|
|
(99,181
|
)
|
|
34.8
|
%
|
|||
|
Underwriting, policy acquisition and operating expenses
|
(112,419
|
)
|
|
(107,972
|
)
|
|
(4,447
|
)
|
|
4.1
|
%
|
|||
|
Segregated portfolio cells dividend (expense) income
|
—
|
|
|
(5,181
|
)
|
|
5,181
|
|
|
(100.0
|
%)
|
|||
|
Segment operating results
|
$
|
781
|
|
|
$
|
57,108
|
|
|
$
|
(56,327
|
)
|
|
(98.6
|
%)
|
|
|
|
|
|
|
|
|
|
|||||||
|
Net loss ratio
|
78.2%
|
|
63.4%
|
|
14.8
|
|
pts
|
|||||||
|
Underwriting expense ratio
|
22.9%
|
|
24.0%
|
|
(1.1
|
)
|
pts
|
|||||||
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Gross premiums written
|
$
|
577,196
|
|
|
$
|
549,323
|
|
|
$
|
27,873
|
|
|
5.1
|
%
|
|
Less: Ceded premiums written
|
83,048
|
|
|
82,702
|
|
|
346
|
|
|
0.4
|
%
|
|||
|
Net premiums written
|
$
|
494,148
|
|
|
$
|
466,621
|
|
|
$
|
27,527
|
|
|
5.9
|
%
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Professional liability
|
|
|
|
|
|
|
|
|||||||
|
Physicians
(1)(8)
|
|
|
|
|
|
|
|
|||||||
|
Twelve month term
|
$
|
352,279
|
|
|
$
|
360,232
|
|
|
$
|
(7,953
|
)
|
|
(2.2
|
%)
|
|
Twenty-four month term
|
22,171
|
|
|
27,370
|
|
|
(5,199
|
)
|
|
(19.0
|
%)
|
|||
|
Total Physicians
|
374,450
|
|
|
387,602
|
|
|
(13,152
|
)
|
|
(3.4
|
%)
|
|||
|
Healthcare facilities
(2)(8)
|
65,014
|
|
|
47,697
|
|
|
17,317
|
|
|
36.3
|
%
|
|||
|
Other healthcare providers
(3)
|
32,200
|
|
|
32,599
|
|
|
(399
|
)
|
|
(1.2
|
%)
|
|||
|
Legal professionals
(4)
|
26,227
|
|
|
25,628
|
|
|
599
|
|
|
2.3
|
%
|
|||
|
Tail coverages
(5)(6)
|
25,579
|
|
|
21,206
|
|
|
4,373
|
|
|
20.6
|
%
|
|||
|
Retroactive coverages
(6)
|
18,708
|
|
|
—
|
|
|
18,708
|
|
|
nm
|
|
|||
|
Total professional liability
|
542,178
|
|
|
514,732
|
|
|
27,446
|
|
|
5.3
|
%
|
|||
|
Medical technology liability
(7)
|
34,528
|
|
|
34,164
|
|
|
364
|
|
|
1.1
|
%
|
|||
|
Other
|
490
|
|
|
427
|
|
|
63
|
|
|
14.8
|
%
|
|||
|
Total
|
$
|
577,196
|
|
|
$
|
549,323
|
|
|
$
|
27,873
|
|
|
5.1
|
%
|
|
(1)
|
Physician policies were our greatest source of premium revenues in both
2018
and
2017
. The decrease in twelve month term policies in
2018
was due to timing differences of $10.9 million primarily related to the shifting in 2018 renewal dates of a few large policies that were renewed in the first quarter of 2019. Excluding the effect of these timing differences, twelve month term policies increased $2.9 million as compared to 2017. This increase was primarily due to new business written, an increase in premiums assumed in which we participate on a quota share basis and an increase in renewal pricing, largely offset by retention losses during the period. Renewal pricing increases in 2018 is reflective of our concern about potential increases in loss severity as well as more moderate marketplace price competition. Twelve month term premium in 2018 also reflected an increase in coverage from one insured who acquired an entity that was not previously insured by us. We also offer twenty-four month term policies to our physician insureds in one selected jurisdiction. The decrease in twenty-four month term policies in
2018
as compared to
2017
primarily reflected the normal cycle of renewals (policies subject to renewal in
2018
were previously written in 2016 rather than in
2017
).
|
|
(2)
|
Our healthcare facilities premium (which includes hospitals, surgery centers and other similar facilities)
increase
d in
2018
as compared to
2017
driven by new business written, primarily due to the addition of two large policies in 2018, and, to a lesser extent, an increase in coverage pertaining to one large entity which consolidated certain policies that were not previously insured by us. Additionally, given the loss environment and initial loss indications we are seeing in the healthcare facilities space, we are seeking rate increases where we believe appropriate. These increases were partially offset by retention losses during the period.
|
|
(3)
|
Our other healthcare providers are primarily dentists, chiropractors and allied health professionals.
|
|
(4)
|
Our legal professionals policies are primarily individual and small group policies in select areas of practice. The increase in
2018
as compared to
2017
was primarily due to new business written and, to a lesser extent, an increase in the rate charged for certain renewed policies in select states due to rate filings, largely offset by retention losses.
|
|
(5)
|
We offer extended reporting endorsement or "tail" coverage to insureds who discontinue their claims-made coverage with us, and we also periodically offer tail coverage through custom policies. The amount of tail coverage premium written can vary significantly from period to period. The increase in tail premiums in
2018
was driven by
$7.9 million
of tail coverage provided in connection with a loss portfolio transfer with a large healthcare organization entered into during the second quarter of 2018 (see further discussion in footnote 6 that follows), partially offset by the effect of tail coverage purchased in 2017 for a few large claims-made policies in one jurisdiction that were rewritten to occurrence coverage. These policies are a part of one of our shared risk arrangements and therefore, a large portion of the premium written was also ceded during 2017 (see further discussion in the Ceded Premiums Written section that follows).
|
|
(6)
|
We offer custom alternative risk solutions including loss portfolio transfers for large healthcare entities who, most commonly, are exiting a line of business, changing an insurance approach, or simply preferring to transfer risk. In the second quarter of 2018, we entered into a loss portfolio transfer with a large healthcare organization. Per the agreement, we will cover a specific inventory of existing claims as well as provide tail coverage. The premiums received for the
|
|
(7)
|
Our
medical technology liability
business is marketed throughout the U.S.; coverage is offered on a primary basis, within specified limits, to manufacturers and distributors of medical technology and life sciences products including entities conducting human clinical trials. In addition to the previously listed factors that affect our premium volume, our
medical technology liability
premium volume is impacted by the sales volume of insureds. The slight increase in
2018
was primarily due to new business written and, to a lesser extent, an increase in the premium charged for certain renewed policies as a result of an increase in the sales volume of the insureds, partially offset by retention losses. Retention losses in
2018
are largely attributable to an increase in competition on terms and pricing.
|
|
(8)
|
Certain components of our gross premiums written include alternative market premiums. We cede either all or a portion of the alternative market premium, net of reinsurance, to certain SPCs of our wholly owned Cayman Islands reinsurance subsidiaries, Eastern Re and Inova Re, which are reported in our Segregated Portfolio Cell Reinsurance segment (see further discussion in the Ceded Premiums Written section that follows). The portion not ceded to the SPCs is retained within our Specialty P&C segment. Alternative market gross premiums written by component were as follows:
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in millions)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Physicians
|
$
|
1.4
|
|
|
$
|
1.2
|
|
|
$
|
0.2
|
|
|
16.7
|
%
|
|
Healthcare facilities
|
4.4
|
|
|
3.1
|
|
|
1.3
|
|
|
41.9
|
%
|
|||
|
Total
|
$
|
5.8
|
|
|
$
|
4.3
|
|
|
$
|
1.5
|
|
|
34.9
|
%
|
|
|
Year Ended December 31
|
||||||
|
(In millions)
|
2018
|
|
2017
|
||||
|
Physicians
|
$
|
19.8
|
|
|
$
|
31.6
|
|
|
Healthcare facilities
|
19.8
|
|
|
5.8
|
|
||
|
Other healthcare providers
|
2.5
|
|
|
2.1
|
|
||
|
Legal professionals
|
2.8
|
|
|
3.6
|
|
||
|
Medical technology liability
|
3.0
|
|
|
5.4
|
|
||
|
Total
|
$
|
47.9
|
|
|
$
|
48.5
|
|
|
|
Year Ended December 31
|
||||
|
|
2018
|
|
2017
|
||
|
Physicians*
|
90
|
%
|
|
90
|
%
|
|
Healthcare facilities*
|
87
|
%
|
|
86
|
%
|
|
Other healthcare providers*
|
87
|
%
|
|
85
|
%
|
|
Legal professionals
|
86
|
%
|
|
84
|
%
|
|
Medical technology liability
|
87
|
%
|
|
87
|
%
|
|
* Excludes certain policies written on an excess and surplus lines basis.
|
|||||
|
|
Year Ended December 31
|
|
|
|
2018
|
|
|
Physicians
(1)(2)
|
3
|
%
|
|
Healthcare facilities
(1)(2)
|
7
|
%
|
|
Other healthcare providers
(1)
|
4
|
%
|
|
Legal professionals
(2)
|
5
|
%
|
|
Medical technology liability
|
3
|
%
|
|
(1)
Excludes certain policies written on an excess and surplus lines basis.
|
||
|
(2)
See Gross Premiums Written section for further explanation of renewal pricing increase.
|
||
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Excess of loss reinsurance arrangements
(1)
|
$
|
35,591
|
|
|
$
|
31,853
|
|
|
$
|
3,738
|
|
|
11.7
|
%
|
|
Premium ceded to Syndicate 1729
(2)
|
2,105
|
|
|
13,983
|
|
|
(11,878
|
)
|
|
(84.9
|
%)
|
|||
|
Other shared risk arrangements
(3)
|
31,358
|
|
|
30,780
|
|
|
578
|
|
|
1.9
|
%
|
|||
|
Premium ceded to SPCs
(4)
|
5,159
|
|
|
3,914
|
|
|
1,245
|
|
|
31.8
|
%
|
|||
|
Other ceded premiums written
|
3,310
|
|
|
3,361
|
|
|
(51
|
)
|
|
(1.5
|
%)
|
|||
|
Adjustment to premiums owed under reinsurance agreements, prior accident years, net
(5)
|
5,525
|
|
|
(1,189
|
)
|
|
6,714
|
|
|
(564.7
|
%)
|
|||
|
Total ceded premiums written
|
$
|
83,048
|
|
|
$
|
82,702
|
|
|
$
|
346
|
|
|
0.4
|
%
|
|
(1)
|
We generally reinsure risks under our excess of loss reinsurance arrangements pursuant to which the reinsurers agree to assume all or a portion of all risks that we insure above our individual risk retention levels, up to the maximum individual limits offered. In the majority of our excess of loss reinsurance arrangements, the premium due to the reinsurer is determined by the loss experience of that business reinsured, subject to certain minimum and maximum amounts. The increase in ceded premiums written under our excess of loss reinsurance arrangements in
2018
primarily reflected an increase in the premiums we expect to owe our reinsurers based upon increases to our estimates of losses recoverable from our reinsurance partners.
|
|
(2)
|
As previously discussed, we are the majority participant in
Syndicate 1729
and normally record our pro rata share of its operating results in our
Lloyd's
Syndicates segment on a quarter delay, except when information is available that is material to the current period. We also recorded the cession to
Syndicate 1729
from our
Specialty P&C
segment on a quarter delay as the amounts were not material and that permitted the cession to be reported by both our
Lloyd's
Syndicates segment and our
Specialty P&C
segment in the same reporting period. The decrease in premiums ceded to
Syndicate 1729
during
2018
primarily reflected the non-renewal of our quota share agreement with
Syndicate 1729
on January 1, 2018; the impact of which was not reflected in ceded premiums written until the second quarter of 2018
|
|
(3)
|
We have entered into various shared risk arrangements, including quota share, fronting, and captive arrangements, with certain large healthcare systems and other insurance entities. These arrangements include our Ascension Health and CAPAssurance programs. While we cede a large portion of the premium written under these arrangements, they provide us an opportunity to grow net premium through strategic partnerships. The increase in 2018 was primarily driven by growth in our Ascension Health and CAPAssurance programs, largely offset by the effect of a few large tail endorsements that were written, and substantially ceded, during 2017 related to one of these shared risk arrangements, as previously discussed under the heading "Gross Premiums Written."
|
|
(4)
|
As previously discussed, as a part of our alternative market solutions, all or a portion of certain healthcare premium written is ceded to the SPCs in our Segregated Portfolio Cell Reinsurance segment under either excess of loss or quota share reinsurance agreements, depending on the structure of the individual program. See the Segment Operating Results - Segregated Portfolio Cell Reinsurance section for further discussion on the cession to the SPCs from our Specialty P&C segment. The increase in premiums ceded to the SPCs during
2018
was primarily driven by new business written (see discussion in footnote 8 under the heading "Gross Premiums Written").
|
|
(5)
|
Given the length of time that it takes to resolve our claims, many years may elapse before all losses recoverable under a reinsurance arrangement are known. As a part of the process of estimating our loss reserve we also make estimates regarding the amounts recoverable under our reinsurance arrangements. As previously discussed, the premiums ultimately ceded under certain of our excess of loss reinsurance arrangements are subject to the losses ceded under the arrangements. For 2018, we increased our estimate of expected losses and associated recoveries for prior year ceded losses, as well as our estimate of ceded premiums owed to reinsurers. The increase in our estimate of ceded premiums owed to reinsurers during 2018 as compared to
2017
was due to an increase in the number of claims that exceeded our individual risk retention levels under certain loss-sensitive treaties. We believe that this increase in claim severity is reflective of the evolving loss trends within the industry. For 2017, we reduced our estimate of expected losses and associated recoveries for prior year ceded losses, as well as our estimate of ceded premiums owed to reinsurers. Changes to estimates of premiums ceded related to prior accident years are fully earned in the period the changes in estimates occur.
|
|
|
Year Ended December 31
|
||||||||
|
|
2018
|
|
2017
|
|
Change
|
||||
|
Ceded premiums ratio, as reported
|
14.4
|
%
|
|
15.1
|
%
|
|
(0.7
|
)
|
pts
|
|
Less the effect of adjustments in premiums owed under reinsurance agreements, prior accident years (as previously discussed)
|
1.0
|
%
|
|
(0.2
|
%)
|
|
1.2
|
|
pts
|
|
Ratio, current accident year
|
13.4
|
%
|
|
15.3
|
%
|
|
(1.9
|
)
|
pts
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Gross premiums earned
|
$
|
580,022
|
|
|
$
|
537,583
|
|
|
$
|
42,439
|
|
|
7.9
|
%
|
|
Less: Ceded premiums earned
|
88,235
|
|
|
87,760
|
|
|
475
|
|
|
0.5
|
%
|
|||
|
Net premiums earned
|
$
|
491,787
|
|
|
$
|
449,823
|
|
|
$
|
41,964
|
|
|
9.3
|
%
|
|
|
Net Loss Ratios
(1)
|
|||||||
|
|
Year Ended December 31
|
|||||||
|
|
2018
|
|
2017
|
|
Change
|
|||
|
Calendar year net loss ratio
|
78.2
|
%
|
|
63.4
|
%
|
|
14.8
|
pts
|
|
Less impact of prior accident years on the net loss ratio
|
(15.6
|
%)
|
|
(26.5
|
%)
|
|
10.9
|
pts
|
|
Current accident year net loss ratio
|
93.8
|
%
|
|
89.9
|
%
|
|
3.9
|
pts
|
|
Less estimated ratio increase (decrease) attributable to:
|
|
|
|
|
|
|
||
|
Ceded premium adjustments, prior accident years
(2)
|
1.0
|
%
|
|
(0.2
|
%)
|
|
1.2
|
pts
|
|
Current accident year net loss ratio, excluding the effect of prior year ceded premium
(3)
|
92.8
|
%
|
|
90.1
|
%
|
|
2.7
|
pts
|
|
(1)
|
Net losses, as specified, divided by net premiums earned.
|
|
(2)
|
During
2018
, we increased the premiums owed under reinsurance agreements for prior accident years which decreased net premiums earned (the denominator of the current accident year ratio). During
2017
, reductions to premiums owed under reinsurance agreements for prior accident years increased net premiums earned. See the discussion in the Premiums section for our
Specialty P&C
segment under the heading "Ceded Premiums Written" for additional information.
|
|
(3)
|
The current accident year net loss ratio, excluding the effect of prior year ceded premium adjustments, increased
2.7
percentage points as compared to
2017
driven by our consideration of potential higher severity trends associated with our excess and surplus lines business, which accounted for approximately
2.0
percentage points of the increase. The remaining increase in the current accident year net loss ratio was primarily due our continued concern around potential loss trends in the broader HCPL industry including large, more complex risks. The increase in the current accident year net loss ratio was partially offset by a decrease to our reserves related to
DDR
coverage endorsements as compared to an increase in 2017. In addition, the current accident year net loss ratio for
2018
also reflected the effect of a loss portfolio transfer (net premiums earned at a
95%
loss ratio) entered into during the second quarter of 2018. See discussion in the Premiums section for our Specialty P&C segment under the heading "Gross Premiums Written" for additional information on the loss portfolio transfer.
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
DPAC amortization
|
$
|
52,253
|
|
|
$
|
47,611
|
|
|
$
|
4,642
|
|
|
9.7
|
%
|
|
Management fees
|
6,968
|
|
|
6,620
|
|
|
348
|
|
|
5.3
|
%
|
|||
|
Other underwriting and operating expenses
|
53,198
|
|
|
53,741
|
|
|
(543
|
)
|
|
(1.0
|
%)
|
|||
|
Total
|
$
|
112,419
|
|
|
$
|
107,972
|
|
|
$
|
4,447
|
|
|
4.1
|
%
|
|
|
Year Ended December 31
|
||||||||
|
|
2018
|
|
2017
|
|
Change
|
||||
|
Underwriting expense ratio
|
22.9
|
%
|
|
24.0
|
%
|
|
(1.1
|
)
|
pts
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Net premiums written
|
$
|
195,350
|
|
|
$
|
173,566
|
|
|
$
|
21,784
|
|
|
12.6
|
%
|
|
|
|
|
|
|
|
|
|
|||||||
|
Net premiums earned
|
$
|
186,079
|
|
|
$
|
163,309
|
|
|
$
|
22,770
|
|
|
13.9
|
%
|
|
Other income
|
2,412
|
|
|
2,096
|
|
|
316
|
|
|
15.1
|
%
|
|||
|
Net losses and loss adjustment expenses
|
(118,483
|
)
|
|
(102,233
|
)
|
|
(16,250
|
)
|
|
15.9
|
%
|
|||
|
Underwriting, policy acquisition and operating expenses
|
(55,693
|
)
|
|
(52,576
|
)
|
|
(3,117
|
)
|
|
5.9
|
%
|
|||
|
Segment operating results
|
$
|
14,315
|
|
|
$
|
10,596
|
|
|
$
|
3,719
|
|
|
35.1
|
%
|
|
|
|
|
|
|
|
|
|
|||||||
|
Net loss ratio
|
63.7%
|
|
62.6%
|
|
1.1
|
|
pts
|
|||||||
|
Underwriting expense ratio
|
29.9%
|
|
32.2%
|
|
(2.3
|
)
|
pts
|
|||||||
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Gross premiums written
|
$
|
293,230
|
|
|
$
|
264,048
|
|
|
$
|
29,182
|
|
|
11.1
|
%
|
|
Less: Ceded premiums written
|
97,880
|
|
|
90,482
|
|
|
7,398
|
|
|
8.2
|
%
|
|||
|
Net premiums written
|
$
|
195,350
|
|
|
$
|
173,566
|
|
|
$
|
21,784
|
|
|
12.6
|
%
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Traditional business:
|
|
|
|
|
|
|
|
|||||||
|
Guaranteed cost
|
$
|
163,138
|
|
|
$
|
143,141
|
|
|
$
|
19,997
|
|
|
14.0
|
%
|
|
Policyholder dividend
|
21,203
|
|
|
20,388
|
|
|
815
|
|
|
4.0
|
%
|
|||
|
Deductible
|
8,143
|
|
|
8,362
|
|
|
(219
|
)
|
|
(2.6
|
%)
|
|||
|
Retrospective
|
6,911
|
|
|
3,428
|
|
|
3,483
|
|
|
101.6
|
%
|
|||
|
Other
|
9,413
|
|
|
8,185
|
|
|
1,228
|
|
|
15.0
|
%
|
|||
|
Alternative market business
|
84,422
|
|
|
80,544
|
|
|
3,878
|
|
|
4.8
|
%
|
|||
|
Total
|
$
|
293,230
|
|
|
$
|
264,048
|
|
|
$
|
29,182
|
|
|
11.1
|
%
|
|
|
Year Ended December 31
|
||||||||||||||||||
|
|
2018
|
|
2017
|
||||||||||||||||
|
($ in millions)
|
Traditional Business
|
Alternative Market Business
|
Segment
Results |
|
Traditional Business
|
Alternative Market Business
|
Segment
Results |
||||||||||||
|
New business
|
$
|
43.2
|
|
$
|
8.3
|
|
$
|
51.5
|
|
|
$
|
37.8
|
|
$
|
9.9
|
|
$
|
47.7
|
|
|
Audit premium (including EBUB)
|
$
|
4.3
|
|
$
|
1.6
|
|
$
|
5.9
|
|
|
$
|
2.7
|
|
$
|
1.4
|
|
$
|
4.1
|
|
|
Retention rate
(1)
|
84
|
%
|
91
|
%
|
86
|
%
|
|
85
|
%
|
92
|
%
|
87
|
%
|
||||||
|
Change in renewal pricing
(2)
|
(1
|
%)
|
—
|
%
|
(1
|
%)
|
|
(3
|
%)
|
(4
|
%)
|
(3
|
%)
|
||||||
|
(1)
We calculate our workers' compensation retention rate as annualized expiring renewed premium divided by all annualized expiring premium subject to renewal. Our retention rate can be impacted by various factors, including price or other competitive issues, insureds being acquired, or a decision not to renew based on our underwriting evaluation.
|
|||||||||||||||||||
|
(2)
The pricing of our business includes an assessment of the underlying policy exposure and the effects of current market conditions. We continue to base our pricing on expected losses, as indicated by our historical loss data.
|
|||||||||||||||||||
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Premiums ceded to SPCs
|
$
|
79,927
|
|
|
$
|
73,761
|
|
|
$
|
6,166
|
|
|
8.4
|
%
|
|
Premiums ceded to external reinsurers
|
13,515
|
|
|
9,823
|
|
|
3,692
|
|
|
37.6
|
%
|
|||
|
Premiums ceded to unaffiliated captive insurers
|
4,495
|
|
|
6,784
|
|
|
(2,289
|
)
|
|
(33.7
|
%)
|
|||
|
Change in return premium estimate under external reinsurance
|
(57
|
)
|
|
114
|
|
|
(171
|
)
|
|
(150.0
|
%)
|
|||
|
Total ceded premiums written
|
$
|
97,880
|
|
|
$
|
90,482
|
|
|
$
|
7,398
|
|
|
8.2
|
%
|
|
|
Year Ended December 31
|
||||||||
|
|
2018
|
|
2017
|
|
Change
|
||||
|
Ceded premiums ratio, as reported
|
34.2
|
%
|
|
35.7
|
%
|
|
(1.5
|
)
|
pts
|
|
Less the effect of:
|
|
|
|
|
|
|
|
||
|
Premiums ceded to SPCs (100%)
|
25.1
|
%
|
|
25.9
|
%
|
|
(0.8
|
)
|
pts
|
|
Premiums ceded to unaffiliated captive insurers (100%)
|
2.4
|
%
|
|
4.1
|
%
|
|
(1.7
|
)
|
pts
|
|
Return premium estimated under external reinsurance
|
—
|
%
|
|
(0.1
|
%)
|
|
0.1
|
|
pts
|
|
Assumed premiums earned (not ceded to external reinsurers)
|
(0.3
|
%)
|
|
(0.3
|
%)
|
|
—
|
|
pts
|
|
Ceded premiums ratio, less the effects of above
|
7.0
|
%
|
|
6.1
|
%
|
|
0.9
|
|
pts
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Gross premiums earned
|
$
|
282,974
|
|
|
$
|
253,944
|
|
|
$
|
29,030
|
|
|
11.4
|
%
|
|
Less: Ceded premiums earned
|
96,895
|
|
|
90,635
|
|
|
6,260
|
|
|
6.9
|
%
|
|||
|
Net premiums earned
|
$
|
186,079
|
|
|
$
|
163,309
|
|
|
$
|
22,770
|
|
|
13.9
|
%
|
|
|
Year Ended December 31
|
||||||||
|
|
2018
|
|
2017
|
|
Change
|
||||
|
Calendar year net loss ratio
|
63.7
|
%
|
|
62.6
|
%
|
|
1.1
|
|
pts
|
|
Less impact of prior accident years on the net loss ratio
|
(4.3
|
%)
|
|
(3.5
|
%)
|
|
(0.8
|
)
|
pts
|
|
Current accident year net loss ratio
|
68.0
|
%
|
|
66.1
|
%
|
|
1.9
|
|
pts
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
DPAC amortization
|
$
|
33,352
|
|
|
$
|
31,433
|
|
|
$
|
1,919
|
|
|
6.1
|
%
|
|
Management fees
|
2,193
|
|
|
1,975
|
|
|
218
|
|
|
11.0
|
%
|
|||
|
Other underwriting and operating expenses
|
37,407
|
|
|
36,791
|
|
|
616
|
|
|
1.7
|
%
|
|||
|
SPC ceding commission offset
|
(17,259
|
)
|
|
(17,623
|
)
|
|
364
|
|
|
(2.1
|
%)
|
|||
|
Total
|
$
|
55,693
|
|
|
$
|
52,576
|
|
|
$
|
3,117
|
|
|
5.9
|
%
|
|
|
Year Ended December 31
|
||||||||
|
|
2018
|
|
2017
|
|
Change
|
||||
|
Underwriting expense ratio, as reported
|
29.9
|
%
|
|
32.2
|
%
|
|
(2.3
|
)
|
pts
|
|
Less estimated ratio increase (decrease) attributable to:
|
|
|
|
|
|
|
|||
|
Impact of ceding commissions received from SPCs
|
2.9
|
%
|
|
3.4
|
%
|
|
(0.5
|
)
|
pts
|
|
Amortization of intangible assets
|
1.3
|
%
|
|
1.2
|
%
|
|
0.1
|
|
pts
|
|
Management fees
|
0.8
|
%
|
|
0.8
|
%
|
|
—
|
|
pts
|
|
Impact of audit premium
|
(0.4
|
%)
|
|
(0.3
|
%)
|
|
(0.1
|
)
|
pts
|
|
Underwriting expense ratio, less listed effects
|
25.3
|
%
|
|
27.1
|
%
|
|
(1.8
|
)
|
pts
|
|
|
Year Ended December 31
|
||||||||||
|
($ in thousands)
|
2018
|
2017
|
Change
|
||||||||
|
Net premiums written
|
$
|
75,547
|
|
$
|
68,862
|
|
$
|
6,685
|
|
9.7
|
%
|
|
|
|
|
|
|
|||||||
|
Net premiums earned
|
$
|
73,940
|
|
$
|
68,197
|
|
$
|
5,743
|
|
8.4
|
%
|
|
Net investment income
|
1,566
|
|
1,059
|
|
507
|
|
47.9
|
%
|
|||
|
Net realized gains (losses)
|
(3,149
|
)
|
3,914
|
|
(7,063
|
)
|
(180.5
|
%)
|
|||
|
Other income
|
211
|
|
115
|
|
96
|
|
83.5
|
%
|
|||
|
Net losses and loss adjustment expenses
|
(38,726
|
)
|
(37,455
|
)
|
(1,271
|
)
|
3.4
|
%
|
|||
|
Underwriting, policy acquisition and operating expenses
|
(22,426
|
)
|
(20,764
|
)
|
(1,662
|
)
|
8.0
|
%
|
|||
|
SPC net operating results
|
11,416
|
|
15,066
|
|
(3,650
|
)
|
(24.2
|
%)
|
|||
|
SPC dividend (expense) income
(1)
|
(9,122
|
)
|
(10,590
|
)
|
1,468
|
|
(13.9
|
%)
|
|||
|
Segment operating results
(2)
|
$
|
2,294
|
|
$
|
4,476
|
|
$
|
(2,182
|
)
|
(48.7
|
%)
|
|
|
|
|
|
|
|||||||
|
Net loss ratio
|
52.4%
|
54.9%
|
(2.5
|
)
|
pts
|
||||||
|
Underwriting expense ratio
|
30.3%
|
30.4%
|
(0.1
|
)
|
pts
|
||||||
|
(1)
Represents the operating (profit) loss due to external cell participants.
|
|||||||||||
|
(2)
Represents our share of the operating profit (loss) of the SPCs in which we participate.
|
|||||||||||
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Gross premiums written
|
$
|
85,086
|
|
|
$
|
77,675
|
|
|
$
|
7,411
|
|
|
9.5
|
%
|
|
Less: Ceded premiums written
|
9,539
|
|
|
8,813
|
|
|
726
|
|
|
8.2
|
%
|
|||
|
Net premiums written
|
$
|
75,547
|
|
|
$
|
68,862
|
|
|
$
|
6,685
|
|
|
9.7
|
%
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Workers' compensation
|
$
|
79,927
|
|
|
$
|
73,761
|
|
|
$
|
6,166
|
|
|
8.4
|
%
|
|
Healthcare professional liability
|
5,159
|
|
|
3,914
|
|
|
1,245
|
|
|
31.8
|
%
|
|||
|
Gross Premiums Written
|
$
|
85,086
|
|
|
$
|
77,675
|
|
|
$
|
7,411
|
|
|
9.5
|
%
|
|
|
|
Year Ended December 31
|
||||||
|
($ in millions)
|
|
2018
|
|
2017
|
||||
|
New business
|
|
$
|
8.3
|
|
|
$
|
9.9
|
|
|
Audit premium (including EBUB)
|
|
$
|
1.6
|
|
|
$
|
1.4
|
|
|
Retention rate
(1)
|
|
91
|
%
|
|
92
|
%
|
||
|
Change in renewal pricing
(2)
|
|
—
|
%
|
|
(4
|
%)
|
||
|
(1)
We calculate our workers' compensation retention rate as annualized expiring renewed premium divided by all annualized expiring premium subject to renewal. Our retention rate can be impacted by various factors, including price or other competitive issues, insureds being acquired, or a decision not to renew based on our underwriting evaluation.
|
||||||||
|
(2)
The pricing of our business includes an assessment of the underlying policy exposure and the effects of current market conditions. We continue to base our pricing on expected losses, as indicated by our historical loss data.
|
||||||||
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Ceded premiums written
|
$
|
9,539
|
|
|
$
|
8,813
|
|
|
$
|
726
|
|
|
8.2
|
%
|
|
|
Year Ended December 31
|
|||||||
|
|
2018
|
|
2017
|
|
Change
|
|||
|
Ceded premiums ratio
|
11.9
|
%
|
|
11.9
|
%
|
|
—
|
pts
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Gross premiums earned
|
$
|
83,264
|
|
|
$
|
76,911
|
|
|
$
|
6,353
|
|
|
8.3
|
%
|
|
Less: Ceded premiums earned
|
9,324
|
|
|
8,714
|
|
|
610
|
|
|
7.0
|
%
|
|||
|
Net premiums earned
|
$
|
73,940
|
|
|
$
|
68,197
|
|
|
$
|
5,743
|
|
|
8.4
|
%
|
|
|
Year Ended December 31
|
||||||||
|
|
2018
|
|
2017
|
|
Change
|
||||
|
Calendar year net loss ratio
|
52.4
|
%
|
|
54.9
|
%
|
|
(2.5
|
)
|
pts
|
|
Less impact of prior accident years on the net loss ratio
|
(12.1
|
%)
|
|
(12.5
|
%)
|
|
0.4
|
|
pts
|
|
Current accident year net loss ratio
|
64.5
|
%
|
|
67.4
|
%
|
|
(2.9
|
)
|
pts
|
|
Less impact of audit premium related to workers' compensation business
|
(1.5
|
%)
|
|
(1.4
|
%)
|
|
(0.1
|
)
|
pts
|
|
Current accident year net loss ratio, excluding the effect of audit premium
|
66.0
|
%
|
|
68.8
|
%
|
|
(2.8
|
)
|
pts
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
DPAC amortization
|
$
|
21,039
|
|
|
$
|
19,927
|
|
|
$
|
1,112
|
|
|
5.6
|
%
|
|
Other underwriting and operating expenses
|
1,387
|
|
|
837
|
|
|
550
|
|
|
65.7
|
%
|
|||
|
Total
|
$
|
22,426
|
|
|
$
|
20,764
|
|
|
$
|
1,662
|
|
|
8.0
|
%
|
|
|
Year Ended December 31
|
||||||||
|
|
2018
|
|
2017
|
|
Change
|
||||
|
Underwriting expense ratio, as reported
|
30.3
|
%
|
|
30.4
|
%
|
|
(0.1
|
)
|
pts
|
|
Less impact of audit premium on expense ratio
|
(0.7
|
%)
|
|
(0.6
|
%)
|
|
(0.1
|
)
|
pts
|
|
Underwriting expense ratio, excluding the effect of audit premium
|
31.0
|
%
|
|
31.0
|
%
|
|
—
|
|
pts
|
|
|
Year Ended December 31
|
||||||||||
|
($ in thousands)
|
2018
|
2017
|
Change
|
||||||||
|
Gross premiums written
|
$
|
88,746
|
|
$
|
70,224
|
|
$
|
18,522
|
|
26.4
|
%
|
|
Ceded premiums written
|
(18,877
|
)
|
(15,255
|
)
|
(3,622
|
)
|
23.7
|
%
|
|||
|
Net premiums written
|
$
|
69,869
|
|
$
|
54,969
|
|
$
|
14,900
|
|
27.1
|
%
|
|
|
|
|
|
|
|||||||
|
Net premiums earned
|
$
|
67,047
|
|
$
|
57,202
|
|
$
|
9,845
|
|
17.2
|
%
|
|
Net investment income
|
3,358
|
|
1,736
|
|
1,622
|
|
93.4
|
%
|
|||
|
Net realized gains (losses)
|
(460
|
)
|
107
|
|
(567
|
)
|
(529.9
|
%)
|
|||
|
Other income (loss)
|
322
|
|
(1,476
|
)
|
1,798
|
|
121.8
|
%
|
|||
|
Net losses and loss adjustment expenses
|
(51,570
|
)
|
(44,220
|
)
|
(7,350
|
)
|
16.6
|
%
|
|||
|
Underwriting, policy acquisition and operating expenses
|
(31,686
|
)
|
(26,963
|
)
|
(4,723
|
)
|
17.5
|
%
|
|||
|
Income tax benefit (expense)
|
317
|
|
568
|
|
(251
|
)
|
(44.2
|
%)
|
|||
|
Segment operating results
|
$
|
(12,672
|
)
|
$
|
(13,046
|
)
|
$
|
374
|
|
2.9
|
%
|
|
|
|
|
|
|
|||||||
|
Net loss ratio
|
76.9
|
%
|
77.3
|
%
|
(0.4
|
)
|
pts
|
||||
|
Underwriting expense ratio
|
47.3
|
%
|
47.1
|
%
|
0.2
|
|
pts
|
||||
|
|
Year Ended December 31
|
||||||||||
|
($ in thousands)
|
2018
|
2017
|
Change
|
||||||||
|
Gross premiums written
|
$
|
913
|
|
$
|
234
|
|
$
|
679
|
|
290.2
|
%
|
|
Ceded premiums written
|
(230
|
)
|
(2,209
|
)
|
1,979
|
|
(89.6
|
%)
|
|||
|
Net premiums written
|
$
|
683
|
|
$
|
(1,975
|
)
|
$
|
2,658
|
|
(134.6
|
%)
|
|
Net premiums earned
|
$
|
683
|
|
$
|
(1,975
|
)
|
$
|
2,658
|
|
(134.6
|
%)
|
|
Gross losses
|
(14,761
|
)
|
(36,297
|
)
|
21,536
|
|
(59.3
|
%)
|
|||
|
Reinsurance recoveries
|
1,952
|
|
31,198
|
|
(29,246
|
)
|
(93.7
|
%)
|
|||
|
Net losses and loss adjustment expenses
|
(12,809
|
)
|
(5,099
|
)
|
(7,710
|
)
|
151.2
|
%
|
|||
|
Segment operating results, current year, before tax
|
(12,126
|
)
|
(7,074
|
)
|
(5,052
|
)
|
71.4
|
%
|
|||
|
Net adjustments to estimated losses, prior year
|
2,116
|
|
—
|
|
2,116
|
|
nm
|
|
|||
|
Segment operating results, before tax
|
$
|
(10,010
|
)
|
$
|
(7,074
|
)
|
$
|
(2,936
|
)
|
41.5
|
%
|
|
|
Year Ended December 31
|
||||||||
|
|
2018
|
|
2017
|
|
Change
|
||||
|
Calendar year net loss ratio
|
76.9
|
%
|
|
77.3
|
%
|
|
(0.4
|
)
|
pts
|
|
Less impact of prior accident years on the net loss ratio
|
2.9
|
%
|
|
(1.4
|
%)
|
|
4.3
|
|
pts
|
|
Current accident year net loss ratio
|
74.0
|
%
|
|
78.7
|
%
|
|
(4.7
|
)
|
pts
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Net investment income
|
$
|
86,960
|
|
|
$
|
92,867
|
|
|
$
|
(5,907
|
)
|
|
(6.4
|
%)
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
$
|
8,948
|
|
|
$
|
8,033
|
|
|
$
|
915
|
|
|
11.4
|
%
|
|
Net realized gains (losses)
|
$
|
(39,879
|
)
|
|
$
|
12,388
|
|
|
$
|
(52,267
|
)
|
|
(421.9
|
%)
|
|
Operating expense
|
$
|
18,767
|
|
|
$
|
29,275
|
|
|
$
|
(10,508
|
)
|
|
(35.9
|
%)
|
|
Interest expense
|
$
|
16,163
|
|
|
$
|
16,844
|
|
|
$
|
(681
|
)
|
|
(4.0
|
%)
|
|
Income tax expense (benefit)
|
$
|
(17,715
|
)
|
|
$
|
21,927
|
|
|
$
|
(39,642
|
)
|
|
(180.8
|
%)
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Fixed maturities
|
$
|
64,523
|
|
|
$
|
72,665
|
|
|
$
|
(8,142
|
)
|
|
(11.2
|
%)
|
|
Equities
|
21,418
|
|
|
17,198
|
|
|
4,220
|
|
|
24.5
|
%
|
|||
|
Short-term investments, including Other
|
5,351
|
|
|
7,643
|
|
|
(2,292
|
)
|
|
(30.0
|
%)
|
|||
|
BOLI
|
1,983
|
|
|
1,979
|
|
|
4
|
|
|
0.2
|
%
|
|||
|
Investment fees and expenses
|
(6,315
|
)
|
|
(6,618
|
)
|
|
303
|
|
|
(4.6
|
%)
|
|||
|
Net investment income
|
$
|
86,960
|
|
|
$
|
92,867
|
|
|
$
|
(5,907
|
)
|
|
(6.4
|
%)
|
|
|
Year Ended December 31
|
||
|
|
2018
|
|
2017
|
|
Average income yield
|
3.3%
|
|
3.1%
|
|
Average tax equivalent income yield
|
3.4%
|
|
3.5%
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
All other investments, primarily investment fund LPs/LLCs
|
$
|
33,270
|
|
|
$
|
28,685
|
|
|
$
|
4,585
|
|
|
16.0
|
%
|
|
Tax credit partnerships
|
(24,322
|
)
|
|
(20,652
|
)
|
|
(3,670
|
)
|
|
17.8
|
%
|
|||
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
$
|
8,948
|
|
|
$
|
8,033
|
|
|
$
|
915
|
|
|
11.4
|
%
|
|
|
Year Ended December 31
|
||||||
|
(In millions)
|
2018
|
|
2017
|
||||
|
Tax credits recognized during the period
|
$
|
21.0
|
|
|
$
|
23.1
|
|
|
Tax benefit of tax credit partnership operating losses
|
$
|
5.1
|
|
|
$
|
7.2
|
|
|
|
Year Ended December 31
|
||||||
|
(In thousands)
|
2018
|
|
2017
|
||||
|
GAAP net investment result:
|
|
|
|
||||
|
Net investment income
|
$
|
86,960
|
|
|
$
|
92,867
|
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
8,948
|
|
|
8,033
|
|
||
|
GAAP net investment result
|
$
|
95,908
|
|
|
$
|
100,900
|
|
|
|
|
|
|
||||
|
Pro forma tax-equivalent investment result
|
$
|
125,533
|
|
|
$
|
148,553
|
|
|
|
|
|
|
||||
|
Reconciliation of pro forma and GAAP tax-equivalent investment result:
|
|
|
|
||||
|
GAAP net investment result
|
$
|
95,908
|
|
|
$
|
100,900
|
|
|
Taxable equivalent adjustments, calculated using the 21% and 35% federal statutory tax rate for 2018 and 2017, respectively:
|
|
|
|
||||
|
State and municipal bonds
|
1,693
|
|
|
9,103
|
|
||
|
BOLI
|
527
|
|
|
1,065
|
|
||
|
Dividends received
|
772
|
|
|
1,930
|
|
||
|
Tax credit partnerships
|
26,633
|
|
|
35,555
|
|
||
|
Pro forma tax-equivalent investment result
|
$
|
125,533
|
|
|
$
|
148,553
|
|
|
|
Year Ended December 31
|
||||||
|
(In thousands)
|
2018
|
|
2017
|
||||
|
OTTI losses, total:
|
|
|
|
||||
|
State and municipal bonds
|
$
|
—
|
|
|
$
|
(850
|
)
|
|
Corporate debt
|
(490
|
)
|
|
(419
|
)
|
||
|
Investment in unconsolidated subsidiaries
|
—
|
|
|
(11,931
|
)
|
||
|
Portion of OTTI losses recognized in other comprehensive income before taxes:
|
|
|
|
||||
|
Corporate debt
|
—
|
|
|
248
|
|
||
|
Net impairment losses recognized in earnings
|
(490
|
)
|
|
(12,952
|
)
|
||
|
Gross realized gains, available-for-sale fixed maturities
|
5,940
|
|
|
6,622
|
|
||
|
Gross realized (losses), available-for-sale fixed maturities
|
(5,715
|
)
|
|
(3,092
|
)
|
||
|
Net realized gains (losses), equity investments
|
12,030
|
|
|
10,109
|
|
||
|
Net realized gains (losses), other investments
|
1,340
|
|
|
2,963
|
|
||
|
Change in unrealized holding gains (losses), equity investments
|
(49,398
|
)
|
|
7,837
|
|
||
|
Change in unrealized holding gains (losses), convertible securities, carried at fair value as a part of other investments
|
(3,849
|
)
|
|
896
|
|
||
|
Other
|
263
|
|
|
5
|
|
||
|
Net realized investment gains (losses)
|
$
|
(39,879
|
)
|
|
$
|
12,388
|
|
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Operating expenses
|
|
$
|
34,437
|
|
|
$
|
44,034
|
|
|
$
|
(9,597
|
)
|
|
(21.8
|
%)
|
|
Management fee offset
|
|
(15,670
|
)
|
|
(14,759
|
)
|
|
(911
|
)
|
|
6.2
|
%
|
|||
|
Segment Total
|
|
$
|
18,767
|
|
|
$
|
29,275
|
|
|
$
|
(10,508
|
)
|
|
(35.9
|
%)
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Senior Notes due 2023
|
$
|
13,429
|
|
|
$
|
13,429
|
|
|
$
|
—
|
|
|
—
|
%
|
|
Revolving Credit Agreement (including fees and amortization)
|
1,388
|
|
|
2,974
|
|
|
(1,586
|
)
|
|
(53.3
|
%)
|
|||
|
Mortgage Loans (including amortization)
|
1,425
|
|
|
65
|
|
|
1,360
|
|
|
2,092.3
|
%
|
|||
|
(Gain)/loss on interest rate cap
|
(153
|
)
|
|
339
|
|
|
(492
|
)
|
|
(145.1
|
%)
|
|||
|
Other
|
28
|
|
|
37
|
|
|
(9
|
)
|
|
(24.3
|
%)
|
|||
|
Interest expense
|
$
|
16,117
|
|
|
$
|
16,844
|
|
|
$
|
(727
|
)
|
|
(4.3
|
%)
|
|
|
Year Ended
December 31 |
||||||
|
(In thousands)
|
2018
|
|
2017
|
||||
|
Corporate segment income tax expense (benefit)
|
$
|
(17,715
|
)
|
|
$
|
21,927
|
|
|
Lloyd's Syndicates segment income tax expense (benefit)
|
(317
|
)
|
|
(568
|
)
|
||
|
Consolidated income tax expense (benefit)
|
$
|
(18,032
|
)
|
|
$
|
21,359
|
|
|
|
Year Ended December 31
|
||||
|
|
2018
|
|
2017
|
||
|
Statutory rate
(1)
|
21.0
|
%
|
|
35.0
|
%
|
|
Tax-exempt income
(2)
|
(8.6
|
%)
|
|
(6.5
|
%)
|
|
Tax credits
|
(72.6
|
%)
|
|
(18.0
|
%)
|
|
Non-U.S. operating results
|
7.8
|
%
|
|
0.7
|
%
|
|
Excess tax benefit on share-based compensation
|
(0.9
|
%)
|
|
(2.1
|
%)
|
|
Change in federal corporate tax rate
|
—
|
%
|
|
5.1
|
%
|
|
Change in limitation of future deductibility of certain executive compensation
|
—
|
%
|
|
2.7
|
%
|
|
Provision-to-return differences
|
(8.0
|
%)
|
|
(1.5
|
%)
|
|
Other
|
(0.8
|
%)
|
|
1.2
|
%
|
|
Effective tax rate
|
(62.1
|
%)
|
|
16.6
|
%
|
|
(1)
Effective January 1, 2018, the corporate statutory tax rate changed from 35% to 21% as a result of tax reform enacted by the TCJA.
|
|||||
|
(2)
Includes tax-exempt interest, dividends received deduction and change in cash surrender value of BOLI.
|
|||||
|
|
Year Ended December 31
|
|||||||||||
|
($ in thousands, except per share data)
|
2017
|
|
2016
|
|
Change
|
|||||||
|
Revenues:
|
|
|
|
|
|
|
||||||
|
Net premiums written
|
$
|
764,018
|
|
|
$
|
738,533
|
|
|
$
|
25,485
|
|
|
|
Net premiums earned
|
$
|
738,531
|
|
|
$
|
733,281
|
|
|
$
|
5,250
|
|
|
|
Net investment result
|
103,695
|
|
|
94,250
|
|
|
9,445
|
|
|
|||
|
Net realized investment gains (losses)
|
16,409
|
|
|
34,875
|
|
|
(18,466
|
)
|
|
|||
|
Other income
|
7,514
|
|
|
7,808
|
|
|
(294
|
)
|
|
|||
|
Total revenues
|
866,149
|
|
|
870,214
|
|
|
(4,065
|
)
|
|
|||
|
|
|
|
|
|
|
|
||||||
|
Expenses:
|
|
|
|
|
|
|
||||||
|
Net losses and loss adjustment expenses
|
469,158
|
|
|
443,229
|
|
|
25,929
|
|
|
|||
|
Underwriting, policy acquisition and operating expenses
|
235,753
|
|
|
227,610
|
|
|
8,143
|
|
|
|||
|
Segregated portfolio cells dividend expense (income)
|
15,771
|
|
|
8,142
|
|
|
7,629
|
|
|
|||
|
Interest expense
|
16,844
|
|
|
15,032
|
|
|
1,812
|
|
|
|||
|
Total expenses
|
737,526
|
|
|
694,013
|
|
|
43,513
|
|
|
|||
|
Income before income taxes
|
128,623
|
|
|
176,201
|
|
|
(47,578
|
)
|
|
|||
|
Income tax expense (benefit)
|
21,359
|
|
|
25,120
|
|
|
(3,761
|
)
|
|
|||
|
Net income
|
$
|
107,264
|
|
|
$
|
151,081
|
|
|
$
|
(43,817
|
)
|
|
|
Non-GAAP operating income
|
$
|
108,538
|
|
|
$
|
129,844
|
|
|
$
|
(21,306
|
)
|
|
|
Earnings per share:
|
|
|
|
|
|
|
||||||
|
Basic
|
$
|
2.01
|
|
|
$
|
2.84
|
|
|
$
|
(0.83
|
)
|
|
|
Diluted
|
$
|
2.00
|
|
|
$
|
2.83
|
|
|
$
|
(0.83
|
)
|
|
|
Non-GAAP operating earnings per share:
|
|
|
|
|
|
|
||||||
|
Basic
|
$
|
2.03
|
|
|
$
|
2.44
|
|
|
$
|
(0.41
|
)
|
|
|
Diluted
|
$
|
2.02
|
|
|
$
|
2.43
|
|
|
$
|
(0.41
|
)
|
|
|
Net loss ratio
|
63.5
|
%
|
|
60.4
|
%
|
|
3.1
|
|
pts
|
|||
|
Underwriting expense ratio
|
31.9
|
%
|
|
31.0
|
%
|
|
0.9
|
|
pts
|
|||
|
Combined ratio
|
95.4
|
%
|
|
91.4
|
%
|
|
4.0
|
|
pts
|
|||
|
Operating ratio
|
82.4
|
%
|
|
77.8
|
%
|
|
4.6
|
|
pts
|
|||
|
Effective tax rate
|
16.6
|
%
|
|
14.3
|
%
|
|
2.3
|
|
pts
|
|||
|
Return on equity
|
6.3
|
%
|
|
8.0
|
%
|
|
(1.7
|
)
|
pts
|
|||
|
In all tables that follow, that abbreviation "
nm
" indicates that the information or the percentage change is not meaningful.
|
||||||||||||
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
|
Net Premiums Earned
|
|
|
|
|
|
|
|
|||||||
|
Specialty P&C
|
$
|
449,823
|
|
|
$
|
454,506
|
|
|
$
|
(4,683
|
)
|
|
(1.0
|
%)
|
|
Workers' Compensation Insurance
|
163,309
|
|
|
161,988
|
|
|
1,321
|
|
|
0.8
|
%
|
|||
|
Segregated Portfolio Cell Reinsurance
|
68,197
|
|
|
62,137
|
|
|
6,060
|
|
|
9.8
|
%
|
|||
|
Lloyd's Syndicate
|
57,202
|
|
|
54,650
|
|
|
2,552
|
|
|
4.7
|
%
|
|||
|
Consolidated total
|
$
|
738,531
|
|
|
$
|
733,281
|
|
|
$
|
5,250
|
|
|
0.7
|
%
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
|
Net investment income
|
$
|
95,662
|
|
|
$
|
100,012
|
|
|
$
|
(4,350
|
)
|
|
(4.3
|
%)
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
8,033
|
|
|
(5,762
|
)
|
|
13,795
|
|
|
239.4
|
%
|
|||
|
Net investment result
|
$
|
103,695
|
|
|
$
|
94,250
|
|
|
$
|
9,445
|
|
|
10.0
|
%
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
|
Net impairment losses recognized in earnings
|
$
|
(12,952
|
)
|
|
$
|
(9,766
|
)
|
|
$
|
(3,186
|
)
|
|
32.6
|
%
|
|
Other net realized investment gains (losses)
|
29,361
|
|
|
44,641
|
|
|
(15,280
|
)
|
|
(34.2
|
%)
|
|||
|
Net realized investment gains (losses)
|
$
|
16,409
|
|
|
$
|
34,875
|
|
|
$
|
(18,466
|
)
|
|
(52.9
|
%)
|
|
|
Year Ended December 31
|
|||||||||||
|
($ in millions)
|
2017
|
|
2016
|
|
Change
|
|||||||
|
Current accident year net loss ratio
|
|
|
|
|
|
|
||||||
|
Consolidated ratio
|
81.7
|
%
|
|
80.1
|
%
|
|
1.6
|
|
pts
|
|||
|
Specialty P&C
|
89.9
|
%
|
|
88.7
|
%
|
|
1.2
|
|
pts
|
|||
|
Workers' Compensation Insurance
|
66.1
|
%
|
|
67.5
|
%
|
|
(1.4
|
)
|
pts
|
|||
|
Segregated Portfolio Cell Reinsurance
|
67.4
|
%
|
|
64.1
|
%
|
|
3.3
|
|
pts
|
|||
|
Lloyd's Syndicate
|
78.7
|
%
|
|
63.3
|
%
|
|
15.4
|
|
pts
|
|||
|
Calendar year net loss ratio
|
|
|
|
|
|
|
||||||
|
Consolidated ratio
|
63.5
|
%
|
|
60.4
|
%
|
|
3.1
|
|
pts
|
|||
|
Specialty P&C
|
63.4
|
%
|
|
58.5
|
%
|
|
4.9
|
|
pts
|
|||
|
Workers' Compensation Insurance
|
62.6
|
%
|
|
66.5
|
%
|
|
(3.9
|
)
|
pts
|
|||
|
Segregated Portfolio Cell Reinsurance
|
54.9
|
%
|
|
56.7
|
%
|
|
(1.8
|
)
|
pts
|
|||
|
Lloyd's Syndicate
|
77.3
|
%
|
|
62.4
|
%
|
|
14.9
|
|
pts
|
|||
|
Favorable (unfavorable) net loss development, prior accident years
|
|
|
|
|
|
|
||||||
|
Consolidated
|
$
|
134.4
|
|
|
$
|
143.8
|
|
|
$
|
(9.4
|
)
|
|
|
Specialty P&C
|
$
|
119.4
|
|
|
$
|
137.2
|
|
|
$
|
(17.8
|
)
|
|
|
Workers' Compensation Insurance
|
$
|
5.7
|
|
|
$
|
1.6
|
|
|
$
|
4.1
|
|
|
|
Segregated Portfolio Cell Reinsurance
|
$
|
8.5
|
|
|
$
|
4.6
|
|
|
$
|
3.9
|
|
|
|
Lloyd's Syndicate
|
$
|
0.8
|
|
|
$
|
0.5
|
|
|
$
|
0.3
|
|
|
|
|
Year Ended December 31
|
||||||||
|
|
2017
|
|
2016
|
|
Change
|
||||
|
Underwriting Expense Ratio
|
|
|
|
|
|
|
|||
|
Consolidated
|
31.9
|
%
|
|
31.0
|
%
|
|
0.9
|
|
pts
|
|
Specialty P&C
|
24.0
|
%
|
|
22.8
|
%
|
|
1.2
|
|
pts
|
|
Workers' Compensation Insurance
|
32.2
|
%
|
|
33.1
|
%
|
|
(0.9
|
)
|
pts
|
|
Segregated Portfolio Cell Reinsurance
|
30.4
|
%
|
|
30.5
|
%
|
|
(0.1
|
)
|
pts
|
|
Lloyd's Syndicate
|
47.1
|
%
|
|
41.8
|
%
|
|
5.3
|
|
pts
|
|
Corporate*
|
4.0
|
%
|
|
4.2
|
%
|
|
(0.2
|
)
|
pts
|
|
*There are no net premiums earned associated with the Corporate segment. Ratios shown are the contribution of the Corporate segment to the consolidated ratio (Corporate operating expenses divided by consolidated net premium earned).
|
|||||||||
|
|
Book Value Per Share
|
||
|
Book Value Per Share at December 31, 2016
|
$
|
33.78
|
|
|
Increase (decrease) to book value per share during the year ended December 31, 2017 attributable to:
|
|
||
|
Dividends declared
|
(5.93
|
)
|
|
|
Net income
|
2.01
|
|
|
|
Decrease in AOCI
|
(0.05
|
)
|
|
|
Other
|
0.02
|
|
|
|
Book Value Per Share at December 31, 2017
|
$
|
29.83
|
|
|
|
Year Ended December 31
|
||||||
|
(In thousands, except per share data)
|
2017
|
|
2016
|
||||
|
Net income
|
$
|
107,264
|
|
|
$
|
151,081
|
|
|
Items excluded in the calculation of Non-GAAP operating income:
|
|
|
|
||||
|
Net realized investment (gains) losses
|
(16,409
|
)
|
|
(34,875
|
)
|
||
|
Net realized gains (losses) attributable to SPCs which no profit/loss is retained
(1)
|
3,083
|
|
|
2,049
|
|
||
|
Guaranty fund assessments (recoupments)
|
(157
|
)
|
|
153
|
|
||
|
Pre-tax effect of exclusions
|
(13,483
|
)
|
|
(32,673
|
)
|
||
|
Tax effect, at 35%
(2)
|
4,719
|
|
|
11,436
|
|
||
|
After-tax effect of exclusions
|
(8,764
|
)
|
|
(21,237
|
)
|
||
|
Non-GAAP operating income, before tax reform adjustments
|
98,500
|
|
|
129,844
|
|
||
|
Tax reform adjustments on our deferred tax balances excluded in the calculation of Non-GAAP operating income:
|
|
|
|
||||
|
Adjustment of deferred taxes upon the change in corporate tax rate
(3)
|
6,541
|
|
|
—
|
|
||
|
Adjustment of deferred taxes upon the change in limitation of future deductibility of certain executive compensation
(3)
|
3,497
|
|
|
—
|
|
||
|
Non-GAAP operating income
|
$
|
108,538
|
|
|
$
|
129,844
|
|
|
Per diluted common share:
|
|
|
|
||||
|
Net income
|
$
|
2.00
|
|
|
$
|
2.83
|
|
|
Effect of exclusions
|
0.02
|
|
|
(0.40
|
)
|
||
|
Non-GAAP operating income per diluted common share
|
$
|
2.02
|
|
|
$
|
2.43
|
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
|
Net premiums written
|
$
|
466,621
|
|
|
$
|
454,718
|
|
|
$
|
11,903
|
|
|
2.6
|
%
|
|
|
|
|
|
|
|
|
|
|||||||
|
Net premiums earned
|
$
|
449,823
|
|
|
$
|
454,506
|
|
|
$
|
(4,683
|
)
|
|
(1.0
|
%)
|
|
Other income
|
5,688
|
|
|
5,306
|
|
|
382
|
|
|
7.2
|
%
|
|||
|
Net losses and loss adjustment expenses
|
(285,250
|
)
|
|
(266,090
|
)
|
|
(19,160
|
)
|
|
7.2
|
%
|
|||
|
Underwriting, policy acquisition and operating expenses
|
(107,972
|
)
|
|
(103,656
|
)
|
|
(4,316
|
)
|
|
4.2
|
%
|
|||
|
Segregated portfolio cells dividend (expense) income
|
(5,181
|
)
|
|
—
|
|
|
(5,181
|
)
|
|
nm
|
|
|||
|
Segment operating results
|
$
|
57,108
|
|
|
$
|
90,066
|
|
|
$
|
(32,958
|
)
|
|
(36.6
|
%)
|
|
|
|
|
|
|
|
|
|
|||||||
|
Net loss ratio
|
63.4%
|
|
58.5%
|
|
4.9
|
|
pts
|
|||||||
|
Underwriting expense ratio
|
24.0%
|
|
22.8%
|
|
1.2
|
|
pts
|
|||||||
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
|
Gross premiums written
|
$
|
549,323
|
|
|
$
|
535,725
|
|
|
$
|
13,598
|
|
|
2.5
|
%
|
|
Less: Ceded premiums written
|
82,702
|
|
|
81,007
|
|
|
1,695
|
|
|
2.1
|
%
|
|||
|
Net premiums written
|
$
|
466,621
|
|
|
$
|
454,718
|
|
|
$
|
11,903
|
|
|
2.6
|
%
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
|
Professional liability
|
|
|
|
|
|
|
|
|||||||
|
Physicians
(1)(7)
|
|
|
|
|
|
|
|
|||||||
|
Twelve month term
|
$
|
360,232
|
|
|
$
|
344,150
|
|
|
$
|
16,082
|
|
|
4.7
|
%
|
|
Twenty-four month term
|
27,370
|
|
|
21,869
|
|
|
5,501
|
|
|
25.2
|
%
|
|||
|
Total Physicians
|
387,602
|
|
|
366,019
|
|
|
21,583
|
|
|
5.9
|
%
|
|||
|
Healthcare facilities
(2)(7)
|
47,697
|
|
|
59,361
|
|
|
(11,664
|
)
|
|
(19.6
|
%)
|
|||
|
Other healthcare providers
(3)
|
32,599
|
|
|
33,353
|
|
|
(754
|
)
|
|
(2.3
|
%)
|
|||
|
Legal professionals
(4)
|
25,628
|
|
|
25,351
|
|
|
277
|
|
|
1.1
|
%
|
|||
|
Tail coverages
(5)
|
21,206
|
|
|
18,092
|
|
|
3,114
|
|
|
17.2
|
%
|
|||
|
Total professional liability
|
514,732
|
|
|
502,176
|
|
|
12,556
|
|
|
2.5
|
%
|
|||
|
Medical technology liability
(6)
|
34,164
|
|
|
33,067
|
|
|
1,097
|
|
|
3.3
|
%
|
|||
|
Other
|
427
|
|
|
482
|
|
|
(55
|
)
|
|
(11.4
|
%)
|
|||
|
Total
|
$
|
549,323
|
|
|
$
|
535,725
|
|
|
$
|
13,598
|
|
|
2.5
|
%
|
|
(1)
|
Physician policies were our greatest source of premium revenues in both 2017 and 2016. The increase in twelve month term policies in 2017 was primarily driven by new business written, including the addition of several large policies, and timing differences related to the renewal of certain policies, largely offset by retention losses. In addition, written premium reflected an increase in renewal pricing, driven by an increase in exposures for a few large policies. We offer twenty-four month term policies to our physician insureds in one selected jurisdiction. The increase in twenty-four month premium, as compared to 2016, primarily reflected the normal cycle of renewals (policies subject to renewal in 2017 were previously written in 2015 rather than in 2016).
|
|
(2)
|
Our healthcare facilities premium (which includes hospitals, surgery centers and other facilities) declined in 2017 as compared to 2016 driven by the effect of a novation agreement entered into during the fourth quarter of 2016. A novation represents a legal replacement of one insurer by another extinguishing the ceding entity's liability to the policyholder. The novation resulted in approximately $11.8 million of one-time gross premiums written and earned during the fourth quarter of 2016 as all the underlying loss events covered by the policy occurred in the past. After removing the impact of the novation, our healthcare facilities premium was relatively flat compared to 2016 due to several offsetting factors. While an increase in renewal pricing and new business written, including one large policy, increased written premium in 2017, the impact was offset by a timing difference related to the renewal of one large policy and retention losses during the period. Renewal pricing increased during 2017 due to changes in loss experience related to a few large policies.
|
|
(3)
|
Our other healthcare providers are primarily dentists, chiropractors and allied health professionals.
|
|
(4)
|
Our legal professionals policies are primarily individual and small group policies in select areas of practice. The increase in 2017 as compared to 2016 was primarily due to new business written and, to a lesser extent, an increase in the rate charged for certain renewed policies, largely offset by retention losses. Retention losses were primarily driven by competitive market conditions.
|
|
(5)
|
We offer extended reporting endorsement or "tail" coverage to insureds who discontinue their claims-made coverage with us, and we also periodically offer tail coverage through custom policies. The amount of tail coverage premium written can vary widely from period to period. The increase in 2017 as compared to 2016 was driven by the purchase of tail coverage for a few large claims-made policies in one jurisdiction that were rewritten to occurrence coverage in 2017. These policies are part of one of our shared risk arrangements and therefore, a large portion of the premium written was ceded during the current period (see further discussion in the Ceded Premiums Written section that follows).
|
|
(6)
|
Our medical technology liability business is marketed throughout the U.S.; coverage is offered on a primary basis, within specified limits, to manufacturers and distributors of medical technology and life sciences products including entities conducting human clinical trials. In addition to the previously listed factors that affect our premium volume, our medical technology liability premium volume is impacted by the sales volume of insureds. The increase in 2017 primarily reflected new business written, including two large policies during the fourth quarter of 2017, partially offset
|
|
(7)
|
Certain components of our gross premiums written include alternative market premiums. We cede either all or a portion of the alternative market premium, net of reinsurance, to certain SPCs of our wholly owned Cayman Islands reinsurance subsidiary, Eastern Re, which are reported in our Segregated Portfolio Cell Reinsurance segment (see further discussion in the Ceded Premiums Written section that follows). The portion not ceded to the SPCs is retained within our Specialty P&C segment. Alternative market gross premiums written by component were as follows:
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in millions)
|
2017
|
|
2016
|
|
Change
|
|||||||||
|
Physicians
|
$
|
1.2
|
|
|
$
|
1.2
|
|
|
$
|
—
|
|
|
—
|
%
|
|
Healthcare facilities
|
3.1
|
|
|
2.9
|
|
|
0.2
|
|
|
6.9
|
%
|
|||
|
Total
|
$
|
4.3
|
|
|
$
|
4.1
|
|
|
$
|
0.2
|
|
|
4.9
|
%
|
|
|
Year Ended December 31
|
||||||
|
(In millions)
|
2017
|
|
2016
|
||||
|
Physicians
|
$
|
31.6
|
|
|
$
|
32.8
|
|
|
Healthcare facilities
|
5.8
|
|
|
17.4
|
|
||
|
Other healthcare providers
|
2.1
|
|
|
3.4
|
|
||
|
Legal professionals
|
3.6
|
|
|
3.8
|
|
||
|
Medical technology liability
|
5.4
|
|
|
5.1
|
|
||
|
Total
|
$
|
48.5
|
|
|
$
|
62.5
|
|
|
|
Year Ended December 31
|
||||
|
|
2017
|
|
2016
|
||
|
Physicians*
|
90
|
%
|
|
88
|
%
|
|
Healthcare facilities*
|
86
|
%
|
|
79
|
%
|
|
Other healthcare providers*
|
85
|
%
|
|
85
|
%
|
|
Legal professionals
|
84
|
%
|
|
78
|
%
|
|
Medical technology liability
|
87
|
%
|
|
85
|
%
|
|
* Excludes certain policies written on an excess and surplus lines basis.
|
|||||
|
|
Year Ended December 31
|
|
|
|
2017
|
|
|
Physicians
(1)(2)
|
1
|
%
|
|
Healthcare facilities
(1)(2)
|
8
|
%
|
|
Other healthcare providers
(1)
|
2
|
%
|
|
Legal professionals
(2)
|
3
|
%
|
|
Medical technology liability
|
1
|
%
|
|
(1)
Excludes certain policies written on an excess and surplus lines basis.
|
||
|
(2)
See Gross Premiums Written section for further explanation of renewal pricing increase.
|
||
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
|
Excess of loss reinsurance arrangements
(1)
|
$
|
31,853
|
|
|
$
|
30,037
|
|
|
$
|
1,816
|
|
|
6.0
|
%
|
|
Premium ceded to Syndicate 1729
(2)
|
13,983
|
|
|
23,832
|
|
|
(9,849
|
)
|
|
(41.3
|
%)
|
|||
|
Other shared risk arrangements
(3)
|
30,780
|
|
|
26,737
|
|
|
4,043
|
|
|
15.1
|
%
|
|||
|
Premiums ceded to SPCs
(4)
|
3,914
|
|
|
3,963
|
|
|
(49
|
)
|
|
(1.2
|
%)
|
|||
|
Other ceded premiums written
|
3,361
|
|
|
3,521
|
|
|
(160
|
)
|
|
(4.5
|
%)
|
|||
|
Reduction in premiums owed under reinsurance agreements, prior accident years, net
(5)
|
(1,189
|
)
|
|
(7,083
|
)
|
|
5,894
|
|
|
(83.2
|
%)
|
|||
|
Total ceded premiums written
|
$
|
82,702
|
|
|
$
|
81,007
|
|
|
$
|
1,695
|
|
|
2.1
|
%
|
|
(1)
|
We generally reinsure risks under our excess of loss reinsurance arrangements pursuant to which the reinsurers agree to assume all or a portion of all risks that we insure above our individual risk retention levels, up to the maximum individual limits offered. In the majority of our excess of loss reinsurance arrangements, the premium due to the reinsurer is determined by the loss experience of that business reinsured, subject to certain minimum and maximum amounts. The increase in ceded premiums written under our excess of loss reinsurance arrangements for 2017 was primarily due to revised contract terms on our medical technology liability reinsurance arrangement effective January 1, 2017, which reduced the amount of excess premium we retain from 20% to 10%.
|
|
(2)
|
As previously discussed, we are the majority participant in Syndicate 1729 and normally record our pro rata share of its operating results in our Lloyd's Syndicate segment on a quarter delay, except when information is available that is material to the current period. We also record the cession to the Lloyd's Syndicate segment from our Specialty P&C segment on a quarter delay as the amounts are not material and this permits the cession to be reported by both the Lloyd's Syndicate segment and the Specialty P&C segment in the same reporting period. The decrease in ceded premiums to Syndicate 1729 for the year ended December 31, 2017 reflected the revised contract terms effective January 1, 2017 which reduced the premiums ceded by essentially half. We did not renew our quota share agreement with Syndicate 1729 on January 1, 2018, however the impact will not be reflected in ceded premiums until the second quarter of 2018 due to the previously mentioned quarter delay. See Lloyd's Syndicate segment results for further discussion on the quota share agreement. As our premiums are earned, we recognize the related ceding commission income which reduces underwriting expense by offsetting
|
|
(3)
|
We have entered into various shared risk arrangements, including quota share, fronting, and captive arrangements, with certain large healthcare systems and other insurance entities. These arrangements include our Ascension Health and CAPAssurance programs. While we cede a large portion of the premium written under these arrangements, they provide us an opportunity to grow net premium through strategic partnerships. The increase in 2017 was primarily driven by a few large tail endorsements that were written, and substantially ceded, related to one of these shared risk arrangements, as previously discussed. The remaining increase was due to growth in our Ascension Health and CAPAssurance programs.
|
|
(4)
|
As previously discussed, as a part of our alternative market solutions, all or a portion of certain healthcare premium written is ceded to the SPCs in our Segregated Portfolio Cell Reinsurance segment under either excess of loss or quota share reinsurance agreements, depending on the structure of the individual program. See the Segment Operating Results - Segregated Portfolio Cell Reinsurance section for further discussion on the cession to the SPCs from our Specialty P&C segment. The slight decrease in premiums ceded to the SPCs during 2017 was primarily driven by retention losses (see discussion in footnote 7 under the heading "Gross Premiums Written").
|
|
(5)
|
Given the length of time that it takes to resolve our claims, many years may elapse before all losses recoverable under a reinsurance arrangement are known. As a part of the process of estimating our loss reserve we also make estimates regarding the amounts recoverable under our reinsurance arrangements. As previously discussed, the premiums ultimately ceded under certain of our excess of loss reinsurance arrangements are subject to the losses ceded under the arrangements. Based upon adjustments in 2017 and 2016 to our estimate of expected losses and associated recoveries for prior year ceded losses, we reduced our estimate of ceded premiums owed to reinsurers. However, prior accident year ceded premium reductions were lower in 2017 as compared to 2016. In addition, the lower prior accident year ceded premium reduction in 2017 reflected an overall change in expected loss recoveries attributable to one large claim during the second quarter of 2017. We do not believe this isolated claim indicates a change in overall loss trends for us or the industry. Changes to estimates of premiums ceded related to prior accident years are fully earned in the period the changes in estimates occur.
|
|
|
Year Ended December 31
|
||||||||
|
|
2017
|
|
2016
|
|
Change
|
||||
|
Ceded premiums ratio, as reported
|
15.1
|
%
|
|
15.1
|
%
|
|
—
|
|
pts
|
|
Less the effect of reduction in premiums owed under reinsurance agreements, prior accident years (as previously discussed)
|
(0.2
|
%)
|
|
(1.3
|
%)
|
|
1.1
|
|
pts
|
|
Ratio, current accident year
|
15.3
|
%
|
|
16.4
|
%
|
|
(1.1
|
)
|
pts
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
|
Gross premiums earned
|
$
|
537,583
|
|
|
$
|
535,931
|
|
|
$
|
1,652
|
|
|
0.3
|
%
|
|
Less: Ceded premiums earned
|
87,760
|
|
|
81,425
|
|
|
6,335
|
|
|
7.8
|
%
|
|||
|
Net premiums earned
|
$
|
449,823
|
|
|
$
|
454,506
|
|
|
$
|
(4,683
|
)
|
|
(1.0
|
%)
|
|
|
Net Loss Ratios
(1)
|
|||||||
|
|
Year Ended December 31
|
|||||||
|
|
2017
|
|
2016
|
|
Change
|
|||
|
Calendar year net loss ratio
|
63.4
|
%
|
|
58.5
|
%
|
|
4.9
|
pts
|
|
Less impact of prior accident years on the net loss ratio
|
(26.5
|
%)
|
|
(30.2
|
%)
|
|
3.7
|
pts
|
|
Current accident year net loss ratio
|
89.9
|
%
|
|
88.7
|
%
|
|
1.2
|
pts
|
|
Less estimated ratio increase (decrease) attributable to:
|
|
|
|
|
|
|
||
|
Ceded premium reductions, prior accident years
(2)
|
(0.2
|
%)
|
|
(1.4
|
%)
|
|
1.2
|
pts
|
|
Current accident year net loss ratio, excluding the effect of prior year ceded premium
(3)
|
90.1
|
%
|
|
90.1
|
%
|
|
—
|
pts
|
|
(1)
|
Net losses, as specified, divided by net premiums earned.
|
|
(2)
|
Reductions to premiums owed under reinsurance agreements for prior accident years increased net premiums earned (the denominator of the current accident year ratio) in both 2017 and 2016, however, the reduction was substantially less in 2017 than in 2016. See the discussion in the Premiums section for our Specialty P&C segment under the heading "Ceded Premiums Written" for additional information.
|
|
(3)
|
The current accident year net loss ratio was unchanged as compared to 2016 primarily due to offsetting factors. Changes in the mix of business resulted in an 1.2 percentage point increase in the current accident year net loss ratio in 2017 as compared to 2016. However, the effect of a DDR reinsurance commutation during the fourth quarter of 2017 (reduction in current year net losses) partially offset the increase by 0.5 percentage points and the effect of a prior year novation (net premiums earned at a high loss ratio) partially offset the increase by 0.4 percentage points. Additional information regarding the prior year novation is included in the Premiums section for our Specialty P&C segment under the heading "Gross Premiums Written."
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
|
Specialty P&C segment:
|
|
|
|
|
|
|
|
|||||||
|
DPAC amortization
|
$
|
47,611
|
|
|
$
|
44,342
|
|
|
$
|
3,269
|
|
|
7.4
|
%
|
|
Management fees
|
6,620
|
|
|
6,447
|
|
|
173
|
|
|
2.7
|
%
|
|||
|
Other underwriting and operating expenses
|
53,741
|
|
|
52,867
|
|
|
874
|
|
|
1.7
|
%
|
|||
|
Total
|
$
|
107,972
|
|
|
$
|
103,656
|
|
|
$
|
4,316
|
|
|
4.2
|
%
|
|
|
Year Ended December 31
|
|||||||
|
|
2017
|
|
2016
|
|
Change
|
|||
|
Underwriting expense ratio
|
24.0
|
%
|
|
22.8
|
%
|
|
1.2
|
pts
|
|
|
Year Ended December 31
|
||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
||||||||
|
Net premiums written
|
$
|
173,566
|
|
|
$
|
163,513
|
|
|
$
|
10,053
|
|
6.1
|
%
|
|
|
|
|
|
|
|
|
|||||||
|
Net premiums earned
|
$
|
163,309
|
|
|
$
|
161,988
|
|
|
$
|
1,321
|
|
0.8
|
%
|
|
Other income
|
2,096
|
|
|
2,218
|
|
|
(122
|
)
|
(5.5
|
%)
|
|||
|
Net losses and loss adjustment expenses
|
(102,233
|
)
|
|
(107,791
|
)
|
|
5,558
|
|
(5.2
|
%)
|
|||
|
Underwriting, policy acquisition and operating expenses
|
(52,576
|
)
|
|
(53,597
|
)
|
|
1,021
|
|
(1.9
|
%)
|
|||
|
Segment operating results
|
$
|
10,596
|
|
|
$
|
2,818
|
|
|
$
|
7,778
|
|
276.0
|
%
|
|
|
|
|
|
|
|
|
|||||||
|
Net loss ratio
|
62.6%
|
|
66.5%
|
|
(3.9
|
)
|
pts
|
||||||
|
Underwriting expense ratio
|
32.2%
|
|
33.1%
|
|
(0.9
|
)
|
pts
|
||||||
|
|
Year Ended December 31
|
||||||||||
|
($ in thousands)
|
2017
|
2016
|
Change
|
||||||||
|
Gross premiums written
|
$
|
264,048
|
|
$
|
248,875
|
|
$
|
15,173
|
|
6.1
|
%
|
|
Less: Ceded premiums written
|
90,482
|
|
85,362
|
|
5,120
|
|
6.0
|
%
|
|||
|
Net premiums written
|
$
|
173,566
|
|
$
|
163,513
|
|
$
|
10,053
|
|
6.1
|
%
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
|
Traditional business:
|
|
|
|
|
|
|
|
|||||||
|
Guaranteed cost
|
$
|
143,141
|
|
|
$
|
128,304
|
|
|
$
|
14,837
|
|
|
11.6
|
%
|
|
Policyholder dividend
|
20,388
|
|
|
21,547
|
|
|
(1,159
|
)
|
|
(5.4
|
%)
|
|||
|
Deductible
|
8,362
|
|
|
9,006
|
|
|
(644
|
)
|
|
(7.2
|
%)
|
|||
|
Retrospective
|
3,428
|
|
|
5,337
|
|
|
(1,909
|
)
|
|
(35.8
|
%)
|
|||
|
Other
|
8,185
|
|
|
8,766
|
|
|
(581
|
)
|
|
(6.6
|
%)
|
|||
|
Alternative market business
|
80,544
|
|
|
75,915
|
|
|
4,629
|
|
|
6.1
|
%
|
|||
|
Total
|
$
|
264,048
|
|
|
$
|
248,875
|
|
|
$
|
15,173
|
|
|
6.1
|
%
|
|
|
Year Ended December 31
|
||||||||||||||||||
|
|
2017
|
|
2016
|
||||||||||||||||
|
($ in millions)
|
Traditional Business
|
Alternative Market Business
|
Segment
Results |
|
Traditional Business
|
Alternative Market Business
|
Segment
Results |
||||||||||||
|
New business
|
$
|
37.8
|
|
$
|
9.9
|
|
$
|
47.7
|
|
|
$
|
22.8
|
|
$
|
10.2
|
|
$
|
33.0
|
|
|
Audit premium (including EBUB)
|
$
|
2.7
|
|
$
|
1.4
|
|
$
|
4.1
|
|
|
$
|
5.2
|
|
$
|
1.1
|
|
$
|
6.3
|
|
|
Retention rate
(1)
|
85
|
%
|
92
|
%
|
87
|
%
|
|
84
|
%
|
88
|
%
|
85
|
%
|
||||||
|
Change in renewal pricing
(2)
|
(3
|
%)
|
(4
|
%)
|
(3
|
%)
|
|
(1
|
%)
|
(1
|
%)
|
(1
|
%)
|
||||||
|
(1)
We calculate our workers' compensation retention rate as annualized expiring renewed premium divided by all annualized expiring premium subject to renewal. Our retention rate can be impacted by various factors, including price or other competitive issues, insureds being acquired, or a decision not to renew based on our underwriting evaluation.
|
|||||||||||||||||||
|
(2)
The pricing of our business includes an assessment of the underlying policy exposure and the effects of current market conditions. We continue to base our pricing on expected losses, as indicated by our historical loss data.
|
|||||||||||||||||||
|
|
Year Ended December 31
|
||||||||||
|
($ in thousands)
|
2017
|
2016
|
Change
|
||||||||
|
Premiums ceded to SPCs
|
$
|
73,761
|
|
$
|
68,258
|
|
$
|
5,503
|
|
8.1
|
%
|
|
Premiums ceded to external reinsurers
|
9,823
|
|
10,255
|
|
(432
|
)
|
(4.2
|
%)
|
|||
|
Premiums ceded to unaffiliated captive insurers
|
6,784
|
|
7,658
|
|
(874
|
)
|
(11.4
|
%)
|
|||
|
Change in return premium estimate under external reinsurance
|
114
|
|
(809
|
)
|
923
|
|
(114.1
|
%)
|
|||
|
Total ceded premiums written
|
$
|
90,482
|
|
$
|
85,362
|
|
$
|
5,120
|
|
6.0
|
%
|
|
|
Year Ended December 31
|
||||||
|
|
2017
|
2016
|
Change
|
||||
|
Ceded premiums ratio, as reported
|
35.7
|
%
|
34.4
|
%
|
1.3
|
|
pts
|
|
Less the effect of:
|
|
|
|
|
|
||
|
Premiums ceded to SPCs (100%)
|
25.9
|
%
|
24.3
|
%
|
1.6
|
|
pts
|
|
Premiums ceded to unaffiliated captive insurer (100%)
|
4.1
|
%
|
4.6
|
%
|
(0.5
|
)
|
pts
|
|
Return premium estimated under external reinsurance
|
(0.1
|
%)
|
0.5
|
%
|
(0.6
|
)
|
pts
|
|
Assumed premiums earned
|
(0.3
|
%)
|
(0.3
|
%)
|
—
|
|
pts
|
|
Ceded premiums ratio, less the effects of above
|
6.1
|
%
|
5.3
|
%
|
0.8
|
|
pts
|
|
|
Year Ended December 31
|
||||||||||
|
($ in thousands)
|
2017
|
2016
|
Change
|
||||||||
|
Gross premiums earned
|
$
|
253,944
|
|
$
|
247,092
|
|
$
|
6,852
|
|
2.8
|
%
|
|
Less: Ceded premiums earned
|
90,635
|
|
85,104
|
|
5,531
|
|
6.5
|
%
|
|||
|
Net premiums earned
|
$
|
163,309
|
|
$
|
161,988
|
|
$
|
1,321
|
|
0.8
|
%
|
|
|
Year Ended December 31
|
||||||
|
|
2017
|
2016
|
Change
|
||||
|
Calendar year net loss ratio
|
62.6
|
%
|
66.5
|
%
|
(3.9
|
)
|
pts
|
|
Less impact of prior accident years on the net loss ratio
|
(3.5
|
%)
|
(1.0
|
%)
|
(2.5
|
)
|
pts
|
|
Current accident year net loss ratio
|
66.1
|
%
|
67.5
|
%
|
(1.4
|
)
|
pts
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
|
DPAC amortization
|
$
|
31,433
|
|
|
$
|
29,325
|
|
|
$
|
2,108
|
|
|
7.2
|
%
|
|
Management fees
|
1,975
|
|
|
1,857
|
|
|
118
|
|
|
6.4
|
%
|
|||
|
Other underwriting and operating expenses
|
36,791
|
|
|
39,159
|
|
|
(2,368
|
)
|
|
(6.0
|
%)
|
|||
|
SPC commission income offset
|
(17,623
|
)
|
|
(16,744
|
)
|
|
(879
|
)
|
|
5.2
|
%
|
|||
|
Total
|
$
|
52,576
|
|
|
$
|
53,597
|
|
|
$
|
(1,021
|
)
|
|
(1.9
|
%)
|
|
|
Year Ended December 31
|
||||||||
|
|
2017
|
|
2016
|
|
Change
|
||||
|
Underwriting expense ratio, as reported
|
32.2
|
%
|
|
33.1
|
%
|
|
(0.9
|
)
|
pts
|
|
Less estimated ratio increase (decrease) attributable to:
|
|
|
|
|
|
|
|
||
|
Impact of commission income received from SPCs
|
3.4
|
%
|
|
3.5
|
%
|
|
(0.1
|
)
|
pts
|
|
Amortization of intangible assets
|
1.2
|
%
|
|
2.2
|
%
|
|
(1.0
|
)
|
pts
|
|
Management fees
|
0.8
|
%
|
|
0.8
|
%
|
|
—
|
|
pts
|
|
Impact of audit premium
|
(0.3
|
%)
|
|
(0.6
|
%)
|
|
0.3
|
|
pts
|
|
Underwriting expense ratio, less listed effects
|
27.1
|
%
|
|
27.2
|
%
|
|
(0.1
|
)
|
pts
|
|
|
Year Ended December 31
|
||||||||||
|
($ in thousands)
|
2017
|
2016
|
Change
|
||||||||
|
Net premiums written
|
$
|
68,862
|
|
$
|
64,028
|
|
$
|
4,834
|
|
7.5
|
%
|
|
|
|
|
|
|
|||||||
|
Net premiums earned
|
$
|
68,197
|
|
$
|
62,137
|
|
$
|
6,060
|
|
9.8
|
%
|
|
Net investment income
|
1,059
|
|
711
|
|
348
|
|
48.9
|
%
|
|||
|
Net realized gains (losses)
|
3,914
|
|
2,525
|
|
1,389
|
|
55.0
|
%
|
|||
|
Other income
|
115
|
|
18
|
|
97
|
|
538.9
|
%
|
|||
|
Net losses and loss adjustment expenses
|
(37,455
|
)
|
(35,232
|
)
|
(2,223
|
)
|
6.3
|
%
|
|||
|
Underwriting, policy acquisition and operating expenses
|
(20,764
|
)
|
(18,936
|
)
|
(1,828
|
)
|
9.7
|
%
|
|||
|
SPC net operating results
|
15,066
|
|
11,223
|
|
3,843
|
|
34.2
|
%
|
|||
|
SPC dividend (expense) income
(1)
|
(10,590
|
)
|
(8,142
|
)
|
(2,448
|
)
|
30.1
|
%
|
|||
|
Segment operating results
(2)
|
$
|
4,476
|
|
$
|
3,081
|
|
$
|
1,395
|
|
45.3
|
%
|
|
|
|
|
|
|
|||||||
|
Net loss ratio
|
54.9%
|
56.7%
|
(1.8
|
)
|
pts
|
||||||
|
Underwriting expense ratio
|
30.4%
|
30.5%
|
(0.1
|
)
|
pts
|
||||||
|
(1)
Represents the operating (profit) loss due to external cell participants.
|
|||||||||||
|
(2)
Represents our share of the operating profit (loss) of the SPCs in which we participate.
|
|||||||||||
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
|
Gross premiums written
|
$
|
77,675
|
|
|
$
|
72,221
|
|
|
$
|
5,454
|
|
|
7.6
|
%
|
|
Less: Ceded premiums written
|
8,813
|
|
|
8,193
|
|
|
620
|
|
|
7.6
|
%
|
|||
|
Net premiums written
|
$
|
68,862
|
|
|
$
|
64,028
|
|
|
$
|
4,834
|
|
|
7.5
|
%
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
|
Workers' compensation
|
$
|
73,761
|
|
|
$
|
68,258
|
|
|
$
|
5,503
|
|
|
8.1
|
%
|
|
Healthcare professional liability
|
3,914
|
|
|
3,963
|
|
|
(49
|
)
|
|
(1.2
|
%)
|
|||
|
Gross Premiums Written
|
$
|
77,675
|
|
|
$
|
72,221
|
|
|
$
|
5,454
|
|
|
7.6
|
%
|
|
|
|
Year Ended December 31
|
||||||
|
($ in millions)
|
|
2017
|
|
2016
|
||||
|
New business
|
|
$
|
9.9
|
|
|
$
|
10.2
|
|
|
Audit premium (including EBUB)
|
|
$
|
1.4
|
|
|
$
|
1.1
|
|
|
Retention rate
(1)
|
|
92
|
%
|
|
88
|
%
|
||
|
Change in renewal pricing
(2)
|
|
(4
|
%)
|
|
(1
|
%)
|
||
|
(1)
We calculate our workers' compensation retention rate as annualized expiring renewed premium divided by all annualized expiring premium subject to renewal. Our retention rate can be impacted by various factors, including price or other competitive issues, insureds being acquired, or a decision not to renew based on our underwriting evaluation.
|
||||||||
|
(2)
The pricing of our business includes an assessment of the underlying policy exposure and the effects of current market conditions. We continue to base our pricing on expected losses, as indicated by our historical loss data.
|
||||||||
|
|
Year Ended December 31
|
||||||||||
|
($ in thousands)
|
2017
|
2016
|
Change
|
||||||||
|
Ceded premiums written
|
$
|
8,813
|
|
$
|
8,193
|
|
$
|
620
|
|
7.6
|
%
|
|
|
Year Ended December 31
|
||||||
|
|
2017
|
|
2016
|
|
Change
|
||
|
Ceded premiums ratio
|
11.9%
|
|
12.0%
|
|
(0.1
|
)
|
pts
|
|
|
Year Ended December 31
|
||||||||||
|
($ in thousands)
|
2017
|
2016
|
Change
|
||||||||
|
Gross premiums earned
|
$
|
76,911
|
|
$
|
70,209
|
|
$
|
6,702
|
|
9.5
|
%
|
|
Less: Ceded premiums earned
|
8,714
|
|
8,072
|
|
642
|
|
8.0
|
%
|
|||
|
Net premiums earned
|
$
|
68,197
|
|
$
|
62,137
|
|
$
|
6,060
|
|
9.8
|
%
|
|
|
Year Ended December 31
|
||||||||
|
|
2017
|
|
2016
|
|
Change
|
||||
|
Calendar year net loss ratio
|
54.9
|
%
|
|
56.7
|
%
|
|
(1.8
|
)
|
pts
|
|
Less impact of prior accident years on the net loss ratio
|
(12.5
|
%)
|
|
(7.4
|
%)
|
|
(5.1
|
)
|
pts
|
|
Current accident year net loss ratio
|
67.4
|
%
|
|
64.1
|
%
|
|
3.3
|
|
pts
|
|
Less impact of audit premium related to workers' compensation business
|
(1.4
|
%)
|
|
(1.2
|
%)
|
|
(0.2
|
)
|
pts
|
|
Current accident year net loss ratio, excluding the effect of audit premium
|
68.8
|
%
|
|
65.3
|
%
|
|
3.5
|
|
pts
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
|
DPAC amortization
|
$
|
19,927
|
|
|
$
|
18,385
|
|
|
$
|
1,542
|
|
|
8.4
|
%
|
|
Other underwriting and operating expenses
|
837
|
|
|
551
|
|
|
286
|
|
|
51.9
|
%
|
|||
|
Total
|
$
|
20,764
|
|
|
$
|
18,936
|
|
|
$
|
1,828
|
|
|
9.7
|
%
|
|
|
Year Ended December 31
|
||||||||
|
|
2017
|
|
2016
|
|
Change
|
||||
|
Underwriting expense ratio, as reported
|
30.4
|
%
|
|
30.5
|
%
|
|
(0.1
|
)
|
pts
|
|
Less impact of audit premium on expense ratio
|
(0.6
|
%)
|
|
(0.6
|
%)
|
|
—
|
|
pts
|
|
Underwriting expense ratio, excluding the effect of audit premium
|
31.0
|
%
|
|
31.1
|
%
|
|
(0.1
|
)
|
pts
|
|
|
Year Ended December 31
|
||||||||||
|
($ in thousands)
|
2017
|
2016
|
Change
|
||||||||
|
Gross premiums written
|
$
|
70,224
|
|
$
|
65,157
|
|
$
|
5,067
|
|
7.8
|
%
|
|
Ceded premiums written
|
(15,255
|
)
|
(8,883
|
)
|
(6,372
|
)
|
71.7
|
%
|
|||
|
Net premiums written
|
$
|
54,969
|
|
$
|
56,274
|
|
$
|
(1,305
|
)
|
(2.3
|
%)
|
|
|
|
|
|
|
|||||||
|
Net premiums earned
|
$
|
57,202
|
|
$
|
54,650
|
|
$
|
2,552
|
|
4.7
|
%
|
|
Net investment income
|
1,736
|
|
1,410
|
|
326
|
|
23.1
|
%
|
|||
|
Net realized gains (losses)
|
107
|
|
76
|
|
31
|
|
40.8
|
%
|
|||
|
Other income
|
(1,476
|
)
|
1,415
|
|
(2,891
|
)
|
(204.3
|
%)
|
|||
|
Net losses and loss adjustment expenses
|
(44,220
|
)
|
(34,116
|
)
|
(10,104
|
)
|
29.6
|
%
|
|||
|
Underwriting, policy acquisition and operating expenses
|
(26,963
|
)
|
(22,832
|
)
|
(4,131
|
)
|
18.1
|
%
|
|||
|
Income tax benefit (expense)
|
568
|
|
(384
|
)
|
952
|
|
(247.9
|
%)
|
|||
|
Segment operating results
|
$
|
(13,046
|
)
|
$
|
219
|
|
$
|
(13,265
|
)
|
(6,057.1
|
%)
|
|
|
|
|
|
|
|||||||
|
Net loss ratio
|
77.3
|
%
|
62.4
|
%
|
14.9
|
|
pts
|
||||
|
Underwriting expense ratio
|
47.1
|
%
|
41.8
|
%
|
5.3
|
|
pts
|
||||
|
(In thousands)
|
Year Ended
December 31, 2017
|
||
|
Gross premiums written
|
$
|
234
|
|
|
Ceded premiums written
|
(2,209
|
)
|
|
|
Net premiums written
|
$
|
(1,975
|
)
|
|
Net premiums earned
|
$
|
(1,975
|
)
|
|
Gross losses
|
(36,297
|
)
|
|
|
Reinsurance recoveries
|
31,198
|
|
|
|
Net losses and loss adjustment expenses
|
(5,099
|
)
|
|
|
Segment operating results, before tax
|
$
|
(7,074
|
)
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
|
Net investment income
|
$
|
92,867
|
|
|
$
|
97,891
|
|
|
$
|
(5,024
|
)
|
|
(5.1
|
%)
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
$
|
8,033
|
|
|
$
|
(5,762
|
)
|
|
$
|
13,795
|
|
|
239.4
|
%
|
|
Net realized gains (losses)
|
$
|
12,388
|
|
|
$
|
32,274
|
|
|
$
|
(19,886
|
)
|
|
61.6
|
%
|
|
Operating expense
|
$
|
29,275
|
|
|
$
|
30,807
|
|
|
$
|
(1,532
|
)
|
|
(5.0
|
%)
|
|
Interest expense
|
$
|
16,844
|
|
|
$
|
15,032
|
|
|
$
|
1,812
|
|
|
12.1
|
%
|
|
Income tax expense (benefit)
|
$
|
21,927
|
|
|
$
|
24,736
|
|
|
$
|
(2,809
|
)
|
|
(11.4
|
%)
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
|
Fixed maturities
|
$
|
72,665
|
|
|
$
|
83,517
|
|
|
$
|
(10,852
|
)
|
|
(13.0
|
%)
|
|
Equities
|
17,198
|
|
|
14,887
|
|
|
2,311
|
|
|
15.5
|
%
|
|||
|
Other investments, including Short-term
|
7,643
|
|
|
3,343
|
|
|
4,300
|
|
|
128.6
|
%
|
|||
|
BOLI
|
1,979
|
|
|
2,008
|
|
|
(29
|
)
|
|
(1.4
|
%)
|
|||
|
Investment fees and expenses
|
(6,618
|
)
|
|
(5,864
|
)
|
|
(754
|
)
|
|
12.9
|
%
|
|||
|
Net investment income
|
$
|
92,867
|
|
|
$
|
97,891
|
|
|
$
|
(5,024
|
)
|
|
(5.1
|
%)
|
|
|
Year Ended December 31
|
||
|
|
2017
|
|
2016
|
|
Average income yield
|
3.1%
|
|
3.3%
|
|
Average tax equivalent income yield
|
3.5%
|
|
3.8%
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
|
Investment LPs/LLCs
|
$
|
28,685
|
|
|
$
|
19,055
|
|
|
$
|
9,630
|
|
|
50.5
|
%
|
|
Tax credit partnerships
|
(20,652
|
)
|
|
(24,817
|
)
|
|
4,165
|
|
|
(16.8
|
%)
|
|||
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
$
|
8,033
|
|
|
$
|
(5,762
|
)
|
|
$
|
13,795
|
|
|
239.4
|
%
|
|
|
Year Ended December 31
|
||||||
|
(In millions)
|
2017
|
|
2016
|
||||
|
Tax credits recognized during the period
|
$
|
23.1
|
|
|
$
|
27.5
|
|
|
Tax benefit of tax credit partnership operating losses
|
$
|
7.2
|
|
|
$
|
8.7
|
|
|
|
Year Ended December 31
|
||||||
|
(In thousands)
|
2017
|
|
2016
|
||||
|
GAAP net investment result:
|
|
|
|
||||
|
Net investment income
|
$
|
92,867
|
|
|
$
|
97,891
|
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
8,033
|
|
|
(5,762
|
)
|
||
|
GAAP net investment result
|
$
|
100,900
|
|
|
$
|
92,129
|
|
|
|
|
|
|
||||
|
Pro forma tax-equivalent investment result
|
$
|
148,553
|
|
|
$
|
149,248
|
|
|
|
|
|
|
||||
|
Reconciliation of pro forma and GAAP tax-equivalent investment result:
|
|
|
|
||||
|
GAAP net investment result
|
$
|
100,900
|
|
|
$
|
92,129
|
|
|
Taxable equivalent adjustments, calculated using the 35% federal statutory tax rate:
|
|
|
|
||||
|
State and municipal bonds
|
9,103
|
|
|
11,698
|
|
||
|
BOLI
|
1,065
|
|
|
1,081
|
|
||
|
Dividends received
|
1,930
|
|
|
1,957
|
|
||
|
Tax credit partnerships
|
35,555
|
|
|
42,383
|
|
||
|
Pro forma tax-equivalent investment result
|
$
|
148,553
|
|
|
$
|
149,248
|
|
|
|
Year Ended December 31
|
||||||
|
(In thousands)
|
2017
|
|
2016
|
||||
|
OTTI losses, total:
|
|
|
|
||||
|
State and municipal bonds
|
$
|
(850
|
)
|
|
$
|
(100
|
)
|
|
Corporate debt
|
(419
|
)
|
|
(7,604
|
)
|
||
|
Investment in unconsolidated subsidiaries
|
(11,931
|
)
|
|
—
|
|
||
|
Other investments
|
—
|
|
|
(3,130
|
)
|
||
|
Portion recognized in OCI:
|
|
|
|
||||
|
Corporate debt
|
248
|
|
|
1,068
|
|
||
|
Net impairment losses recognized in earnings
|
(12,952
|
)
|
|
(9,766
|
)
|
||
|
Gross realized gains, available-for-sale fixed maturities
|
6,622
|
|
|
12,369
|
|
||
|
Gross realized (losses), available-for-sale fixed maturities
|
(3,092
|
)
|
|
(7,027
|
)
|
||
|
Net realized gains (losses), equity investments
|
10,109
|
|
|
6,646
|
|
||
|
Net realized gains (losses), other investments
|
2,963
|
|
|
1,115
|
|
||
|
Change in unrealized holding gains (losses), equity investments
|
7,837
|
|
|
28,013
|
|
||
|
Change in unrealized holding gains (losses), convertible securities, carried at fair value as a part of other investments
|
896
|
|
|
899
|
|
||
|
Other
|
5
|
|
|
25
|
|
||
|
Net realized investment gains (losses)
|
$
|
12,388
|
|
|
$
|
32,274
|
|
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
|
2017
|
|
2016
|
|
Change
|
|||||||||
|
Operating expenses
|
|
$
|
44,034
|
|
|
$
|
45,116
|
|
|
$
|
(1,082
|
)
|
|
(2.4
|
%)
|
|
Management fee offset
|
|
(14,759
|
)
|
|
(14,309
|
)
|
|
(450
|
)
|
|
3.1
|
%
|
|||
|
Segment Total
|
|
$
|
29,275
|
|
|
$
|
30,807
|
|
|
$
|
(1,532
|
)
|
|
(5.0
|
%)
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2017
|
|
2016
|
|
Change
|
|||||||||
|
Senior Notes due 2023
|
$
|
13,429
|
|
|
$
|
13,429
|
|
|
$
|
—
|
|
|
—
|
%
|
|
Revolving Credit Agreement (including fees and amortization)
|
2,974
|
|
|
1,564
|
|
|
1,410
|
|
|
90.2
|
%
|
|||
|
Mortgage Loans (including amortization)
|
65
|
|
|
—
|
|
|
65
|
|
|
nm
|
|
|||
|
(Gain)/loss on interest rate cap
|
339
|
|
|
—
|
|
|
339
|
|
|
nm
|
|
|||
|
Other
|
37
|
|
|
39
|
|
|
(2
|
)
|
|
(5.1
|
%)
|
|||
|
Interest expense
|
$
|
16,844
|
|
|
$
|
15,032
|
|
|
$
|
1,812
|
|
|
12.1
|
%
|
|
|
Year Ended
December 31 |
||||||
|
(In thousands)
|
2017
|
|
2016
|
||||
|
Corporate segment income tax expense (benefit)
|
$
|
21,927
|
|
|
$
|
24,736
|
|
|
Lloyd's Syndicate segment income tax expense (benefit)
|
(568
|
)
|
|
384
|
|
||
|
Consolidated income tax expense (benefit)
|
$
|
21,359
|
|
|
$
|
25,120
|
|
|
|
Year Ended
December 31 |
||||
|
|
2017
|
|
2016
|
||
|
Statutory rate
|
35.0
|
%
|
|
35.0
|
%
|
|
Tax-exempt income
*
|
(6.5
|
%)
|
|
(5.6
|
%)
|
|
Tax credits
|
(18.0
|
%)
|
|
(15.6
|
%)
|
|
Non-U.S. operating results
|
0.7
|
%
|
|
(1.0
|
%)
|
|
Excess tax benefit on share-based compensation
|
(2.1
|
%)
|
|
—
|
%
|
|
Change in federal corporate tax rate
|
5.1
|
%
|
|
—
|
%
|
|
Change in limitation of future deductibility of certain executive compensation
|
2.7
|
%
|
|
—
|
%
|
|
Provision-to-return differences
|
(1.5
|
%)
|
|
0.7
|
%
|
|
Other
|
1.2
|
%
|
|
0.8
|
%
|
|
Effective tax rate
|
16.6
|
%
|
|
14.3
|
%
|
|
*
Includes tax-exempt interest, dividends received deduction and change in cash surrender value of BOLI.
|
|||||
|
|
Interest Rate Shift in Basis Points
|
||||||||||||||||||
|
|
December 31, 2018
|
||||||||||||||||||
|
($ in millions)
|
(200)
|
|
(100)
|
|
Current
|
|
100
|
|
200
|
||||||||||
|
Fair Value:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
U.S. Treasury obligations
|
$
|
127
|
|
|
$
|
124
|
|
|
$
|
120
|
|
|
$
|
117
|
|
|
$
|
114
|
|
|
U.S. Government-sponsored enterprise obligations
|
36
|
|
|
36
|
|
|
35
|
|
|
34
|
|
|
33
|
|
|||||
|
State and municipal bonds
|
316
|
|
|
305
|
|
|
294
|
|
|
283
|
|
|
273
|
|
|||||
|
Corporate debt
|
1,300
|
|
|
1,261
|
|
|
1,224
|
|
|
1,187
|
|
|
1,153
|
|
|||||
|
Asset-backed securities
|
443
|
|
|
432
|
|
|
421
|
|
|
409
|
|
|
396
|
|
|||||
|
Total fixed maturities, available for sale
|
$
|
2,222
|
|
|
$
|
2,158
|
|
|
$
|
2,094
|
|
|
$
|
2,030
|
|
|
$
|
1,969
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Duration:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
U.S. Treasury obligations
|
2.77
|
|
|
2.70
|
|
|
2.63
|
|
|
2.57
|
|
|
2.50
|
|
|||||
|
U.S. Government-sponsored enterprise obligations
|
0.66
|
|
|
0.98
|
|
|
2.65
|
|
|
3.77
|
|
|
4.18
|
|
|||||
|
State and municipal bonds
|
3.61
|
|
|
3.58
|
|
|
3.59
|
|
|
3.64
|
|
|
3.73
|
|
|||||
|
Corporate debt
|
2.98
|
|
|
2.97
|
|
|
2.93
|
|
|
2.89
|
|
|
2.83
|
|
|||||
|
Asset-backed securities
|
2.18
|
|
|
2.46
|
|
|
2.86
|
|
|
3.11
|
|
|
3.23
|
|
|||||
|
Total fixed maturities, available for sale
|
2.86
|
|
|
2.91
|
|
|
2.99
|
|
|
3.04
|
|
|
3.04
|
|
|||||
|
|
Interest Rate Shift in Basis Points
|
||||||||||||||||||
|
|
December 31, 2017
|
||||||||||||||||||
|
($ in millions)
|
(200)
|
|
(100)
|
|
Current
|
|
100
|
|
200
|
||||||||||
|
Fair Value:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
U.S. Treasury obligations
|
$
|
142
|
|
|
$
|
138
|
|
|
$
|
134
|
|
|
$
|
130
|
|
|
$
|
126
|
|
|
U.S. Government-sponsored enterprise obligations
|
22
|
|
|
21
|
|
|
21
|
|
|
20
|
|
|
19
|
|
|||||
|
State and municipal bonds
|
683
|
|
|
657
|
|
|
632
|
|
|
609
|
|
|
585
|
|
|||||
|
Corporate debt
|
1,249
|
|
|
1,208
|
|
|
1,167
|
|
|
1,128
|
|
|
1,090
|
|
|||||
|
Asset-backed securities
|
341
|
|
|
335
|
|
|
326
|
|
|
315
|
|
|
302
|
|
|||||
|
Total fixed maturities, available for sale
|
$
|
2,437
|
|
|
$
|
2,359
|
|
|
$
|
2,280
|
|
|
$
|
2,202
|
|
|
$
|
2,122
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Duration:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
U.S. Treasury obligations
|
3.11
|
|
|
3.02
|
|
|
2.94
|
|
|
2.86
|
|
|
2.79
|
|
|||||
|
U.S. Government-sponsored enterprise obligations
|
1.38
|
|
|
1.34
|
|
|
3.59
|
|
|
4.58
|
|
|
4.87
|
|
|||||
|
State and municipal bonds
|
3.83
|
|
|
3.79
|
|
|
3.78
|
|
|
3.80
|
|
|
3.85
|
|
|||||
|
Corporate debt
|
3.37
|
|
|
3.33
|
|
|
3.38
|
|
|
3.38
|
|
|
3.34
|
|
|||||
|
Asset-backed securities
|
1.72
|
|
|
2.21
|
|
|
3.15
|
|
|
3.89
|
|
|
4.24
|
|
|||||
|
Total fixed maturities, available for sale
|
3.23
|
|
|
3.26
|
|
|
3.43
|
|
|
3.55
|
|
|
3.59
|
|
|||||
|
Index to Consolidated Financial Statements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
Financial Statements
. The following consolidated financial statements of ProAssurance Corporation and subsidiaries are included herein in accordance with Item 8 of Part II of this report.
|
|
(b)
|
The exhibits required to be filed by Item 15(b) are listed herein in the Exhibit Index.
|
|
PROASSURANCE CORPORATION
|
|
|
|
|
|
By:
|
/
S
/ W. S
TANCIL
S
TARNES
|
|
|
W. Stancil Starnes
|
|
|
Name
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
|
|
/
S
/ W. S
TANCIL
S
TARNES
, J.D.
|
|
Chairman of the Board, Chief Executive Officer
|
|
February 21, 2019
|
|
|
W. Stancil Starnes, J.D.
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ E
DWARD
L. R
AND
, J
R
.
|
|
President and Chief Operating Officer
|
|
February 21, 2019
|
|
|
Edward L. Rand, Jr.
|
|
(Principal Financial Officer)
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ D
ANA
S. H
ENDRICKS
|
|
Chief Financial Officer
|
|
February 21, 2019
|
|
|
Dana S. Hendricks
|
|
(Principal Accounting Officer)
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ S
AMUEL
A. D
I
P
IAZZA,
J
R.
|
|
Director
|
|
February 21, 2019
|
|
|
Samuel A. Di Piazza, Jr.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ R
OBERT
E. F
LOWERS,
M.D
.
|
|
Director
|
|
February 21, 2019
|
|
|
Robert E. Flowers, M.D.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ M. J
AMES
G
ORRIE
|
|
Director
|
|
February 21, 2019
|
|
|
M. James Gorrie
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ B
RUCE
D. A
NGIOLILLO, J.D.
|
|
Director
|
|
February 21, 2019
|
|
|
Bruce D. Angiolillo, J.D.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ J
OHN
J. M
C
M
AHON,
J
R.
|
|
Director
|
|
February 21, 2019
|
|
|
John J. McMahon, Jr.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/S/ K
ATISHA
T. V
ANCE,
M.D.
|
|
Director
|
|
February 21, 2019
|
|
|
Katisha T. Vance, M.D.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ F
RANK
A. S
PINOSA
, D.P.M.
|
|
Director
|
|
February 21, 2019
|
|
|
Frank A. Spinosa, D.P.M.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ Z
IAD
R. H
AYDAR
, M.D.
|
|
Director
|
|
February 21, 2019
|
|
|
Ziad R. Haydar, M.D.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ T
HOMAS
A.S. W
ILSON
, J
R
., M.D.
|
|
Director
|
|
February 21, 2019
|
|
|
Thomas A. S. Wilson, Jr., M.D.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ K
EDRICK
D. A
DKINS
, J
R
.
|
|
Director
|
|
February 21, 2019
|
|
|
Kedrick D. Adkins, Jr.
|
|
|
|
|
|
|
December 31,
2018 |
|
December 31,
2017 |
||||
|
Assets
|
|
|
|
||||
|
Investments
|
|
|
|
||||
|
Fixed maturities, at fair value; cost or amortized cost, $2,155,270 and $2,257,188, respectively
|
$
|
2,131,986
|
|
|
$
|
2,280,242
|
|
|
Equity investments, at fair value; cost, $450,931 and $425,942, respectively
|
442,937
|
|
|
470,609
|
|
||
|
Short-term investments
|
308,319
|
|
|
432,126
|
|
||
|
Business owned life insurance
|
64,096
|
|
|
62,113
|
|
||
|
Investment in unconsolidated subsidiaries
|
367,757
|
|
|
330,591
|
|
||
|
Other investments, $31,344 and $52,301 at fair value, respectively, otherwise at cost or amortized cost
|
34,287
|
|
|
110,847
|
|
||
|
Total Investments
|
3,349,382
|
|
|
3,686,528
|
|
||
|
Cash and cash equivalents
|
80,471
|
|
|
134,495
|
|
||
|
Premiums receivable
|
261,466
|
|
|
238,085
|
|
||
|
Receivable from reinsurers on paid losses and loss adjustment expenses
|
11,558
|
|
|
7,317
|
|
||
|
Receivable from reinsurers on unpaid losses and loss adjustment expenses
|
343,820
|
|
|
335,585
|
|
||
|
Prepaid reinsurance premiums
|
40,631
|
|
|
39,916
|
|
||
|
Deferred policy acquisition costs
|
54,116
|
|
|
50,261
|
|
||
|
Deferred tax asset, net
|
29,108
|
|
|
9,930
|
|
||
|
Real estate, net
|
31,114
|
|
|
31,975
|
|
||
|
Intangible assets, net
|
76,776
|
|
|
82,952
|
|
||
|
Goodwill
|
210,725
|
|
|
210,725
|
|
||
|
Other assets
|
111,559
|
|
|
101,428
|
|
||
|
Total Assets
|
$
|
4,600,726
|
|
|
$
|
4,929,197
|
|
|
Liabilities and Shareholders' Equity
|
|
|
|
||||
|
Liabilities
|
|
|
|
||||
|
Policy liabilities and accruals
|
|
|
|
||||
|
Reserve for losses and loss adjustment expenses
|
$
|
2,119,847
|
|
|
$
|
2,048,381
|
|
|
Unearned premiums
|
415,211
|
|
|
398,884
|
|
||
|
Reinsurance premiums payable
|
55,614
|
|
|
37,726
|
|
||
|
Total Policy Liabilities
|
2,590,672
|
|
|
2,484,991
|
|
||
|
Other liabilities
|
199,295
|
|
|
437,600
|
|
||
|
Debt less debt issuance costs
|
287,757
|
|
|
411,811
|
|
||
|
Total Liabilities
|
3,077,724
|
|
|
3,334,402
|
|
||
|
Shareholders' Equity
|
|
|
|
||||
|
Common shares, par value $0.01 per share, 100,000,000 shares authorized, 62,989,421 and 62,824,523 shares issued, respectively
|
630
|
|
|
628
|
|
||
|
Additional paid-in capital
|
384,713
|
|
|
383,077
|
|
||
|
Accumulated other comprehensive income (loss), net of deferred tax expense (benefit) of ($4,355) and $5,218, respectively
|
(16,911
|
)
|
|
14,911
|
|
||
|
Retained earnings
|
1,571,847
|
|
|
1,614,186
|
|
||
|
Treasury shares, at cost, 9,352,373 shares and 9,367,502 shares, respectively
|
(417,277
|
)
|
|
(418,007
|
)
|
||
|
Total Shareholders' Equity
|
1,523,002
|
|
|
1,594,795
|
|
||
|
Total Liabilities and Shareholders' Equity
|
$
|
4,600,726
|
|
|
$
|
4,929,197
|
|
|
|
Common Stock
|
|
Additional Paid-in Capital
|
|
Accumulated Other Comprehensive Income (Loss)
|
|
Retained Earnings
|
|
Treasury Stock
|
|
Total
|
||||||||||||
|
Balance at January 1, 2016
|
$
|
625
|
|
|
$
|
365,399
|
|
|
$
|
23,855
|
|
|
$
|
1,988,035
|
|
|
$
|
(419,560
|
)
|
|
$
|
1,958,354
|
|
|
Common shares reacquired
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,106
|
)
|
|
(2,106
|
)
|
||||||
|
Common shares issued for compensation and effect of shares reissued to stock purchase plan
|
—
|
|
|
1,696
|
|
|
—
|
|
|
—
|
|
|
1,736
|
|
|
3,432
|
|
||||||
|
Share-based compensation
|
—
|
|
|
12,455
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12,455
|
|
||||||
|
Net effect of restricted and performance shares issued
|
2
|
|
|
(3,032
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,030
|
)
|
||||||
|
Dividends to shareholders
|
—
|
|
|
—
|
|
|
—
|
|
|
(315,028
|
)
|
|
—
|
|
|
(315,028
|
)
|
||||||
|
Other comprehensive income (loss)
|
—
|
|
|
—
|
|
|
(6,456
|
)
|
|
—
|
|
|
—
|
|
|
(6,456
|
)
|
||||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
151,081
|
|
|
—
|
|
|
151,081
|
|
||||||
|
Balance at December 31, 2016
|
627
|
|
|
376,518
|
|
|
17,399
|
|
|
1,824,088
|
|
|
(419,930
|
)
|
|
1,798,702
|
|
||||||
|
Cumulative-effect adjustment-
ASU 2016-09 adoption |
—
|
|
|
425
|
|
|
—
|
|
|
(276
|
)
|
|
—
|
|
|
149
|
|
||||||
|
Common shares issued for compensation and effect of shares reissued to stock purchase plan
|
—
|
|
|
957
|
|
|
—
|
|
|
—
|
|
|
1,923
|
|
|
2,880
|
|
||||||
|
Share-based compensation
|
—
|
|
|
10,615
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
10,615
|
|
||||||
|
Net effect of restricted and performance shares issued
|
1
|
|
|
(5,438
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(5,437
|
)
|
||||||
|
Dividends to shareholders
|
—
|
|
|
—
|
|
|
—
|
|
|
(316,890
|
)
|
|
—
|
|
|
(316,890
|
)
|
||||||
|
Other comprehensive income (loss)
|
—
|
|
|
—
|
|
|
(2,488
|
)
|
|
—
|
|
|
—
|
|
|
(2,488
|
)
|
||||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
107,264
|
|
|
—
|
|
|
107,264
|
|
||||||
|
Balance at December 31, 2017
|
628
|
|
|
383,077
|
|
|
14,911
|
|
|
1,614,186
|
|
|
(418,007
|
)
|
|
1,594,795
|
|
||||||
|
Cumulative-effect adjustment-
ASU 2016-01 adoption* |
—
|
|
|
—
|
|
|
—
|
|
|
8,334
|
|
|
—
|
|
|
8,334
|
|
||||||
|
Cumulative-effect adjustment-
ASU 2018-02 adoption* |
—
|
|
|
—
|
|
|
3,416
|
|
|
(3,416
|
)
|
|
—
|
|
|
—
|
|
||||||
|
Common shares issued for compensation and effect of shares reissued to stock purchase plan
|
—
|
|
|
314
|
|
|
—
|
|
|
—
|
|
|
730
|
|
|
1,044
|
|
||||||
|
Share-based compensation
|
—
|
|
|
5,258
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,258
|
|
||||||
|
Net effect of restricted and performance shares issued
|
2
|
|
|
(3,936
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,934
|
)
|
||||||
|
Dividends to shareholders
|
—
|
|
|
—
|
|
|
—
|
|
|
(94,314
|
)
|
|
—
|
|
|
(94,314
|
)
|
||||||
|
Other comprehensive income (loss)
|
—
|
|
|
—
|
|
|
(35,238
|
)
|
|
—
|
|
|
—
|
|
|
(35,238
|
)
|
||||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
47,057
|
|
|
—
|
|
|
47,057
|
|
||||||
|
Balance at December 31, 2018
|
$
|
630
|
|
|
$
|
384,713
|
|
|
$
|
(16,911
|
)
|
|
$
|
1,571,847
|
|
|
$
|
(417,277
|
)
|
|
$
|
1,523,002
|
|
|
|
Year Ended December 31
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Revenues
|
|
|
|
|
|
||||||
|
Net premiums earned
|
$
|
818,853
|
|
|
$
|
738,531
|
|
|
$
|
733,281
|
|
|
Net investment income
|
91,884
|
|
|
95,662
|
|
|
100,012
|
|
|||
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
8,948
|
|
|
8,033
|
|
|
(5,762
|
)
|
|||
|
Net realized investment gains (losses):
|
|
|
|
|
|
||||||
|
OTTI losses
|
(490
|
)
|
|
(13,200
|
)
|
|
(10,834
|
)
|
|||
|
Portion of OTTI losses recognized in other comprehensive income before taxes
|
—
|
|
|
248
|
|
|
1,068
|
|
|||
|
Net impairment losses recognized in earnings
|
(490
|
)
|
|
(12,952
|
)
|
|
(9,766
|
)
|
|||
|
Other net realized investment gains (losses)
|
(42,998
|
)
|
|
29,361
|
|
|
44,641
|
|
|||
|
Total net realized investment gains (losses)
|
(43,488
|
)
|
|
16,409
|
|
|
34,875
|
|
|||
|
Other income
|
9,833
|
|
|
7,514
|
|
|
7,808
|
|
|||
|
Total revenues
|
886,030
|
|
|
866,149
|
|
|
870,214
|
|
|||
|
Expenses
|
|
|
|
|
|
||||||
|
Net losses and loss adjustment expenses
|
593,210
|
|
|
469,158
|
|
|
443,229
|
|
|||
|
Underwriting, policy acquisition and operating expenses
|
|
|
|
|
|
||||||
|
Operating expense
|
134,055
|
|
|
140,002
|
|
|
139,232
|
|
|||
|
DPAC Amortization
|
104,501
|
|
|
95,751
|
|
|
88,378
|
|
|||
|
Segregated portfolio cells dividend expense (income)
|
9,122
|
|
|
15,771
|
|
|
8,142
|
|
|||
|
Interest expense
|
16,117
|
|
|
16,844
|
|
|
15,032
|
|
|||
|
Total expenses
|
857,005
|
|
|
737,526
|
|
|
694,013
|
|
|||
|
Income before income taxes
|
29,025
|
|
|
128,623
|
|
|
176,201
|
|
|||
|
Provision for income taxes
|
|
|
|
|
|
||||||
|
Current expense (benefit)
|
(6,208
|
)
|
|
19,666
|
|
|
16,586
|
|
|||
|
Deferred expense (benefit)
|
(11,824
|
)
|
|
1,693
|
|
|
8,534
|
|
|||
|
Total income tax expense (benefit)
|
(18,032
|
)
|
|
21,359
|
|
|
25,120
|
|
|||
|
Net income
|
47,057
|
|
|
107,264
|
|
|
151,081
|
|
|||
|
Other comprehensive income (loss), after tax, net of reclassification adjustments
|
(35,238
|
)
|
|
(2,488
|
)
|
|
(6,456
|
)
|
|||
|
Comprehensive income (loss)
|
$
|
11,819
|
|
|
$
|
104,776
|
|
|
$
|
144,625
|
|
|
Earnings per share
|
|
|
|
|
|
||||||
|
Basic
|
$
|
0.88
|
|
|
$
|
2.01
|
|
|
$
|
2.84
|
|
|
Diluted
|
$
|
0.88
|
|
|
$
|
2.00
|
|
|
$
|
2.83
|
|
|
Weighted average number of common shares outstanding:
|
|
|
|
|
|
||||||
|
Basic
|
53,598
|
|
|
53,393
|
|
|
53,216
|
|
|||
|
Diluted
|
53,749
|
|
|
53,611
|
|
|
53,448
|
|
|||
|
Cash dividends declared per common share
|
$
|
1.74
|
|
|
$
|
5.93
|
|
|
$
|
5.93
|
|
|
|
Year Ended December 31
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Operating Activities
|
|
|
|
|
|
||||||
|
Net income
|
$
|
47,057
|
|
|
$
|
107,264
|
|
|
$
|
151,081
|
|
|
Adjustments to reconcile income to net cash provided by operating activities:
|
|
|
|
|
|
||||||
|
Depreciation and amortization, net of accretion
|
21,255
|
|
|
28,796
|
|
|
32,789
|
|
|||
|
(Increase) decrease in cash surrender value of BOLI
|
(1,983
|
)
|
|
(1,979
|
)
|
|
(2,008
|
)
|
|||
|
Net realized investment (gains) losses
|
43,488
|
|
|
(16,409
|
)
|
|
(34,875
|
)
|
|||
|
Share-based compensation
|
5,321
|
|
|
10,615
|
|
|
12,455
|
|
|||
|
Deferred income tax expense (benefit)
|
(11,824
|
)
|
|
1,693
|
|
|
8,534
|
|
|||
|
Policy acquisition costs, net of amortization (net deferral)
|
(3,855
|
)
|
|
(3,452
|
)
|
|
(2,421
|
)
|
|||
|
Equity in (earnings) loss of unconsolidated subsidiaries
|
(8,948
|
)
|
|
(8,033
|
)
|
|
5,762
|
|
|||
|
Distributed earnings from unconsolidated subsidiaries
|
31,219
|
|
|
24,392
|
|
|
9,863
|
|
|||
|
Other
|
1,168
|
|
|
108
|
|
|
1,772
|
|
|||
|
Other changes in assets and liabilities:
|
|
|
|
|
|
||||||
|
Premiums receivable
|
(23,381
|
)
|
|
(14,605
|
)
|
|
(6,446
|
)
|
|||
|
Reinsurance related assets and liabilities
|
4,697
|
|
|
(56,449
|
)
|
|
(26,108
|
)
|
|||
|
Other assets
|
(4,206
|
)
|
|
(792
|
)
|
|
15,665
|
|
|||
|
Reserve for losses and loss adjustment expenses
|
71,466
|
|
|
54,953
|
|
|
(11,898
|
)
|
|||
|
Unearned premiums
|
16,327
|
|
|
26,321
|
|
|
10,497
|
|
|||
|
Other liabilities
|
(10,536
|
)
|
|
20,965
|
|
|
14,321
|
|
|||
|
Net cash provided (used) by operating activities
|
177,265
|
|
|
173,388
|
|
|
178,983
|
|
|||
|
Investing Activities
|
|
|
|
|
|
||||||
|
Purchases of:
|
|
|
|
|
|
||||||
|
Fixed maturities, available for sale
|
(780,698
|
)
|
|
(614,440
|
)
|
|
(636,377
|
)
|
|||
|
Fixed maturities, trading
|
(38,544
|
)
|
|
—
|
|
|
—
|
|
|||
|
Equity investments
|
(203,157
|
)
|
|
(207,857
|
)
|
|
(112,912
|
)
|
|||
|
Other investments
|
(32,153
|
)
|
|
(50,362
|
)
|
|
(18,613
|
)
|
|||
|
Funding of qualified affordable housing project tax credit partnerships
|
—
|
|
|
(507
|
)
|
|
(1,019
|
)
|
|||
|
Investment in unconsolidated subsidiaries
|
(78,141
|
)
|
|
(42,183
|
)
|
|
(50,890
|
)
|
|||
|
Proceeds from sales or maturities of:
|
|
|
|
|
|
||||||
|
Fixed maturities, available for sale
|
914,021
|
|
|
932,070
|
|
|
752,516
|
|
|||
|
Equity investments
|
210,481
|
|
|
146,356
|
|
|
85,226
|
|
|||
|
Other investments
|
29,815
|
|
|
25,372
|
|
|
13,797
|
|
|||
|
Return of invested capital from unconsolidated subsidiaries
|
84,534
|
|
|
32,539
|
|
|
7,084
|
|
|||
|
Net sales or maturities (purchases) of short-term investments
|
123,886
|
|
|
4,167
|
|
|
(322,872
|
)
|
|||
|
Unsettled security transactions, net change
|
(4,022
|
)
|
|
(2,031
|
)
|
|
1,388
|
|
|||
|
Purchases of capital assets
|
(9,636
|
)
|
|
(10,485
|
)
|
|
(10,922
|
)
|
|||
|
Repayments (advances) under Syndicate Credit Agreement
|
(184
|
)
|
|
(10,339
|
)
|
|
(1,395
|
)
|
|||
|
Other
|
(1,305
|
)
|
|
(2,025
|
)
|
|
6,187
|
|
|||
|
Net cash provided (used) by investing activities
|
214,897
|
|
|
200,275
|
|
|
(288,802
|
)
|
|||
|
Continued on following page.
|
|
|
|
|
|
||||||
|
|
Year Ended December 31
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Continued from the previous page.
|
|
|
|
|
|
||||||
|
Financing Activities
|
|
|
|
|
|
||||||
|
Borrowings (repayments) under Revolving Credit Agreement
|
(123,000
|
)
|
|
(77,000
|
)
|
|
100,000
|
|
|||
|
Proceeds (repayments) of Mortgage Loans
|
(1,396
|
)
|
|
40,460
|
|
|
—
|
|
|||
|
Repurchase of common stock
|
—
|
|
|
—
|
|
|
(2,106
|
)
|
|||
|
Dividends to shareholders
|
(316,476
|
)
|
|
(315,228
|
)
|
|
(118,812
|
)
|
|||
|
Capital contribution received from (return of capital to) external segregated portfolio cell participants
|
(1,005
|
)
|
|
2,936
|
|
|
9,952
|
|
|||
|
Other
|
(4,309
|
)
|
|
(7,683
|
)
|
|
(2,968
|
)
|
|||
|
Net cash provided (used) by financing activities
|
(446,186
|
)
|
|
(356,515
|
)
|
|
(13,934
|
)
|
|||
|
Increase (decrease) in cash and cash equivalents
|
(54,024
|
)
|
|
17,148
|
|
|
(123,753
|
)
|
|||
|
Cash and cash equivalents at beginning of period
|
134,495
|
|
|
117,347
|
|
|
241,100
|
|
|||
|
Cash and cash equivalents at end of period
|
$
|
80,471
|
|
|
$
|
134,495
|
|
|
$
|
117,347
|
|
|
|
|
|
|
|
|
||||||
|
Supplemental Disclosure of Cash Flow Information
|
|
|
|
|
|
||||||
|
Cash paid during the year for income taxes, net of refunds
|
$
|
5,726
|
|
|
$
|
17,193
|
|
|
$
|
(8,683
|
)
|
|
Cash paid during the year for interest
|
$
|
16,165
|
|
|
$
|
15,892
|
|
|
$
|
14,732
|
|
|
|
|
|
|
|
|
||||||
|
Significant Non-Cash Transactions
|
|
|
|
|
|
||||||
|
Dividends declared and not yet paid
|
$
|
43,446
|
|
|
$
|
267,292
|
|
|
$
|
265,659
|
|
|
•
|
if there is intent to sell the security;
|
|
•
|
if it is more likely than not that the security will be required to be sold before full recovery of its amortized cost basis; or
|
|
•
|
if the entire amortized basis of the security is not expected to be recovered.
|
|
•
|
third-party research and credit rating reports;
|
|
•
|
the current credit standing of the issuer, including credit rating downgrades, whether before or after the balance sheet date;
|
|
•
|
the extent to which the decline in fair value is attributable to credit risk specifically associated with the security or its issuer;
|
|
•
|
internal assessments and the assessments of external portfolio managers regarding specific circumstances surrounding an investment, which indicate the investment is more or less likely to recover its amortized cost than other investments with a similar structure;
|
|
•
|
for asset-backed securities, the origination date of the underlying loans, the remaining average life, the probability that credit performance of the underlying loans will deteriorate in the future, and the Company's assessment of the quality of the collateral underlying the loan;
|
|
•
|
failure of the issuer of the security to make scheduled interest or principal payments;
|
|
•
|
any changes to the rating of the security by a rating agency; and
|
|
•
|
recoveries or additional declines in fair value subsequent to the balance sheet date.
|
|
•
|
ProAssurance's ability and intent to hold the investment until the recovery of its carrying value; and
|
|
•
|
in situations where there was not a previous OTTI for the investment, whether the current expected cash flows from the investment, primarily tax benefits, are less than those expected at the time the investment was acquired due to various factors, such as a change in the statutory tax rate; or
|
|
•
|
in situations where there was a previous OTTI for the investment, whether the expected cash flows from the investment at the time of the OTTI, primarily tax benefits, are less than its current carrying value.
|
|
|
Gross Carrying Value
|
|
Accumulated Amortization
|
|
Amortization Expense
|
||||||||||||||||||||||
|
|
December 31
|
|
December 31
|
|
Year Ended December 31
|
||||||||||||||||||||||
|
(In millions)
|
2018
|
|
2017
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
|
2016
|
||||||||||||||
|
Intangible Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Non-amortizable
|
$
|
25.8
|
|
|
$
|
25.8
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Amortizable
|
97.5
|
|
|
97.5
|
|
|
$
|
46.5
|
|
|
$
|
40.3
|
|
|
$
|
6.2
|
|
|
$
|
5.8
|
|
|
$
|
8.1
|
|
||
|
Total Intangible Assets
|
$
|
123.3
|
|
|
$
|
123.3
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
(In thousands)
|
|
2018
|
|
2017
|
||||
|
SPC dividends payable
|
|
$
|
53,604
|
|
|
$
|
46,925
|
|
|
Unpaid dividends
|
|
43,446
|
|
|
267,292
|
|
||
|
All other
|
|
102,245
|
|
|
123,383
|
|
||
|
Total other liabilities
|
|
$
|
199,295
|
|
|
$
|
437,600
|
|
|
|
Level 1:
|
quoted (unadjusted) market prices in active markets for identical assets and liabilities. For ProAssurance, Level 1 inputs are generally quotes for debt or equity securities actively traded in exchange or over-the-counter markets.
|
|
|
Level 2:
|
market data obtained from sources independent of the reporting entity (observable inputs). For ProAssurance, Level 2 inputs generally include quoted prices in markets that are not active, quoted prices for similar assets or liabilities, and results from pricing models that use observable inputs such as interest rates and yield curves that are generally available at commonly quoted intervals.
|
|
|
Level 3:
|
the reporting entity’s own assumptions about market participant assumptions based on the best information available in the circumstances (non-observable inputs). For ProAssurance, Level 3 inputs are used in situations where little or no Level 1 or 2 inputs are available or are inappropriate given the particular circumstances. Level 3 inputs include results from pricing models for which some or all of the inputs are not observable, discounted cash flow methodologies, single non-binding broker quotes and adjustments to externally quoted prices that are based on management judgment or estimation.
|
|
|
December 31, 2018
|
||||||||||||||
|
|
Fair Value Measurements Using
|
|
Total
|
||||||||||||
|
(In thousands)
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Fair Value
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
||||||||
|
U.S. Treasury obligations
|
$
|
—
|
|
|
$
|
120,201
|
|
|
$
|
—
|
|
|
$
|
120,201
|
|
|
U.S. Government-sponsored enterprise obligations
|
—
|
|
|
35,354
|
|
|
—
|
|
|
35,354
|
|
||||
|
State and municipal bonds
|
—
|
|
|
293,772
|
|
|
—
|
|
|
293,772
|
|
||||
|
Corporate debt, multiple observable inputs
|
2,319
|
|
|
1,216,834
|
|
|
—
|
|
|
1,219,153
|
|
||||
|
Corporate debt, limited observable inputs
|
—
|
|
|
—
|
|
|
4,322
|
|
|
4,322
|
|
||||
|
Residential mortgage-backed securities
|
—
|
|
|
181,238
|
|
|
—
|
|
|
181,238
|
|
||||
|
Agency commercial mortgage-backed securities
|
—
|
|
|
13,108
|
|
|
—
|
|
|
13,108
|
|
||||
|
Other commercial mortgage-backed securities
|
—
|
|
|
30,993
|
|
|
—
|
|
|
30,993
|
|
||||
|
Other asset-backed securities
|
—
|
|
|
191,807
|
|
|
3,850
|
|
|
195,657
|
|
||||
|
Fixed maturities, trading
|
—
|
|
|
38,188
|
|
|
—
|
|
|
38,188
|
|
||||
|
Equity investments
|
|
|
|
|
|
|
|
||||||||
|
Financial
|
62,344
|
|
|
—
|
|
|
—
|
|
|
62,344
|
|
||||
|
Utilities/Energy
|
46,533
|
|
|
—
|
|
|
—
|
|
|
46,533
|
|
||||
|
Consumer oriented
|
47,462
|
|
|
—
|
|
|
—
|
|
|
47,462
|
|
||||
|
Industrial
|
41,487
|
|
|
—
|
|
|
—
|
|
|
41,487
|
|
||||
|
Bond funds
|
174,753
|
|
|
—
|
|
|
—
|
|
|
174,753
|
|
||||
|
All other
|
50,066
|
|
|
—
|
|
|
—
|
|
|
50,066
|
|
||||
|
Short-term investments
|
265,910
|
|
|
42,409
|
|
|
—
|
|
|
308,319
|
|
||||
|
Other investments
|
—
|
|
|
31,341
|
|
|
3
|
|
|
31,344
|
|
||||
|
Other assets
|
—
|
|
|
1,884
|
|
|
—
|
|
|
1,884
|
|
||||
|
Total assets categorized within the fair value hierarchy
|
$
|
690,874
|
|
|
$
|
2,197,129
|
|
|
$
|
8,175
|
|
|
2,896,178
|
|
|
|
Assets carried at NAV, which approximates fair value and which are not categorized within the fair value hierarchy, reported as a part of:
|
|
|
|
|
|
|
|
||||||||
|
Equity investments
|
|
|
|
|
|
|
20,292
|
|
|||||||
|
Investment in unconsolidated subsidiaries
|
|
|
|
|
|
|
268,436
|
|
|||||||
|
Total assets at fair value
|
|
|
|
|
|
|
$
|
3,184,906
|
|
||||||
|
|
December 31, 2017
|
||||||||||||||
|
|
Fair Value Measurements Using
|
|
Total
|
||||||||||||
|
(In thousands)
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Fair Value
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
||||||||
|
U.S. Treasury obligations
|
$
|
—
|
|
|
$
|
133,627
|
|
|
$
|
—
|
|
|
$
|
133,627
|
|
|
U.S. Government-sponsored enterprise obligations
|
—
|
|
|
20,956
|
|
|
—
|
|
|
20,956
|
|
||||
|
State and municipal bonds
|
—
|
|
|
632,243
|
|
|
—
|
|
|
632,243
|
|
||||
|
Corporate debt, multiple observable inputs
|
2,371
|
|
|
1,151,084
|
|
|
—
|
|
|
1,153,455
|
|
||||
|
Corporate debt, limited observable inputs
|
—
|
|
|
—
|
|
|
13,703
|
|
|
13,703
|
|
||||
|
Residential mortgage-backed securities
|
—
|
|
|
196,789
|
|
|
1,055
|
|
|
197,844
|
|
||||
|
Agency commercial mortgage-backed securities
|
—
|
|
|
10,742
|
|
|
—
|
|
|
10,742
|
|
||||
|
Other commercial mortgage-backed securities
|
—
|
|
|
15,961
|
|
|
—
|
|
|
15,961
|
|
||||
|
Other asset-backed securities
|
—
|
|
|
97,780
|
|
|
3,931
|
|
|
101,711
|
|
||||
|
Equity investments
|
|
|
|
|
|
|
|
||||||||
|
Financial
|
76,051
|
|
|
—
|
|
|
—
|
|
|
76,051
|
|
||||
|
Utilities/Energy
|
54,388
|
|
|
—
|
|
|
—
|
|
|
54,388
|
|
||||
|
Consumer oriented
|
54,529
|
|
|
—
|
|
|
—
|
|
|
54,529
|
|
||||
|
Industrial
|
53,936
|
|
|
—
|
|
|
—
|
|
|
53,936
|
|
||||
|
Bond funds
|
156,563
|
|
|
—
|
|
|
—
|
|
|
156,563
|
|
||||
|
All other
|
75,142
|
|
|
—
|
|
|
—
|
|
|
75,142
|
|
||||
|
Short-term investments
|
404,204
|
|
|
27,922
|
|
|
—
|
|
|
432,126
|
|
||||
|
Other investments
|
607
|
|
|
31,155
|
|
|
409
|
|
|
32,171
|
|
||||
|
Other assets
|
—
|
|
|
1,731
|
|
|
—
|
|
|
1,731
|
|
||||
|
Total assets categorized within the fair value hierarchy
|
$
|
877,791
|
|
|
$
|
2,319,990
|
|
|
$
|
19,098
|
|
|
3,216,879
|
|
|
|
Assets carried at NAV, which approximates fair value and which are not categorized within the fair value hierarchy, reported as a part of:
|
|
|
|
|
|
|
|
||||||||
|
Investment in unconsolidated subsidiaries
|
|
|
|
|
|
|
210,759
|
|
|||||||
|
Other investments
|
|
|
|
|
|
|
20,130
|
|
|||||||
|
Total assets at fair value
|
|
|
|
|
|
|
$
|
3,447,768
|
|
||||||
|
|
|
Fair Value at
|
|
|
|
|
|
|
||
|
($ in thousands)
|
|
December 31, 2018
|
|
December 31, 2017
|
|
Valuation Technique
|
|
Unobservable Input
|
|
Range
(Weighted Average) |
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
Corporate debt, limited observable inputs
|
|
$4,322
|
|
$13,703
|
|
Market Comparable
Securities |
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
|
|
|
|
|
|
|
Discounted Cash Flows
|
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
|
Residential mortgage-backed and other asset-backed securities
|
|
$3,850
|
|
$4,986
|
|
Market Comparable
Securities |
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
|
|
|
|
|
|
|
Discounted Cash Flows
|
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
|
Other investments
|
|
$3
|
|
$409
|
|
Discounted Cash Flows
|
|
Comparability Adjustment
|
|
0% - 10% (5%)
|
|
|
December 31, 2018
|
||||||||||||||
|
|
Level 3 Fair Value Measurements – Assets
|
||||||||||||||
|
(In thousands)
|
Corporate Debt
|
|
Asset-backed Securities
|
|
Other investments
|
|
Total
|
||||||||
|
Balance December 31, 2017
|
$
|
13,703
|
|
|
$
|
4,986
|
|
|
$
|
409
|
|
|
$
|
19,098
|
|
|
Total gains (losses) realized and unrealized:
|
|
|
|
|
|
|
|
||||||||
|
Included in earnings, as a part of:
|
|
|
|
|
|
|
|
||||||||
|
Net investment income
|
(148
|
)
|
|
2
|
|
|
—
|
|
|
(146
|
)
|
||||
|
Net realized investment gains (losses)
|
(8
|
)
|
|
—
|
|
|
(40
|
)
|
|
(48
|
)
|
||||
|
Included in other comprehensive income
|
(233
|
)
|
|
(105
|
)
|
|
—
|
|
|
(338
|
)
|
||||
|
Purchases
|
8,005
|
|
|
20,093
|
|
|
—
|
|
|
28,098
|
|
||||
|
Sales
|
(6,406
|
)
|
|
(438
|
)
|
|
(366
|
)
|
|
(7,210
|
)
|
||||
|
Transfers in
|
2,627
|
|
|
—
|
|
|
—
|
|
|
2,627
|
|
||||
|
Transfers out
|
(13,218
|
)
|
|
(20,688
|
)
|
|
—
|
|
|
(33,906
|
)
|
||||
|
Balance December 31, 2018
|
$
|
4,322
|
|
|
$
|
3,850
|
|
|
$
|
3
|
|
|
$
|
8,175
|
|
|
Change in unrealized gains (losses) included in earnings for the above period for Level 3 assets held at period-end
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
December 31, 2017
|
||||||||||||||
|
|
Level 3 Fair Value Measurements – Assets
|
||||||||||||||
|
(In thousands)
|
Corporate Debt
|
|
Asset-backed Securities
|
|
Other investments
|
|
Total
|
||||||||
|
Balance December 31, 2016
|
$
|
14,810
|
|
|
$
|
3,007
|
|
|
$
|
3
|
|
|
$
|
17,820
|
|
|
Total gains (losses) realized and unrealized:
|
|
|
|
|
|
|
|
||||||||
|
Included in earnings, as a part of:
|
|
|
|
|
|
|
|
||||||||
|
Net investment income
|
(163
|
)
|
|
—
|
|
|
—
|
|
|
(163
|
)
|
||||
|
Net realized investment gains (losses)
|
13
|
|
|
—
|
|
|
(143
|
)
|
|
(130
|
)
|
||||
|
Included in other comprehensive income
|
(369
|
)
|
|
(71
|
)
|
|
140
|
|
|
(300
|
)
|
||||
|
Purchases
|
13,016
|
|
|
2,627
|
|
|
—
|
|
|
15,643
|
|
||||
|
Sales
|
(4,837
|
)
|
|
—
|
|
|
(912
|
)
|
|
(5,749
|
)
|
||||
|
Transfers in
|
999
|
|
|
—
|
|
|
1,321
|
|
|
2,320
|
|
||||
|
Transfers out
|
(9,766
|
)
|
|
(577
|
)
|
|
—
|
|
|
(10,343
|
)
|
||||
|
Balance December 31, 2017
|
$
|
13,703
|
|
|
$
|
4,986
|
|
|
$
|
409
|
|
|
$
|
19,098
|
|
|
Change in unrealized gains (losses) included in earnings for the above period for Level 3 assets held at period-end
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
Unfunded
Commitments |
|
Fair Value
|
||||||||
|
(In thousands)
|
December 31,
2018 |
|
December 31,
2018 |
|
December 31,
2017 |
||||||
|
Equity investments:
|
|
|
|
|
|
||||||
|
Mortgage fund
(1)*
|
$
|
—
|
|
|
$
|
20,292
|
|
|
$
|
—
|
|
|
Investment in unconsolidated subsidiaries:
|
|
|
|
|
|
||||||
|
Private debt funds
(2)
|
$
|
20,954
|
|
|
18,196
|
|
|
42,206
|
|
||
|
Long equity fund
(3)
|
None
|
|
|
6,561
|
|
|
7,847
|
|
|||
|
Long/short equity funds
(4)
|
None
|
|
|
28,805
|
|
|
31,352
|
|
|||
|
Non-public equity funds
(5)
|
$
|
80,076
|
|
|
114,811
|
|
|
100,062
|
|
||
|
Multi-strategy fund of funds
(6)
|
None
|
|
|
9,322
|
|
|
9,100
|
|
|||
|
Credit funds
(7)
|
$
|
8,916
|
|
|
29,164
|
|
|
6,561
|
|
||
|
Long/short commodities fund
(8)
|
None
|
|
|
12,958
|
|
|
13,025
|
|
|||
|
Strategy focused funds
(9)
|
$
|
24,539
|
|
|
48,619
|
|
|
606
|
|
||
|
|
|
|
268,436
|
|
|
210,759
|
|
||||
|
Other investments:
|
|
|
|
|
|
||||||
|
Mortgage fund
(1)*
|
See above
|
|
|
—
|
|
|
20,130
|
|
|||
|
|
|
|
|
|
|
||||||
|
Total investments carried at NAV
|
|
|
$
|
288,728
|
|
|
$
|
230,889
|
|
||
|
* In the first quarter of 2018, ProAssurance began presenting this investment previously reported as a part of other investments as a part of equity investments on the Consolidated Balance Sheet. Prior year amounts have not been reclassified.
|
|||||||||||
|
(1)
|
This investment fund is focused on the structured mortgage market. The fund will primarily invest in U.S. Agency mortgage-backed securities. Redemptions are allowed at the end of any calendar quarter with a prior notice requirement of
65 days
and are paid within
45 days
at the end of the redemption dealing day.
|
|
(2)
|
This investment is comprised of interests in
three
unrelated
LP
funds that are structured to provide interest distributions primarily through diversified portfolios of private debt instruments.
One
LP
allows redemption by special consent; the other
two
do not permit redemption. Income and capital are to be periodically distributed at the discretion of the
LP
s over an anticipated time frame that spans from
three
to
eight
years.
|
|
(3)
|
This fund is a
LP
that holds long equities of public international companies. Redemptions are allowed at the end of any calendar month with a prior notice requirement of
15 days
and are paid within
10 days
of the end of the calendar month of the redemption request.
|
|
(4)
|
This investment is comprised of interests in multiple unrelated
LP
funds. The funds hold primarily long and short North American equities and target absolute returns using strategies designed to take advantage of market opportunities. The funds generally permit quarterly or semi-annual capital redemptions subject to notice requirements of
30
to
90 days
. For some funds, redemptions above specified thresholds (lowest threshold is
90%
) may be only partially payable until after a fund audit is completed and are then payable within
30 days
.
|
|
(5)
|
This investment is comprised of interests in multiple unrelated
LP
funds, each structured to provide capital appreciation through diversified investments in private equity, which can include investments in buyout, venture capital, debt including senior, second lien and mezzanine, distressed debt and other private equity-oriented
LP
s. Two
|
|
(6)
|
This fund is a
LLC
structured to build and manage low volatility, multi-manager portfolios that have little or no correlation to the broader fixed income and equity security markets. Redemptions are not permitted but offers to repurchase units of the
LLC
may be extended periodically.
|
|
(7)
|
This investment is comprised of three unrelated
LP
funds. Two funds seek to obtain superior risk-adjusted absolute returns through a diversified portfolio of debt securities, including bonds, loans and other asset-backed instruments. The remaining fund seeks event driven opportunities across the corporate credit spectrum. Two funds are allowed redemptions at any quarter-end with a prior notice requirement of
90 days
;
one fund permits redemption at any quarter-end with a prior notice requirement of
180 days
.
|
|
(8)
|
This fund is a
LLC
invested across a broad range of commodities and focuses primarily on market neutral, relative value strategies, seeking to generate absolute returns with low correlation to broad commodity, equity and fixed income markets. Following an initial
one
-year lock-up period, redemptions are allowed with a prior notice requirement of
30 days
and are payable within
30 days
.
|
|
(9)
|
This investment is comprised of multiple unrelated LPs/LLCs funds. One fund is a LLC focused on investing in North American consumer products companies, comprised of equity and equity-related securities, as well as debt instruments. Redemptions are not permitted. Another fund is a LP focused on North American energy infrastructure assets that allows redemption with consent of the General Partner. The remaining funds are real estate focused LPs, one of which allows for redemption with prior notice.
|
|
|
December 31, 2018
|
|
December 31, 2017
|
||||||||||||
|
(In thousands)
|
Carrying
Value |
|
Fair
Value |
|
Carrying
Value |
|
Fair
Value |
||||||||
|
Financial assets:
|
|
|
|
|
|
|
|
||||||||
|
BOLI
|
$
|
64,096
|
|
|
$
|
64,096
|
|
|
$
|
62,113
|
|
|
$
|
62,113
|
|
|
Other investments
|
$
|
2,943
|
|
|
$
|
2,943
|
|
|
$
|
58,546
|
|
|
$
|
69,095
|
|
|
Other assets
|
$
|
35,921
|
|
|
$
|
35,468
|
|
|
$
|
34,020
|
|
|
$
|
33,742
|
|
|
Financial liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Senior notes due 2023*
|
$
|
250,000
|
|
|
$
|
264,810
|
|
|
$
|
250,000
|
|
|
$
|
273,153
|
|
|
Revolving Credit Agreement*
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
123,000
|
|
|
$
|
123,000
|
|
|
Mortgage Loans*
|
$
|
39,064
|
|
|
$
|
39,064
|
|
|
$
|
40,460
|
|
|
$
|
40,460
|
|
|
Other liabilities
|
$
|
21,300
|
|
|
$
|
21,300
|
|
|
$
|
21,154
|
|
|
$
|
21,154
|
|
|
* Carrying value excludes debt issuance costs.
|
|||||||||||||||
|
|
December 31, 2018
|
||||||||||||||
|
(In thousands)
|
Amortized
Cost |
|
Gross Unrealized Gains
|
|
Gross Unrealized Losses
|
|
Estimated Fair Value
|
||||||||
|
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
||||||||
|
U.S. Treasury obligations
|
$
|
121,274
|
|
|
$
|
331
|
|
|
$
|
1,404
|
|
|
$
|
120,201
|
|
|
U.S. Government-sponsored enterprise obligations
|
35,758
|
|
|
25
|
|
|
429
|
|
|
35,354
|
|
||||
|
State and municipal bonds
|
289,544
|
|
|
4,877
|
|
|
649
|
|
|
293,772
|
|
||||
|
Corporate debt
|
1,244,577
|
|
|
3,328
|
|
|
24,430
|
|
|
1,223,475
|
|
||||
|
Residential mortgage-backed securities
|
184,463
|
|
|
814
|
|
|
4,039
|
|
|
181,238
|
|
||||
|
Agency commercial mortgage-backed securities
|
13,296
|
|
|
12
|
|
|
200
|
|
|
13,108
|
|
||||
|
Other commercial mortgage-backed securities
|
31,330
|
|
|
38
|
|
|
375
|
|
|
30,993
|
|
||||
|
Other asset-backed securities
|
196,583
|
|
|
254
|
|
|
1,180
|
|
|
195,657
|
|
||||
|
|
$
|
2,116,825
|
|
|
$
|
9,679
|
|
|
$
|
32,706
|
|
|
$
|
2,093,798
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
December 31, 2017
|
||||||||||||||
|
(In thousands)
|
Amortized
Cost |
|
Gross Unrealized Gains
|
|
Gross Unrealized Losses
|
|
Estimated Fair Value
|
||||||||
|
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
||||||||
|
U.S. Treasury obligations
|
$
|
134,323
|
|
|
$
|
485
|
|
|
$
|
1,181
|
|
|
$
|
133,627
|
|
|
U.S. Government-sponsored enterprise obligations
|
21,089
|
|
|
73
|
|
|
206
|
|
|
20,956
|
|
||||
|
State and municipal bonds
|
618,414
|
|
|
14,248
|
|
|
419
|
|
|
632,243
|
|
||||
|
Corporate debt
|
1,157,660
|
|
|
15,205
|
|
|
5,707
|
|
|
1,167,158
|
|
||||
|
Residential mortgage-backed securities
|
196,741
|
|
|
2,438
|
|
|
1,335
|
|
|
197,844
|
|
||||
|
Agency commercial mortgage-backed securities
|
10,827
|
|
|
23
|
|
|
108
|
|
|
10,742
|
|
||||
|
Other commercial mortgage-backed securities
|
16,004
|
|
|
91
|
|
|
134
|
|
|
15,961
|
|
||||
|
Other asset-backed securities
|
102,130
|
|
|
47
|
|
|
466
|
|
|
101,711
|
|
||||
|
|
$
|
2,257,188
|
|
|
$
|
32,610
|
|
|
$
|
9,556
|
|
|
$
|
2,280,242
|
|
|
(In thousands)
|
Amortized
Cost |
|
Due in one
year or less |
|
Due after
one year through five years |
|
Due after
five years through ten years |
|
Due after
ten years |
|
Total Fair
Value |
||||||||||||
|
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
U.S. Treasury obligations
|
$
|
121,274
|
|
|
$
|
27,187
|
|
|
$
|
74,196
|
|
|
$
|
18,416
|
|
|
$
|
402
|
|
|
$
|
120,201
|
|
|
U.S. Government-sponsored enterprise obligations
|
35,758
|
|
|
3,279
|
|
|
12,301
|
|
|
19,640
|
|
|
134
|
|
|
35,354
|
|
||||||
|
State and municipal bonds
|
289,544
|
|
|
10,506
|
|
|
126,225
|
|
|
129,118
|
|
|
27,923
|
|
|
293,772
|
|
||||||
|
Corporate debt
|
1,244,577
|
|
|
147,223
|
|
|
726,570
|
|
|
324,467
|
|
|
25,215
|
|
|
1,223,475
|
|
||||||
|
Residential mortgage-backed securities
|
184,463
|
|
|
|
|
|
|
|
|
|
|
181,238
|
|
||||||||||
|
Agency commercial mortgage-backed securities
|
13,296
|
|
|
|
|
|
|
|
|
|
|
13,108
|
|
||||||||||
|
Other commercial mortgage-backed securities
|
31,330
|
|
|
|
|
|
|
|
|
|
|
30,993
|
|
||||||||||
|
Other asset-backed securities
|
196,583
|
|
|
|
|
|
|
|
|
|
|
195,657
|
|
||||||||||
|
|
$
|
2,116,825
|
|
|
|
|
|
|
|
|
|
|
$
|
2,093,798
|
|
||||||||
|
|
December 31, 2018
|
||||||||||||||||||||||
|
|
Total
|
|
Less than 12 months
|
|
12 months or longer
|
||||||||||||||||||
|
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
||||||||||||
|
(In thousands)
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
||||||||||||
|
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
U.S. Treasury obligations
|
$
|
97,969
|
|
|
$
|
1,405
|
|
|
$
|
20,221
|
|
|
$
|
119
|
|
|
$
|
77,748
|
|
|
$
|
1,286
|
|
|
U.S. Government-sponsored enterprise obligations
|
33,677
|
|
|
429
|
|
|
20,479
|
|
|
126
|
|
|
13,198
|
|
|
303
|
|
||||||
|
State and municipal bonds
|
63,094
|
|
|
648
|
|
|
30,924
|
|
|
143
|
|
|
32,170
|
|
|
505
|
|
||||||
|
Corporate debt
|
938,651
|
|
|
24,429
|
|
|
447,891
|
|
|
8,804
|
|
|
490,760
|
|
|
15,625
|
|
||||||
|
Residential mortgage-backed securities
|
157,120
|
|
|
4,039
|
|
|
27,311
|
|
|
209
|
|
|
129,809
|
|
|
3,830
|
|
||||||
|
Agency commercial mortgage-backed securities
|
9,822
|
|
|
200
|
|
|
4,566
|
|
|
22
|
|
|
5,256
|
|
|
178
|
|
||||||
|
Other commercial mortgage-backed securities
|
22,924
|
|
|
375
|
|
|
13,348
|
|
|
164
|
|
|
9,576
|
|
|
211
|
|
||||||
|
Other asset-backed securities
|
142,470
|
|
|
1,181
|
|
|
70,218
|
|
|
236
|
|
|
72,252
|
|
|
945
|
|
||||||
|
|
$
|
1,465,727
|
|
|
$
|
32,706
|
|
|
$
|
634,958
|
|
|
$
|
9,823
|
|
|
$
|
830,769
|
|
|
$
|
22,883
|
|
|
|
December 31, 2017
|
||||||||||||||||||||||
|
|
Total
|
|
Less than 12 months
|
|
12 months or longer
|
||||||||||||||||||
|
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
||||||||||||
|
(In thousands)
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
||||||||||||
|
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
U.S. Treasury obligations
|
$
|
110,788
|
|
|
$
|
1,181
|
|
|
$
|
67,135
|
|
|
$
|
554
|
|
|
$
|
43,653
|
|
|
$
|
627
|
|
|
U.S. Government-sponsored enterprise obligations
|
17,032
|
|
|
206
|
|
|
10,182
|
|
|
64
|
|
|
6,850
|
|
|
142
|
|
||||||
|
State and municipal bonds
|
23,122
|
|
|
419
|
|
|
15,168
|
|
|
102
|
|
|
7,954
|
|
|
317
|
|
||||||
|
Corporate debt
|
487,578
|
|
|
5,707
|
|
|
365,541
|
|
|
2,730
|
|
|
122,037
|
|
|
2,977
|
|
||||||
|
Residential mortgage-backed securities
|
109,659
|
|
|
1,335
|
|
|
64,121
|
|
|
402
|
|
|
45,538
|
|
|
933
|
|
||||||
|
Agency commercial mortgage-backed securities
|
4,423
|
|
|
108
|
|
|
2,458
|
|
|
34
|
|
|
1,965
|
|
|
74
|
|
||||||
|
Other commercial mortgage-backed securities
|
12,878
|
|
|
134
|
|
|
7,939
|
|
|
82
|
|
|
4,939
|
|
|
52
|
|
||||||
|
Other asset-backed securities
|
85,358
|
|
|
466
|
|
|
70,924
|
|
|
346
|
|
|
14,434
|
|
|
120
|
|
||||||
|
|
$
|
850,838
|
|
|
$
|
9,556
|
|
|
$
|
603,468
|
|
|
$
|
4,314
|
|
|
$
|
247,370
|
|
|
$
|
5,242
|
|
|
|
Year Ended December 31
|
||||||||
|
(In millions)
|
2018
|
2017
|
2016
|
||||||
|
Proceeds from sales (exclusive of maturities and paydowns)
|
$
|
599.6
|
|
$
|
530.2
|
|
$
|
361.8
|
|
|
Purchases
|
$
|
780.7
|
|
$
|
614.4
|
|
$
|
636.4
|
|
|
|
Year Ended December 31
|
||||||||||
|
(In thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
|
Fixed maturities
|
$
|
69,515
|
|
|
$
|
75,669
|
|
|
$
|
85,818
|
|
|
Equities
|
21,418
|
|
|
17,198
|
|
|
14,887
|
|
|||
|
Short-term investments, including Other
|
5,649
|
|
|
7,793
|
|
|
3,402
|
|
|||
|
BOLI
|
1,983
|
|
|
1,979
|
|
|
2,008
|
|
|||
|
Investment fees and expenses
|
(6,681
|
)
|
|
(6,977
|
)
|
|
(6,103
|
)
|
|||
|
Net investment income
|
$
|
91,884
|
|
|
$
|
95,662
|
|
|
$
|
100,012
|
|
|
|
December 31, 2018
|
|
Carrying Value
|
|||||||
|
(In thousands)
|
Percentage
Ownership |
|
December 31,
2018 |
|
December 31,
2017 |
|||||
|
Qualified affordable housing project tax credit partnerships
|
See below
|
|
$
|
65,677
|
|
|
$
|
84,607
|
|
|
|
Other tax credit partnerships
|
See below
|
|
3,757
|
|
|
6,118
|
|
|||
|
All other investments, primarily investment fund LPs/LLCs
|
See below
|
|
298,323
|
|
|
239,866
|
|
|||
|
|
|
|
$
|
367,757
|
|
|
$
|
330,591
|
|
|
|
|
Year Ended December 31
|
||||||||||
|
(In thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
|
Qualified affordable housing project tax credit partnerships
|
|
|
|
|
|
||||||
|
Losses recorded
|
$
|
18,889
|
|
|
$
|
14,297
|
|
|
$
|
20,047
|
|
|
Tax credits recognized
|
$
|
18,474
|
|
|
$
|
17,774
|
|
|
$
|
18,531
|
|
|
|
|
|
|
|
|
||||||
|
Historic tax credit partnerships
|
|
|
|
|
|
||||||
|
Losses recorded
|
$
|
5,434
|
|
|
$
|
6,355
|
|
|
$
|
4,771
|
|
|
Tax credits recognized
|
$
|
2,567
|
|
|
$
|
5,337
|
|
|
$
|
9,018
|
|
|
|
Year Ended December 31
|
||||||||||
|
(In thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
|
Total OTTI losses:
|
|
|
|
|
|
||||||
|
State and municipal bonds
|
$
|
—
|
|
|
$
|
(850
|
)
|
|
$
|
(100
|
)
|
|
Corporate debt
|
(490
|
)
|
|
(419
|
)
|
|
(7,604
|
)
|
|||
|
Investment in unconsolidated subsidiaries
|
—
|
|
|
(11,931
|
)
|
|
—
|
|
|||
|
Other investments
|
—
|
|
|
—
|
|
|
(3,130
|
)
|
|||
|
Portion of OTTI losses recognized in other comprehensive income before taxes:
|
|
|
|
|
|
||||||
|
Corporate debt
|
—
|
|
|
248
|
|
|
1,068
|
|
|||
|
Net impairment losses recognized in earnings
|
(490
|
)
|
|
(12,952
|
)
|
|
(9,766
|
)
|
|||
|
Gross realized gains, available-for-sale fixed maturities
|
5,942
|
|
|
6,653
|
|
|
12,451
|
|
|||
|
Gross realized (losses), available-for-sale fixed maturities
|
(5,799
|
)
|
|
(3,123
|
)
|
|
(7,038
|
)
|
|||
|
Net realized gains (losses), short-term investments
|
(1
|
)
|
|
(2
|
)
|
|
18
|
|
|||
|
Net realized gains (losses), trading fixed maturities
|
(100
|
)
|
|
—
|
|
|
—
|
|
|||
|
Net realized gains (losses), equity investments
|
12,230
|
|
|
10,724
|
|
|
6,632
|
|
|||
|
Net realized gains (losses), other investments
|
1,340
|
|
|
2,963
|
|
|
1,115
|
|
|||
|
Change in unrealized holding gains (losses), trading fixed maturities
|
(317
|
)
|
|
—
|
|
|
—
|
|
|||
|
Change in unrealized holding gains (losses), equity investments
|
(52,707
|
)
|
|
11,243
|
|
|
30,557
|
|
|||
|
Change in unrealized holding gains (losses), convertible securities, carried at fair value
|
(3,849
|
)
|
|
896
|
|
|
899
|
|
|||
|
Other
|
263
|
|
|
7
|
|
|
7
|
|
|||
|
Net realized investment gains (losses)
|
$
|
(43,488
|
)
|
|
$
|
16,409
|
|
|
$
|
34,875
|
|
|
(In thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
|
Balance beginning of period
|
$
|
1,313
|
|
|
$
|
1,158
|
|
|
$
|
5,751
|
|
|
Additional credit losses recognized during the period, related to securities for which:
|
|
|
|
|
|
||||||
|
No OTTI has been previously recognized
|
—
|
|
|
171
|
|
|
2,398
|
|
|||
|
OTTI has been previously recognized
|
—
|
|
|
—
|
|
|
2,154
|
|
|||
|
Reductions due to:
|
|
|
|
|
|
||||||
|
Securities sold during the period (realized)
|
(1,220
|
)
|
|
(16
|
)
|
|
(9,145
|
)
|
|||
|
Balance December 31
|
$
|
93
|
|
|
$
|
1,313
|
|
|
$
|
1,158
|
|
|
|
|
Year Ended December 31
|
||||||||||
|
(In thousands)
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Direct
|
|
$
|
910,198
|
|
|
$
|
842,968
|
|
|
$
|
794,377
|
|
|
Assumed
|
|
47,113
|
|
|
31,908
|
|
|
40,637
|
|
|||
|
Ceded
|
|
(122,397
|
)
|
|
(110,858
|
)
|
|
(96,481
|
)
|
|||
|
Net premiums written
|
|
$
|
834,914
|
|
|
$
|
764,018
|
|
|
$
|
738,533
|
|
|
|
|
|
|
|
|
|
||||||
|
Direct
|
|
$
|
903,354
|
|
|
$
|
821,249
|
|
|
$
|
790,791
|
|
|
Assumed
|
|
41,535
|
|
|
27,629
|
|
|
37,805
|
|
|||
|
Ceded
|
|
(126,036
|
)
|
|
(110,347
|
)
|
|
(95,315
|
)
|
|||
|
Net premiums earned
|
|
$
|
818,853
|
|
|
$
|
738,531
|
|
|
$
|
733,281
|
|
|
|
|
|
|
|
|
|
||||||
|
Losses and loss adjustment expenses
|
|
$
|
675,784
|
|
|
$
|
592,218
|
|
|
$
|
515,242
|
|
|
Reinsurance recoveries
|
|
(82,574
|
)
|
|
(123,060
|
)
|
|
(72,013
|
)
|
|||
|
Net losses and loss adjustment expenses
|
|
$
|
593,210
|
|
|
$
|
469,158
|
|
|
$
|
443,229
|
|
|
|
December 31
|
||||||
|
(In thousands)
|
2018
|
|
2017
|
||||
|
Deferred tax assets
|
|
|
|
||||
|
Unpaid loss discount
|
$
|
30,629
|
|
|
$
|
20,368
|
|
|
Unearned premium adjustment
|
16,620
|
|
|
14,449
|
|
||
|
Compensation related
|
9,879
|
|
|
11,467
|
|
||
|
Unrealized losses on investments, net
|
4,403
|
|
|
—
|
|
||
|
Basis differentials–investments
|
912
|
|
|
—
|
|
||
|
Intangibles
|
433
|
|
|
514
|
|
||
|
Foreign NOL
|
6,795
|
|
|
4,116
|
|
||
|
Total gross deferred tax assets
|
69,671
|
|
|
50,914
|
|
||
|
Valuation allowance
|
(7,074
|
)
|
|
(4,116
|
)
|
||
|
Total deferred tax assets, net of valuation allowance
|
62,597
|
|
|
46,798
|
|
||
|
Deferred tax liabilities
|
|
|
|
||||
|
Deferred policy acquisition costs
|
(9,972
|
)
|
|
(6,333
|
)
|
||
|
Unpaid loss discount–transition
|
(10,128
|
)
|
|
—
|
|
||
|
Unrealized gains on investments, net
|
—
|
|
|
(5,166
|
)
|
||
|
Fixed assets
|
(542
|
)
|
|
(826
|
)
|
||
|
Basis differentials–investments
|
—
|
|
|
(10,397
|
)
|
||
|
Intangibles
|
(11,243
|
)
|
|
(12,548
|
)
|
||
|
Other
|
(1,604
|
)
|
|
(1,598
|
)
|
||
|
Total deferred tax liabilities
|
(33,489
|
)
|
|
(36,868
|
)
|
||
|
Net deferred tax assets (liabilities)
|
$
|
29,108
|
|
|
$
|
9,930
|
|
|
(In thousands)
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Balance at January 1
|
|
$
|
5,341
|
|
|
$
|
8,353
|
|
|
$
|
8,195
|
|
|
Increases for tax positions taken during the current year
|
|
—
|
|
|
—
|
|
|
361
|
|
|||
|
(Decreases) for tax positions taken during the current year
|
|
(777
|
)
|
|
(3,500
|
)
|
|
—
|
|
|||
|
(Decreases)/increases for tax positions taken during prior years
|
|
(800
|
)
|
|
700
|
|
|
—
|
|
|||
|
(Decreases) relating to a lapse of the applicable statute of limitations
|
|
(163
|
)
|
|
(212
|
)
|
|
(203
|
)
|
|||
|
Balance at December 31
|
|
$
|
3,601
|
|
|
$
|
5,341
|
|
|
$
|
8,353
|
|
|
(In thousands)
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Provision for income taxes
|
|
|
|
|
|
|
||||||
|
Current expense (benefit)
|
|
|
|
|
|
|
||||||
|
Federal and foreign
|
|
$
|
(6,509
|
)
|
|
$
|
19,546
|
|
|
$
|
15,857
|
|
|
State
|
|
301
|
|
|
120
|
|
|
729
|
|
|||
|
Total current expense (benefit)
|
|
(6,208
|
)
|
|
19,666
|
|
|
16,586
|
|
|||
|
Deferred expense (benefit)
|
|
|
|
|
|
|
||||||
|
Federal and foreign
|
|
(11,765
|
)
|
|
1,331
|
|
|
8,284
|
|
|||
|
State
|
|
(59
|
)
|
|
362
|
|
|
250
|
|
|||
|
Total deferred expense (benefit)
|
|
(11,824
|
)
|
|
1,693
|
|
|
8,534
|
|
|||
|
Total income tax expense (benefit)
|
|
$
|
(18,032
|
)
|
|
$
|
21,359
|
|
|
$
|
25,120
|
|
|
(In thousands)
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Computed “expected” tax expense
|
|
$
|
6,095
|
|
|
$
|
45,018
|
|
|
$
|
61,670
|
|
|
Tax-exempt income
|
|
(2,505
|
)
|
|
(8,356
|
)
|
|
(9,917
|
)
|
|||
|
Tax credits
|
|
(21,059
|
)
|
|
(23,111
|
)
|
|
(27,549
|
)
|
|||
|
Non-U.S. operating results
|
|
2,269
|
|
|
918
|
|
|
(1,688
|
)
|
|||
|
Excess tax benefit on share-based compensation
|
|
(275
|
)
|
|
(2,762
|
)
|
|
—
|
|
|||
|
Change in federal corporate tax rate
|
|
—
|
|
|
6,541
|
|
|
—
|
|
|||
|
Change in limitation of future deductibility of certain executive compensation
|
|
—
|
|
|
3,497
|
|
|
—
|
|
|||
|
Provision-to-return differences
|
|
(2,309
|
)
|
|
(1,979
|
)
|
|
1,209
|
|
|||
|
Other
|
|
(248
|
)
|
|
1,593
|
|
|
1,395
|
|
|||
|
Total income tax expense (benefit)
|
|
$
|
(18,032
|
)
|
|
$
|
21,359
|
|
|
$
|
25,120
|
|
|
(In thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
|
Balance, beginning of year
|
$
|
2,048,381
|
|
|
$
|
1,993,428
|
|
|
$
|
2,005,326
|
|
|
Less reinsurance recoverables on unpaid losses and loss adjustment expenses
|
335,585
|
|
|
273,475
|
|
|
249,350
|
|
|||
|
Net balance, beginning of year
|
1,712,796
|
|
|
1,719,953
|
|
|
1,755,976
|
|
|||
|
Net losses:
|
|
|
|
|
|
||||||
|
Current year*
|
685,326
|
|
|
603,518
|
|
|
587,007
|
|
|||
|
Favorable development of reserves established in prior years, net
|
(92,116
|
)
|
|
(134,360
|
)
|
|
(143,778
|
)
|
|||
|
Total
|
593,210
|
|
|
469,158
|
|
|
443,229
|
|
|||
|
Paid related to:
|
|
|
|
|
|
||||||
|
Current year
|
(117,268
|
)
|
|
(106,633
|
)
|
|
(96,190
|
)
|
|||
|
Prior years
|
(412,711
|
)
|
|
(369,682
|
)
|
|
(383,062
|
)
|
|||
|
Total paid
|
(529,979
|
)
|
|
(476,315
|
)
|
|
(479,252
|
)
|
|||
|
Net balance, end of year
|
1,776,027
|
|
|
1,712,796
|
|
|
1,719,953
|
|
|||
|
Plus reinsurance recoverables on unpaid losses and loss adjustment expenses
|
343,820
|
|
|
335,585
|
|
|
273,475
|
|
|||
|
Balance, end of year
|
$
|
2,119,847
|
|
|
$
|
2,048,381
|
|
|
$
|
1,993,428
|
|
|
* Current year net losses in 2018 included incurred losses of $25.4 million related to a loss portfolio transfer entered into during the second quarter of 2018 (see Note 4).
|
|||||||||||
|
Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
|
December 31, 2018
|
||||||||||||||||||||||||||||||||||
|
($ in thousands)
|
Year Ended December 31,
|
|
IBNR*
|
Cumulative Number of Reported Claims
|
||||||||||||||||||||||||||||||||
|
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
2017
|
2018
|
|
|||||||||||||||||||||||||
|
Accident Year
|
Unaudited
|
|
|
|||||||||||||||||||||||||||||||||
|
2009
|
$
|
379,259
|
|
$
|
370,642
|
|
$
|
345,714
|
|
$
|
320,368
|
|
$
|
284,511
|
|
$
|
265,478
|
|
$
|
246,146
|
|
$
|
230,849
|
|
$
|
224,768
|
|
$
|
220,703
|
|
|
$
|
(455
|
)
|
3,828
|
|
|
2010
|
—
|
|
$
|
364,996
|
|
$
|
354,787
|
|
$
|
338,170
|
|
$
|
312,813
|
|
$
|
291,553
|
|
$
|
279,713
|
|
$
|
270,484
|
|
$
|
258,466
|
|
257,714
|
|
|
$
|
(243
|
)
|
3,847
|
|
||
|
2011
|
—
|
|
—
|
|
$
|
348,916
|
|
$
|
344,808
|
|
$
|
331,884
|
|
$
|
305,540
|
|
$
|
289,400
|
|
$
|
278,258
|
|
$
|
264,777
|
|
254,329
|
|
|
$
|
(2,091
|
)
|
3,532
|
|
|||
|
2012
|
—
|
|
—
|
|
—
|
|
$
|
341,289
|
|
$
|
324,418
|
|
$
|
319,613
|
|
$
|
306,956
|
|
$
|
291,075
|
|
$
|
279,589
|
|
271,110
|
|
|
$
|
276
|
|
3,702
|
|
||||
|
2013
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
315,346
|
|
$
|
304,209
|
|
$
|
296,550
|
|
$
|
287,140
|
|
$
|
272,364
|
|
258,251
|
|
|
$
|
173
|
|
3,783
|
|
|||||
|
2014
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
290,020
|
|
$
|
289,397
|
|
$
|
280,043
|
|
$
|
267,442
|
|
256,968
|
|
|
$
|
(5,200
|
)
|
3,320
|
|
||||||
|
2015
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
276,492
|
|
$
|
269,980
|
|
$
|
271,138
|
|
270,814
|
|
|
$
|
(8,030
|
)
|
3,266
|
|
|||||||
|
2016
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
271,765
|
|
$
|
274,643
|
|
287,551
|
|
|
$
|
(21,456
|
)
|
3,481
|
|
||||||||
|
2017
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
283,746
|
|
295,883
|
|
|
$
|
(11,228
|
)
|
3,677
|
|
|||||||||
|
2018
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
320,772
|
|
|
$
|
129,334
|
|
3,558
|
|
||||||||||
|
Total
|
|
|
|
|
|
|
|
|
|
$
|
2,694,095
|
|
|
|
|
|||||||||||||||||||||
|
* Includes expected development on reported claims
|
||||||||||||||||||||||||||||||||||||
|
Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
||||||||||||||||||||||||||||||
|
(In thousands)
|
Year Ended December 31,
|
|||||||||||||||||||||||||||||
|
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
2017
|
2018
|
||||||||||||||||||||
|
Accident Year
|
Unaudited
|
|
||||||||||||||||||||||||||||
|
2009
|
$
|
15,051
|
|
$
|
71,272
|
|
$
|
114,318
|
|
$
|
153,563
|
|
$
|
178,445
|
|
$
|
191,420
|
|
$
|
200,425
|
|
$
|
205,372
|
|
$
|
209,016
|
|
$
|
213,568
|
|
|
2010
|
—
|
|
$
|
15,464
|
|
$
|
69,551
|
|
$
|
137,712
|
|
$
|
180,432
|
|
$
|
209,777
|
|
$
|
221,693
|
|
$
|
236,171
|
|
$
|
240,945
|
|
243,675
|
|
||
|
2011
|
—
|
|
—
|
|
$
|
14,417
|
|
$
|
71,208
|
|
$
|
133,004
|
|
$
|
177,089
|
|
$
|
198,112
|
|
$
|
214,502
|
|
$
|
224,982
|
|
233,103
|
|
|||
|
2012
|
—
|
|
—
|
|
—
|
|
$
|
15,382
|
|
$
|
73,571
|
|
$
|
145,488
|
|
$
|
190,997
|
|
$
|
215,220
|
|
$
|
231,652
|
|
244,512
|
|
||||
|
2013
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
16,938
|
|
$
|
69,657
|
|
$
|
127,496
|
|
$
|
171,681
|
|
$
|
197,265
|
|
213,879
|
|
|||||
|
2014
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
16,764
|
|
$
|
59,485
|
|
$
|
116,791
|
|
$
|
154,236
|
|
186,239
|
|
||||||
|
2015
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
9,172
|
|
$
|
55,731
|
|
$
|
111,741
|
|
161,896
|
|
|||||||
|
2016
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
9,027
|
|
$
|
51,869
|
|
109,756
|
|
||||||||
|
2017
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
16,309
|
|
63,171
|
|
|||||||||
|
2018
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
14,051
|
|
||||||||||
|
Total
|
|
|
|
|
|
|
|
|
|
1,683,850
|
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
All outstanding liabilities before 2009, net of reinsurance
|
|
|
11,724
|
|
||||||||||||||||||||||||||
|
Liabilities for losses and loss adjustment expenses, net of reinsurance
|
|
|
$
|
1,021,969
|
|
|||||||||||||||||||||||||
|
Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
|
December 31, 2018
|
||||||||||||||||||||||||||||||||||
|
($ in thousands)
|
Year Ended December 31,
|
|
IBNR*
|
Cumulative Number of Reported Claims
|
||||||||||||||||||||||||||||||||
|
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
2017
|
2018
|
|
|||||||||||||||||||||||||
|
Accident Year
|
Unaudited
|
|
|
|||||||||||||||||||||||||||||||||
|
2009
|
$
|
34,450
|
|
$
|
35,366
|
|
$
|
36,802
|
|
$
|
37,437
|
|
$
|
34,099
|
|
$
|
32,675
|
|
$
|
28,731
|
|
$
|
26,340
|
|
$
|
24,572
|
|
$
|
23,387
|
|
|
$
|
1,519
|
|
246
|
|
|
2010
|
—
|
|
$
|
41,721
|
|
$
|
43,238
|
|
$
|
43,195
|
|
$
|
42,233
|
|
$
|
37,920
|
|
$
|
35,831
|
|
$
|
33,361
|
|
$
|
29,338
|
|
26,501
|
|
|
$
|
946
|
|
290
|
|
||
|
2011
|
—
|
|
—
|
|
$
|
45,882
|
|
$
|
44,956
|
|
$
|
41,453
|
|
$
|
39,917
|
|
$
|
37,150
|
|
$
|
35,004
|
|
$
|
32,343
|
|
29,784
|
|
|
$
|
2,136
|
|
342
|
|
|||
|
2012
|
—
|
|
—
|
|
—
|
|
$
|
45,703
|
|
$
|
46,513
|
|
$
|
44,848
|
|
$
|
40,692
|
|
$
|
34,774
|
|
$
|
32,691
|
|
29,857
|
|
|
$
|
3,816
|
|
399
|
|
||||
|
2013
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
32,746
|
|
$
|
36,602
|
|
$
|
35,624
|
|
$
|
34,393
|
|
$
|
30,906
|
|
26,919
|
|
|
$
|
971
|
|
356
|
|
|||||
|
2014
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
30,420
|
|
$
|
29,918
|
|
$
|
32,143
|
|
$
|
29,869
|
|
25,885
|
|
|
$
|
2,778
|
|
355
|
|
||||||
|
2015
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
35,648
|
|
$
|
35,347
|
|
$
|
37,346
|
|
40,960
|
|
|
$
|
4,667
|
|
355
|
|
|||||||
|
2016
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
29,609
|
|
$
|
28,790
|
|
27,240
|
|
|
$
|
6,244
|
|
322
|
|
||||||||
|
2017
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
24,571
|
|
23,760
|
|
|
$
|
19,890
|
|
270
|
|
|||||||||
|
2018
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
38,420
|
|
|
$
|
36,196
|
|
118
|
|
||||||||||
|
Total
|
|
|
|
|
|
|
|
|
|
$
|
292,713
|
|
|
|
|
|||||||||||||||||||||
|
* Includes expected development on reported claims
|
||||||||||||||||||||||||||||||||||||
|
Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
||||||||||||||||||||||||||||||
|
(In thousands)
|
Year Ended December 31,
|
|||||||||||||||||||||||||||||
|
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
2017
|
2018
|
||||||||||||||||||||
|
Accident Year
|
Unaudited
|
|
||||||||||||||||||||||||||||
|
2009
|
$
|
175
|
|
$
|
2,255
|
|
$
|
5,067
|
|
$
|
7,947
|
|
$
|
10,823
|
|
$
|
13,248
|
|
$
|
15,380
|
|
$
|
16,025
|
|
$
|
16,270
|
|
$
|
17,022
|
|
|
2010
|
—
|
|
$
|
285
|
|
$
|
1,881
|
|
$
|
5,647
|
|
$
|
9,120
|
|
$
|
15,147
|
|
$
|
21,837
|
|
$
|
22,804
|
|
$
|
23,313
|
|
23,832
|
|
||
|
2011
|
—
|
|
—
|
|
$
|
291
|
|
$
|
2,803
|
|
$
|
8,059
|
|
$
|
16,544
|
|
$
|
19,197
|
|
$
|
21,416
|
|
$
|
23,194
|
|
24,539
|
|
|||
|
2012
|
—
|
|
—
|
|
—
|
|
$
|
363
|
|
$
|
2,430
|
|
$
|
7,705
|
|
$
|
12,212
|
|
$
|
19,275
|
|
$
|
21,435
|
|
23,095
|
|
||||
|
2013
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
369
|
|
$
|
3,170
|
|
$
|
7,826
|
|
$
|
14,753
|
|
$
|
16,787
|
|
18,949
|
|
|||||
|
2014
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
394
|
|
$
|
2,260
|
|
$
|
7,460
|
|
$
|
10,519
|
|
14,604
|
|
||||||
|
2015
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
(350
|
)
|
$
|
786
|
|
$
|
4,854
|
|
11,626
|
|
|||||||
|
2016
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
(182
|
)
|
$
|
(195
|
)
|
2,883
|
|
||||||||
|
2017
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
(6,809
|
)
|
(5,858
|
)
|
|||||||||
|
2018
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
65
|
|
||||||||||
|
Total
|
|
|
|
|
|
|
|
|
|
130,757
|
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
All outstanding liabilities before 2009, net of reinsurance
|
|
|
7,985
|
|
||||||||||||||||||||||||||
|
Liabilities for losses and loss adjustment expenses, net of reinsurance
|
|
|
$
|
169,941
|
|
|||||||||||||||||||||||||
|
Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance
|
||||||||||
|
|
||||||||||
|
Years
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
|
|
Unaudited
|
|||||||||
|
Healthcare Professional Liability Claims-Made
|
5.4%
|
19.5%
|
22.8%
|
17.0%
|
10.4%
|
5.9%
|
4.6%
|
2.4%
|
1.4%
|
2.1%
|
|
Healthcare Professional Liability Occurrence
|
(2.3%)
|
6.1%
|
15.0%
|
17.6%
|
15.2%
|
11.7%
|
6.1%
|
3.1%
|
1.5%
|
3.2%
|
|
Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
|
December 31, 2018
|
||||||||||||||||||||||||||||||||||
|
($ in thousands)
|
Year Ended December 31,
|
|
IBNR*
|
Cumulative Number of Reported Claims
|
||||||||||||||||||||||||||||||||
|
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
2017
|
2018
|
|
|||||||||||||||||||||||||
|
Accident Year
|
Unaudited
|
|
|
|||||||||||||||||||||||||||||||||
|
2009
|
$
|
30,462
|
|
$
|
31,183
|
|
$
|
27,523
|
|
$
|
26,181
|
|
$
|
23,425
|
|
$
|
21,733
|
|
$
|
20,551
|
|
$
|
19,264
|
|
$
|
18,176
|
|
$
|
17,984
|
|
|
$
|
251
|
|
699
|
|
|
2010
|
—
|
|
$
|
26,077
|
|
$
|
27,063
|
|
$
|
25,175
|
|
$
|
23,307
|
|
$
|
19,315
|
|
$
|
17,439
|
|
$
|
16,047
|
|
$
|
16,878
|
|
18,611
|
|
|
$
|
402
|
|
498
|
|
||
|
2011
|
—
|
|
—
|
|
$
|
17,249
|
|
$
|
20,930
|
|
$
|
19,166
|
|
$
|
15,836
|
|
$
|
13,794
|
|
$
|
12,487
|
|
$
|
12,358
|
|
8,202
|
|
|
$
|
500
|
|
521
|
|
|||
|
2012
|
—
|
|
—
|
|
—
|
|
$
|
11,162
|
|
$
|
9,989
|
|
$
|
8,906
|
|
$
|
7,441
|
|
$
|
5,824
|
|
$
|
4,797
|
|
5,051
|
|
|
$
|
732
|
|
220
|
|
||||
|
2013
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
9,807
|
|
$
|
9,955
|
|
$
|
9,536
|
|
$
|
7,226
|
|
$
|
4,697
|
|
3,566
|
|
|
$
|
380
|
|
218
|
|
|||||
|
2014
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
9,989
|
|
$
|
10,306
|
|
$
|
9,012
|
|
$
|
8,984
|
|
7,679
|
|
|
$
|
2,544
|
|
272
|
|
||||||
|
2015
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
9,376
|
|
$
|
8,757
|
|
$
|
7,193
|
|
5,929
|
|
|
$
|
2,770
|
|
155
|
|
|||||||
|
2016
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
9,200
|
|
$
|
8,467
|
|
7,413
|
|
|
$
|
3,482
|
|
180
|
|
||||||||
|
2017
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
11,049
|
|
10,143
|
|
|
$
|
7,834
|
|
95
|
|
|||||||||
|
2018
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
10,141
|
|
|
$
|
9,818
|
|
188
|
|
||||||||||
|
Total
|
|
|
|
|
|
|
|
|
|
$
|
94,719
|
|
|
|
|
|||||||||||||||||||||
|
* Includes expected development on reported claims
|
||||||||||||||||||||||||||||||||||||
|
Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
||||||||||||||||||||||||||||||
|
(In thousands)
|
Year Ended December 31,
|
|||||||||||||||||||||||||||||
|
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
2017
|
2018
|
||||||||||||||||||||
|
Accident Year
|
Unaudited
|
|
||||||||||||||||||||||||||||
|
2009
|
$
|
116
|
|
$
|
5,071
|
|
$
|
7,742
|
|
$
|
14,675
|
|
$
|
14,933
|
|
$
|
15,097
|
|
$
|
15,184
|
|
$
|
15,186
|
|
$
|
16,515
|
|
$
|
17,522
|
|
|
2010
|
—
|
|
$
|
485
|
|
$
|
3,557
|
|
$
|
8,491
|
|
$
|
12,283
|
|
$
|
11,725
|
|
$
|
12,146
|
|
$
|
12,253
|
|
$
|
15,366
|
|
17,660
|
|
||
|
2011
|
—
|
|
—
|
|
$
|
118
|
|
$
|
2,034
|
|
$
|
3,846
|
|
$
|
5,062
|
|
$
|
7,376
|
|
$
|
7,240
|
|
$
|
7,799
|
|
7,664
|
|
|||
|
2012
|
—
|
|
—
|
|
—
|
|
$
|
568
|
|
$
|
1,520
|
|
$
|
2,805
|
|
$
|
3,247
|
|
$
|
3,366
|
|
$
|
3,676
|
|
3,800
|
|
||||
|
2013
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
102
|
|
$
|
1,029
|
|
$
|
1,967
|
|
$
|
2,599
|
|
$
|
3,092
|
|
3,102
|
|
|||||
|
2014
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
388
|
|
$
|
1,527
|
|
$
|
2,564
|
|
$
|
3,046
|
|
3,724
|
|
||||||
|
2015
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
25
|
|
$
|
440
|
|
$
|
1,625
|
|
2,097
|
|
|||||||
|
2016
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
53
|
|
$
|
1,690
|
|
2,365
|
|
||||||||
|
2017
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
56
|
|
1,681
|
|
|||||||||
|
2018
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
6
|
|
||||||||||
|
Total
|
|
|
|
|
|
|
|
|
|
59,621
|
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
All outstanding liabilities before 2009, net of reinsurance
|
|
|
1,101
|
|
||||||||||||||||||||||||||
|
Liabilities for losses and loss adjustment expenses, net of reinsurance
|
|
|
$
|
36,199
|
|
|||||||||||||||||||||||||
|
Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance
|
||||||||||||||||||||
|
Years
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
||||||||||
|
|
Unaudited
|
|||||||||||||||||||
|
Medical Technology Liability
|
2.6
|
%
|
19.1
|
%
|
19.7
|
%
|
16.4
|
%
|
8.6
|
%
|
1.6
|
%
|
2.6
|
%
|
5.0
|
%
|
9.9
|
%
|
5.6
|
%
|
|
Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
|
December 31, 2018
|
||||||||||||||||||||||||||||||||||
|
($ in thousands)
|
Year Ended December 31,
|
|
IBNR*
|
Cumulative Number of Reported Claims
|
||||||||||||||||||||||||||||||||
|
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
2017
|
2018
|
|
|||||||||||||||||||||||||
|
Accident Year
|
Unaudited
|
|
|
|||||||||||||||||||||||||||||||||
|
2009
|
$
|
45,354
|
|
$
|
45,354
|
|
$
|
45,354
|
|
$
|
45,354
|
|
$
|
47,811
|
|
$
|
48,372
|
|
$
|
47,905
|
|
$
|
47,480
|
|
$
|
47,480
|
|
$
|
47,480
|
|
|
$
|
80
|
|
10,129
|
|
|
2010
|
—
|
|
$
|
55,852
|
|
$
|
55,852
|
|
$
|
55,852
|
|
$
|
54,837
|
|
$
|
54,779
|
|
$
|
55,200
|
|
$
|
54,600
|
|
$
|
54,600
|
|
54,600
|
|
|
$
|
58
|
|
12,913
|
|
||
|
2011
|
—
|
|
—
|
|
$
|
65,665
|
|
$
|
65,783
|
|
$
|
71,521
|
|
$
|
72,280
|
|
$
|
72,420
|
|
$
|
72,495
|
|
$
|
72,795
|
|
72,795
|
|
|
$
|
354
|
|
15,244
|
|
|||
|
2012
|
—
|
|
—
|
|
—
|
|
$
|
80,285
|
|
$
|
76,551
|
|
$
|
75,848
|
|
$
|
76,357
|
|
$
|
75,836
|
|
$
|
75,636
|
|
75,136
|
|
|
$
|
724
|
|
16,204
|
|
||||
|
2013
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
86,973
|
|
$
|
85,935
|
|
$
|
86,928
|
|
$
|
88,010
|
|
$
|
88,810
|
|
88,810
|
|
|
$
|
1,017
|
|
16,429
|
|
|||||
|
2014
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
93,019
|
|
$
|
93,529
|
|
$
|
93,029
|
|
$
|
92,229
|
|
92,229
|
|
|
$
|
3,350
|
|
16,210
|
|
||||||
|
2015
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
100,101
|
|
$
|
100,454
|
|
$
|
98,454
|
|
97,654
|
|
|
$
|
8,522
|
|
16,548
|
|
|||||||
|
2016
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
101,348
|
|
$
|
97,348
|
|
92,148
|
|
|
$
|
13,540
|
|
15,972
|
|
||||||||
|
2017
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
99,874
|
|
99,874
|
|
|
$
|
12,489
|
|
16,058
|
|
|||||||||
|
2018
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
118,095
|
|
|
$
|
32,816
|
|
17,556
|
|
||||||||||
|
Total
|
|
|
|
|
|
|
|
|
|
$
|
838,821
|
|
|
|
|
|||||||||||||||||||||
|
* Includes expected development on reported claims
|
||||||||||||||||||||||||||||||||||||
|
Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
||||||||||||||||||||||||||||||
|
(In thousands)
|
Year Ended December 31,
|
|||||||||||||||||||||||||||||
|
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
2017
|
2018
|
||||||||||||||||||||
|
Accident Year
|
Unaudited
|
|
||||||||||||||||||||||||||||
|
2009
|
$
|
14,701
|
|
$
|
31,465
|
|
$
|
39,351
|
|
$
|
43,436
|
|
$
|
45,689
|
|
$
|
46,321
|
|
$
|
46,928
|
|
$
|
47,012
|
|
$
|
47,089
|
|
$
|
47,189
|
|
|
2010
|
—
|
|
$
|
20,086
|
|
$
|
39,098
|
|
$
|
46,762
|
|
$
|
51,117
|
|
$
|
52,530
|
|
$
|
53,443
|
|
$
|
53,734
|
|
$
|
53,974
|
|
54,014
|
|
||
|
2011
|
—
|
|
—
|
|
$
|
21,993
|
|
$
|
50,900
|
|
$
|
62,307
|
|
$
|
67,945
|
|
$
|
70,146
|
|
$
|
70,934
|
|
$
|
71,662
|
|
71,856
|
|
|||
|
2012
|
—
|
|
—
|
|
—
|
|
$
|
27,448
|
|
$
|
56,122
|
|
$
|
65,908
|
|
$
|
70,558
|
|
$
|
72,766
|
|
$
|
73,662
|
|
73,676
|
|
||||
|
2013
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
30,554
|
|
$
|
63,825
|
|
$
|
76,813
|
|
$
|
82,369
|
|
$
|
85,689
|
|
86,783
|
|
|||||
|
2014
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
30,368
|
|
$
|
65,922
|
|
$
|
77,631
|
|
$
|
85,022
|
|
87,314
|
|
||||||
|
2015
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
32,078
|
|
$
|
65,070
|
|
$
|
78,947
|
|
83,483
|
|
|||||||
|
2016
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
28,377
|
|
$
|
58,192
|
|
69,237
|
|
||||||||
|
2017
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
31,586
|
|
70,333
|
|
|||||||||
|
2018
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
41,619
|
|
||||||||||
|
Total
|
|
|
|
|
|
|
|
|
|
685,504
|
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
All outstanding liabilities before 2009, net of reinsurance
|
|
|
2,208
|
|
||||||||||||||||||||||||||
|
Liabilities for losses and loss adjustment expenses, net of reinsurance
|
|
|
$
|
155,525
|
|
|||||||||||||||||||||||||
|
Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance
|
||||||||||||||||||||
|
Years
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
||||||||||
|
|
Unaudited
|
|||||||||||||||||||
|
Workers' Compensation Insurance
|
33.2
|
%
|
36.5
|
%
|
14.1
|
%
|
7.1
|
%
|
3.3
|
%
|
1.3
|
%
|
0.7
|
%
|
0.3
|
%
|
0.1
|
%
|
0.2
|
%
|
|
Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
|
December 31, 2018
|
||||||||||||||||||||||||||||||||||
|
($ in thousands)
|
Year Ended December 31,
|
|
IBNR*
|
Cumulative Number of Reported Claims
|
||||||||||||||||||||||||||||||||
|
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
2017
|
2018
|
|
|||||||||||||||||||||||||
|
Accident Year
|
Unaudited
|
|
|
|||||||||||||||||||||||||||||||||
|
2009
|
$
|
17,790
|
|
$
|
16,337
|
|
$
|
15,886
|
|
$
|
15,948
|
|
$
|
15,809
|
|
$
|
15,695
|
|
$
|
15,618
|
|
$
|
15,277
|
|
$
|
15,277
|
|
$
|
15,279
|
|
|
$
|
107
|
|
2,962
|
|
|
2010
|
—
|
|
$
|
19,767
|
|
$
|
18,265
|
|
$
|
17,715
|
|
$
|
17,825
|
|
$
|
17,736
|
|
$
|
17,541
|
|
$
|
17,320
|
|
$
|
17,278
|
|
17,224
|
|
|
$
|
275
|
|
2,914
|
|
||
|
2011
|
—
|
|
—
|
|
$
|
18,790
|
|
$
|
19,360
|
|
$
|
19,629
|
|
$
|
19,282
|
|
$
|
18,644
|
|
$
|
18,725
|
|
$
|
18,666
|
|
18,606
|
|
|
$
|
363
|
|
3,154
|
|
|||
|
2012
|
—
|
|
—
|
|
—
|
|
$
|
22,940
|
|
$
|
21,513
|
|
$
|
21,048
|
|
$
|
20,028
|
|
$
|
19,972
|
|
$
|
19,864
|
|
19,799
|
|
|
$
|
441
|
|
3,454
|
|
||||
|
2013
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
23,809
|
|
$
|
25,310
|
|
$
|
26,758
|
|
$
|
26,619
|
|
$
|
26,260
|
|
26,033
|
|
|
$
|
544
|
|
3,723
|
|
|||||
|
2014
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
28,248
|
|
$
|
28,423
|
|
$
|
29,000
|
|
$
|
28,373
|
|
28,281
|
|
|
$
|
942
|
|
4,433
|
|
||||||
|
2015
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
36,423
|
|
$
|
32,519
|
|
$
|
28,746
|
|
27,548
|
|
|
$
|
1,601
|
|
4,949
|
|
|||||||
|
2016
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
37,601
|
|
$
|
34,055
|
|
30,998
|
|
|
$
|
2,528
|
|
5,326
|
|
||||||||
|
2017
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
42,725
|
|
38,594
|
|
|
$
|
7,314
|
|
5,699
|
|
|||||||||
|
2018
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
43,654
|
|
|
$
|
18,788
|
|
6,228
|
|
||||||||||
|
Total
|
|
|
|
|
|
|
|
|
|
$
|
266,016
|
|
|
|
|
|||||||||||||||||||||
|
* Includes expected development on reported claims
|
||||||||||||||||||||||||||||||||||||
|
Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
||||||||||||||||||||||||||||||
|
(In thousands)
|
Year Ended December 31,
|
|||||||||||||||||||||||||||||
|
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
2017
|
2018
|
||||||||||||||||||||
|
Accident Year
|
Unaudited
|
|
||||||||||||||||||||||||||||
|
2009
|
$
|
5,000
|
|
$
|
10,782
|
|
$
|
13,202
|
|
$
|
14,660
|
|
$
|
14,881
|
|
$
|
14,954
|
|
$
|
15,147
|
|
$
|
15,165
|
|
$
|
15,166
|
|
$
|
15,172
|
|
|
2010
|
—
|
|
$
|
6,503
|
|
$
|
12,904
|
|
$
|
15,087
|
|
$
|
16,214
|
|
$
|
16,757
|
|
$
|
16,842
|
|
$
|
16,810
|
|
$
|
16,850
|
|
16,904
|
|
||
|
2011
|
—
|
|
—
|
|
$
|
5,940
|
|
$
|
14,045
|
|
$
|
17,197
|
|
$
|
17,869
|
|
$
|
18,054
|
|
$
|
18,177
|
|
$
|
18,176
|
|
18,185
|
|
|||
|
2012
|
—
|
|
—
|
|
—
|
|
$
|
7,808
|
|
$
|
14,740
|
|
$
|
17,728
|
|
$
|
18,474
|
|
$
|
19,208
|
|
$
|
19,402
|
|
19,328
|
|
||||
|
2013
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
8,131
|
|
$
|
19,054
|
|
$
|
24,268
|
|
$
|
25,209
|
|
$
|
25,366
|
|
25,489
|
|
|||||
|
2014
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
9,933
|
|
$
|
21,880
|
|
$
|
26,173
|
|
$
|
26,810
|
|
26,959
|
|
||||||
|
2015
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
11,257
|
|
$
|
21,706
|
|
$
|
23,977
|
|
24,781
|
|
|||||||
|
2016
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
10,980
|
|
$
|
23,003
|
|
26,285
|
|
||||||||
|
2017
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
$
|
12,404
|
|
24,791
|
|
|||||||||
|
2018
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
12,517
|
|
||||||||||
|
Total
|
|
|
|
|
|
|
|
|
|
210,411
|
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
All outstanding liabilities before 2009, net of reinsurance
|
|
|
912
|
|
||||||||||||||||||||||||||
|
Liabilities for losses and loss adjustment expenses, net of reinsurance
|
|
|
$
|
56,517
|
|
|||||||||||||||||||||||||
|
Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance
|
||||||||||||||||||||
|
Years
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
||||||||||
|
|
Unaudited
|
|||||||||||||||||||
|
Segregated Portfolio Cell Reinsurance - Workers' Compensation
|
34.5
|
%
|
38.5
|
%
|
14.3
|
%
|
4.6
|
%
|
1.7
|
%
|
0.6
|
%
|
0.2
|
%
|
0.1
|
%
|
0.2
|
%
|
—
|
%
|
|
Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
|
December 31, 2018
|
||||||||||||||||||
|
($ in thousands)
|
Year Ended December 31,
|
|
IBNR
(1)
|
Cumulative Number of Reported Claims
(2)
|
||||||||||||||||
|
|
2014
|
2015
|
2016
|
2017
|
2018
|
|
||||||||||||||
|
Accident Year
|
|
Unaudited
|
|
|
||||||||||||||||
|
2014
|
$
|
6,110
|
|
$
|
5,812
|
|
$
|
5,610
|
|
$
|
5,547
|
|
$
|
5,472
|
|
|
$
|
1,086
|
|
nm
|
|
2015
|
—
|
|
$
|
14,810
|
|
$
|
14,510
|
|
$
|
14,398
|
|
14,232
|
|
|
$
|
1,984
|
|
nm
|
||
|
2016
|
—
|
|
—
|
|
$
|
19,535
|
|
$
|
19,669
|
|
19,552
|
|
|
$
|
5,098
|
|
nm
|
|||
|
2017
|
—
|
|
—
|
|
—
|
|
$
|
22,069
|
|
21,824
|
|
|
$
|
9,960
|
|
nm
|
||||
|
2018
|
—
|
|
—
|
|
—
|
|
—
|
|
18,688
|
|
|
$
|
16,014
|
|
nm
|
|||||
|
Total
|
|
|
|
|
$
|
79,768
|
|
|
|
|
||||||||||
|
(1)
Includes expected development on reported claims
|
||||||||||||||||||||
|
(2)
The abbreviation "
nm
" indicates that the information is not meaningful
|
||||||||||||||||||||
|
Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
|||||||||||||||
|
(In thousands)
|
Year Ended December 31,
|
||||||||||||||
|
|
2014
|
2015
|
2016
|
2017
|
2018
|
||||||||||
|
Accident Year
|
|
Unaudited
|
|
||||||||||||
|
2014
|
$
|
20
|
|
$
|
474
|
|
$
|
4,092
|
|
$
|
4,214
|
|
$
|
4,320
|
|
|
2015
|
—
|
|
$
|
724
|
|
$
|
6,307
|
|
$
|
10,313
|
|
10,947
|
|
||
|
2016
|
—
|
|
—
|
|
$
|
2,495
|
|
$
|
8,441
|
|
12,869
|
|
|||
|
2017
|
—
|
|
—
|
|
—
|
|
$
|
2,611
|
|
8,301
|
|
||||
|
2018
|
—
|
|
—
|
|
—
|
|
—
|
|
1,852
|
|
|||||
|
Total
|
|
|
|
|
38,289
|
|
|||||||||
|
|
|
|
|
|
|
||||||||||
|
All outstanding liabilities before 2014, net of reinsurance
|
—
|
|
|||||||||||||
|
Liabilities for losses and loss adjustment expenses, net of reinsurance
|
$
|
41,479
|
|
||||||||||||
|
Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
|
December 31, 2018
|
|||||||||||||||||||
|
($ in thousands)
|
Year Ended December 31,
|
|
IBNR*
|
Cumulative Number of Reported Claims
|
|||||||||||||||||
|
|
2014
|
2015
|
2016
|
2017
|
2018
|
|
|||||||||||||||
|
Accident Year
|
Unaudited
|
|
|
||||||||||||||||||
|
2014
|
$
|
890
|
|
$
|
1,089
|
|
$
|
888
|
|
$
|
864
|
|
$
|
866
|
|
|
$
|
(6
|
)
|
118
|
|
|
2015
|
—
|
|
$
|
5,519
|
|
$
|
5,917
|
|
$
|
6,194
|
|
6,159
|
|
|
$
|
1,128
|
|
921
|
|
||
|
2016
|
—
|
|
—
|
|
$
|
11,896
|
|
$
|
12,984
|
|
12,823
|
|
|
$
|
12
|
|
2,484
|
|
|||
|
2017
|
—
|
|
—
|
|
—
|
|
$
|
15,018
|
|
17,634
|
|
|
$
|
(883
|
)
|
4,240
|
|
||||
|
2018
|
—
|
|
—
|
|
—
|
|
—
|
|
20,636
|
|
|
$
|
6,898
|
|
3,681
|
|
|||||
|
Total
|
|
|
|
|
$
|
58,118
|
|
|
|
|
|||||||||||
|
* Includes expected development on reported claims
|
|||||||||||||||||||||
|
Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
|||||||||||||||
|
(In thousands)
|
Year Ended December 31,
|
||||||||||||||
|
|
2014
|
2015
|
2016
|
2017
|
2018
|
||||||||||
|
Accident Year
|
Unaudited
|
|
|||||||||||||
|
2014
|
$
|
267
|
|
$
|
1,005
|
|
$
|
836
|
|
$
|
854
|
|
$
|
857
|
|
|
2015
|
—
|
|
$
|
3,165
|
|
$
|
4,022
|
|
$
|
4,808
|
|
4,869
|
|
||
|
2016
|
—
|
|
—
|
|
$
|
7,751
|
|
$
|
10,939
|
|
12,343
|
|
|||
|
2017
|
—
|
|
—
|
|
—
|
|
$
|
8,221
|
|
16,439
|
|
||||
|
2018
|
—
|
|
—
|
|
—
|
|
—
|
|
9,918
|
|
|||||
|
Total
|
|
|
|
|
44,426
|
|
|||||||||
|
|
|
|
|
|
|
||||||||||
|
All outstanding liabilities before 2014, net of reinsurance
|
—
|
|
|||||||||||||
|
Liabilities for losses and loss adjustment expenses, net of reinsurance
|
$
|
13,692
|
|
||||||||||||
|
Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
|
December 31, 2018
|
||||||||||||||||||
|
($ in thousands)
|
Year Ended December 31,
|
|
IBNR
(1)
|
Cumulative Number of Reported Claims
(2)
|
||||||||||||||||
|
|
2014
|
2015
|
2016
|
2017
|
2018
|
|
||||||||||||||
|
Accident Year
|
Unaudited
|
|
|
|||||||||||||||||
|
2014
|
$
|
831
|
|
$
|
929
|
|
$
|
989
|
|
$
|
989
|
|
$
|
1,125
|
|
|
$
|
—
|
|
nm
|
|
2015
|
|
|
$
|
2,788
|
|
$
|
2,825
|
|
$
|
2,275
|
|
2,328
|
|
|
$
|
(91
|
)
|
nm
|
||
|
2016
|
|
|
|
|
$
|
4,497
|
|
$
|
4,050
|
|
3,368
|
|
|
$
|
943
|
|
nm
|
|||
|
2017
|
|
|
|
|
|
|
$
|
6,861
|
|
7,832
|
|
|
$
|
371
|
|
nm
|
||||
|
2018
|
|
|
|
|
|
|
|
|
8,840
|
|
|
$
|
8,154
|
|
nm
|
|||||
|
Total
|
|
|
|
|
$
|
23,493
|
|
|
|
|
||||||||||
|
(1)
Includes expected development on reported claims
|
||||||||||||||||||||
|
(2)
The abbreviation "
nm
" indicates that the information is not meaningful
|
||||||||||||||||||||
|
Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance
|
|||||||||||||||
|
(In thousands)
|
Year Ended December 31,
|
||||||||||||||
|
|
2014
|
2015
|
2016
|
2017
|
2018
|
||||||||||
|
Accident Year
|
Unaudited
|
|
|||||||||||||
|
2014
|
$
|
79
|
|
$
|
917
|
|
$
|
984
|
|
$
|
984
|
|
$
|
1,125
|
|
|
2015
|
—
|
|
$
|
1,313
|
|
$
|
1,804
|
|
$
|
1,996
|
|
2,234
|
|
||
|
2016
|
—
|
|
—
|
|
$
|
613
|
|
$
|
1,667
|
|
2,136
|
|
|||
|
2017
|
—
|
|
—
|
|
—
|
|
$
|
4,147
|
|
7,300
|
|
||||
|
2018
|
—
|
|
—
|
|
—
|
|
—
|
|
547
|
|
|||||
|
Total
|
|
|
|
|
13,342
|
|
|||||||||
|
|
|
|
|
|
|
||||||||||
|
All outstanding liabilities before 2014, net of reinsurance
|
—
|
|
|||||||||||||
|
Liabilities for losses and loss adjustment expenses, net of reinsurance
|
$
|
10,151
|
|
||||||||||||
|
Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance
|
||||||||||||||||||||
|
Years
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
||||||||||
|
|
Unaudited
|
|||||||||||||||||||
|
Syndicate 1729 Casualty
|
18.7
|
%
|
40.3
|
%
|
22.6
|
%
|
12.8
|
%
|
3.2
|
%
|
1.1
|
%
|
1.0
|
%
|
0.4
|
%
|
—
|
%
|
—
|
%
|
|
Syndicate 1729 Property Insurance
|
81.4
|
%
|
15.9
|
%
|
2.1
|
%
|
0.2
|
%
|
0.2
|
%
|
0.1
|
%
|
0.1
|
%
|
0.1
|
%
|
—
|
%
|
—
|
%
|
|
Syndicate 1729 Property Reinsurance
|
82.0
|
%
|
13.3
|
%
|
2.8
|
%
|
1.1
|
%
|
0.4
|
%
|
0.2
|
%
|
0.1
|
%
|
—
|
%
|
—
|
%
|
—
|
%
|
|
(In thousands)
|
December 31, 2018
|
||
|
Net outstanding liabilities
|
|
||
|
Healthcare professional liability claims-made
|
$
|
1,021,969
|
|
|
Healthcare professional liability occurrence
|
169,941
|
|
|
|
Medical technology liability claims-made
|
36,199
|
|
|
|
Workers' compensation insurance
|
155,525
|
|
|
|
Segregated portfolio cell reinsurance - workers' compensation
|
56,517
|
|
|
|
Syndicate 1729 casualty
|
41,479
|
|
|
|
Syndicate 1729 property insurance
|
13,692
|
|
|
|
Syndicate 1729 property reinsurance
|
10,151
|
|
|
|
Other short-duration lines
|
91,365
|
|
|
|
Liabilities for losses and loss adjustment expenses, net of reinsurance
|
1,596,838
|
|
|
|
|
|
||
|
Reinsurance recoverable on unpaid losses
|
|
||
|
Healthcare professional liability claims-made
|
151,870
|
|
|
|
Healthcare professional liability occurrence
|
37,683
|
|
|
|
Medical technology liability claims-made
|
32,604
|
|
|
|
Workers' compensation insurance
|
67,631
|
|
|
|
Segregated portfolio cell reinsurance - workers' compensation
|
24,177
|
|
|
|
Syndicate 1729 casualty
|
678
|
|
|
|
Syndicate 1729 property insurance
|
10,323
|
|
|
|
Syndicate 1729 property reinsurance
|
9,717
|
|
|
|
Other short-duration lines
|
9,137
|
|
|
|
Total reinsurance recoverable on unpaid losses and loss adjustment expenses
|
343,820
|
|
|
|
|
|
||
|
Reserve for the future utilization of the DDR benefit
|
67,200
|
|
|
|
Unallocated loss adjustment expenses
|
100,123
|
|
|
|
Loss portfolio transfer*
|
18,252
|
|
|
|
Purchase accounting
|
1,551
|
|
|
|
Other
|
(7,937
|
)
|
|
|
|
179,189
|
|
|
|
Gross liability for losses and loss adjustment expenses
|
$
|
2,119,847
|
|
|
* Represents the reserve for retroactive coverage, net of a deferred gain, related to a loss portfolio transfer entered into in the second quarter of 2018 (see Note 4).
|
|||
|
Operating Leases
|
|||
|
(In thousands)
|
|||
|
2019
|
$
|
4,829
|
|
|
2020
|
4,020
|
|
|
|
2021
|
3,557
|
|
|
|
2022
|
2,618
|
|
|
|
2023
|
1,888
|
|
|
|
Thereafter
|
10,212
|
|
|
|
Total minimum lease payments
|
$
|
27,124
|
|
|
(In thousands)
|
December 31,
2018 |
|
December 31,
2017 |
||||
|
Senior Notes due 2023, unsecured, interest at 5.3% annually
|
$
|
250,000
|
|
|
$
|
250,000
|
|
|
Revolving Credit Agreement, outstanding borrowings were fully secured and carried at a weighted average interest rate of 1.91%. The interest rate on borrowings is set at the time the respective borrowing is initiated or renewed.
|
—
|
|
|
123,000
|
|
||
|
Mortgage Loans, outstanding borrowings are secured by first priority liens on two office buildings, and bear an interest rate of three-month LIBOR plus 1.325% (4.10% and 2.86%, respectively) determined on a quarterly basis.
|
39,064
|
|
|
40,460
|
|
||
|
Total principal
|
289,064
|
|
|
413,460
|
|
||
|
Less debt issuance costs
|
1,307
|
|
|
1,649
|
|
||
|
Debt less debt issuance costs
|
$
|
287,757
|
|
|
$
|
411,811
|
|
|
(1)
|
ProAssurance is not permitted to have a leverage ratio of Consolidated Funded Indebtedness (principally, obligations for borrowed money, obligations evidenced by instruments such as notes or acceptances, standby and commercial Letters of Credit, and contingent obligations) to Consolidated Total Capitalization (principally, total non-trade liabilities on a consolidated basis plus consolidated shareholders’ equity, exclusive of
AOCI
) greater than
0.35
to
1.0
, determined at the end of each fiscal quarter.
|
|
(2)
|
ProAssurance is required to maintain a minimum net worth, excluding
AOCI
, of at least
$1.3 billion
.
|
|
(1)
|
Each of the two ProAssurance subsidiaries are not permitted to have a leverage ratio of Consolidated Funded Debt (principally, obligations for borrowed money, obligations for deferred purchase price of property or services, obligations evidenced by notes, bonds, debentures, standby and commercial Letters of Credit and contingent obligations of the subsidiary) to Consolidated Total Capitalization (principally,
SAP
Consolidated Net Worth plus Consolidated Funded Debt of the subsidiary) greater than
0.35
, determined at the end of each fiscal quarter.
|
|
(In thousands)
|
Principal Payments Due by Period
|
|||
|
2019
|
$
|
1,448
|
|
|
|
2020
|
1,503
|
|
||
|
2021
|
1,559
|
|
||
|
2022
|
1,617
|
|
||
|
2023
|
1,677
|
|
||
|
Thereafter
|
31,260
|
|
||
|
Total principal payments
|
$
|
39,064
|
|
|
|
($ in thousands)
|
December 31, 2018
|
|
December 31, 2017
|
|||||||||||||
|
Derivatives Not Designated as Hedging Instruments
|
Location in the Consolidated Balance Sheets
|
Number of Instruments
|
Notional Amount
(1)
|
Estimated Fair Value
(2)
|
|
Number of Instruments
|
Notional Amount
(1)
|
Estimated Fair Value
(2)
|
||||||||
|
Interest Rate Cap
|
Other assets
|
1
|
$
|
35,000
|
|
$
|
1,884
|
|
|
1
|
$
|
35,000
|
|
$
|
1,731
|
|
|
(1)
Volume is represented by the derivative instrument's notional amount.
|
||||||||||||||||
|
(2)
Additional information regarding the fair value of the Company's interest rate cap is provided in Note 2.
|
||||||||||||||||
|
|
Gains (Losses) Recognized in Income on Derivatives
|
|||||||||||
|
(In thousands)
|
Year Ended December 31
|
|||||||||||
|
Derivatives Not Designated as Hedging Instruments
|
Location in the Consolidated Statements of Income and Comprehensive Income
|
2018
|
|
2017
|
|
2016
|
||||||
|
Interest Rate Cap
|
Interest expense
|
$
|
153
|
|
|
$
|
(339
|
)
|
|
$
|
—
|
|
|
(In thousands)
|
2018
|
|
2017
|
|
2016
|
|||
|
Issued and outstanding shares - January 1
|
53,457
|
|
|
53,251
|
|
|
53,101
|
|
|
Repurchase of shares, at cost of $2 million for 2016
|
—
|
|
|
—
|
|
|
(44
|
)
|
|
Shares issued due to exercise of options and vesting of share-based compensation awards
|
135
|
|
|
132
|
|
|
108
|
|
|
Other shares issued for compensation and shares reissued to stock purchase plan
*
|
45
|
|
|
74
|
|
|
86
|
|
|
Issued and outstanding shares - December 31
|
53,637
|
|
|
53,457
|
|
|
53,251
|
|
|
* Shares issued were valued at fair value (the market price of a ProAssurance common share on the date of issue).
|
||||||||
|
|
|
Cash Dividends Declared, per Share
|
||||||||||
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
First Quarter
|
|
$
|
0.31
|
|
|
$
|
0.31
|
|
|
$
|
0.31
|
|
|
Second Quarter
|
|
$
|
0.31
|
|
|
$
|
0.31
|
|
|
$
|
0.31
|
|
|
Third Quarter
|
|
$
|
0.31
|
|
|
$
|
0.31
|
|
|
$
|
0.31
|
|
|
Fourth Quarter*
|
|
$
|
0.81
|
|
|
$
|
5.00
|
|
|
$
|
5.00
|
|
|
(In thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
|
Reclassifications from AOCI to net income:
|
|
|
|
|
|
||||||
|
Realized investment gains (losses)
|
$
|
274
|
|
|
$
|
2,512
|
|
|
$
|
2,417
|
|
|
Non-credit impairment losses reclassified to earnings, due to sale of securities or reclassification as a credit loss
|
(621
|
)
|
|
(3
|
)
|
|
(3,641
|
)
|
|||
|
Unrecognized losses in defined benefit plan liabilities reclassified to earnings, due to the termination and settlement of the plan
|
—
|
|
|
—
|
|
|
(1,500
|
)
|
|||
|
Total gains (losses) reclassified, before-tax effect
|
(347
|
)
|
|
2,509
|
|
|
(2,724
|
)
|
|||
|
Tax effect*
|
73
|
|
|
(878
|
)
|
|
953
|
|
|||
|
Net reclassification adjustments
|
$
|
(274
|
)
|
|
$
|
1,631
|
|
|
$
|
(1,771
|
)
|
|
|
|
|
|
|
|
||||||
|
Deferred tax expense (benefit) included in OCI
|
$
|
(9,573
|
)
|
|
$
|
(4,676
|
)
|
|
$
|
(3,078
|
)
|
|
* Tax effects were computed using a 21% for the year ended December 31, 2018 and a 35% rate for the years ended December 31, 2017 and 2016.
|
|||||||||||
|
|
|
Share-Based
Compensation Expense |
|
Unrecognized Compensation Cost
|
||||||||||||||
|
|
|
Year Ended December 31
|
|
December 31, 2018
|
||||||||||||||
|
($ in millions, except remaining recognition period)
|
|
2018
|
|
2017
|
|
2016
|
|
Amount
|
|
Weighted Average Remaining
Recognition Period |
||||||||
|
Total share-based compensation expense
|
|
$
|
5.3
|
|
|
$
|
10.6
|
|
|
$
|
12.5
|
|
|
$
|
5.9
|
|
|
1.5
|
|
Tax benefit recognized
|
|
$
|
1.1
|
|
|
$
|
3.7
|
|
|
$
|
4.4
|
|
|
|
|
|
||
|
|
|
2018
|
|
2017
|
|
2016
|
|||||||||||||||
|
|
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|||||||||
|
Beginning non-vested balance
|
|
269,520
|
|
|
$
|
48.63
|
|
|
240,149
|
|
|
$
|
44.07
|
|
|
178,468
|
|
|
$
|
43.13
|
|
|
Granted
|
|
85,797
|
|
|
$
|
44.73
|
|
|
84,565
|
|
|
$
|
58.35
|
|
|
109,181
|
|
|
$
|
45.59
|
|
|
Forfeited
|
|
(3,878
|
)
|
|
$
|
50.07
|
|
|
(4,087
|
)
|
|
$
|
52.35
|
|
|
(5,954
|
)
|
|
$
|
43.99
|
|
|
Vested and released
|
|
(84,116
|
)
|
|
$
|
42.90
|
|
|
(51,107
|
)
|
|
$
|
43.01
|
|
|
(41,546
|
)
|
|
$
|
44.04
|
|
|
Ending non-vested balance
|
|
267,323
|
|
|
$
|
49.16
|
|
|
269,520
|
|
|
$
|
48.63
|
|
|
240,149
|
|
|
$
|
44.07
|
|
|
|
|
2018
|
|
2017
|
|
2016
|
|||||||||||||||
|
|
|
Base Units
|
|
Weighted
Average Grant Date Fair Value |
|
Base Units
|
|
Weighted
Average Grant Date Fair Value |
|
Base Units
|
|
Weighted
Average Grant Date Fair Value |
|||||||||
|
Beginning non-vested balance
|
|
212,105
|
|
|
$
|
47.11
|
|
|
305,240
|
|
|
$
|
43.41
|
|
|
390,350
|
|
|
$
|
44.65
|
|
|
Granted
|
|
27,202
|
|
|
$
|
44.73
|
|
|
48,000
|
|
|
$
|
58.35
|
|
|
60,000
|
|
|
$
|
45.59
|
|
|
Forfeited
|
|
—
|
|
|
$
|
—
|
|
|
(227
|
)
|
|
$
|
42.79
|
|
|
(5,162
|
)
|
|
$
|
43.02
|
|
|
Vested and released
|
|
(104,105
|
)
|
|
$
|
42.79
|
|
|
(140,908
|
)
|
|
$
|
42.95
|
|
|
(139,948
|
)
|
|
$
|
44.05
|
|
|
Ending non-vested balance
|
|
135,202
|
|
|
$
|
49.95
|
|
|
212,105
|
|
|
$
|
47.11
|
|
|
305,240
|
|
|
$
|
43.41
|
|
|
|
|
2018
|
|
2017
|
|
2016
|
|||||||||||||||
|
|
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|||||||||
|
Beginning non-vested balance
|
|
70,292
|
|
|
$
|
49.40
|
|
|
72,615
|
|
|
$
|
45.77
|
|
|
74,483
|
|
|
$
|
42.80
|
|
|
Granted
|
|
—
|
|
|
$
|
—
|
|
|
24,444
|
|
|
$
|
51.83
|
|
|
23,903
|
|
|
$
|
50.18
|
|
|
Forfeited
|
|
(1,594
|
)
|
|
$
|
50.19
|
|
|
(2,012
|
)
|
|
$
|
48.29
|
|
|
(2,875
|
)
|
|
$
|
43.77
|
|
|
Vested and released
|
|
(24,016
|
)
|
|
$
|
46.28
|
|
|
(24,755
|
)
|
|
$
|
41.33
|
|
|
(22,896
|
)
|
|
$
|
40.88
|
|
|
Ending non-vested balance
|
|
44,682
|
|
|
$
|
51.05
|
|
|
70,292
|
|
|
$
|
49.40
|
|
|
72,615
|
|
|
$
|
45.77
|
|
|
|
|
2018
|
|
2017
|
|
2016
|
|||||||||||||||
|
|
|
Options
|
|
Weighted
Average Exercise Price |
|
Options
|
|
Weighted
Average Exercise Price |
|
Options
|
|
Weighted
Average Exercise Price |
|||||||||
|
Outstanding, vested and exercisable, beginning of year
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
2,144
|
|
|
$
|
25.02
|
|
|
Exercised
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
(2,144
|
)
|
|
$
|
25.02
|
|
|
Outstanding, vested and exercisable, end of year
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
(In thousands, except per share data)
|
Year Ended December 31
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
|||||||
|
Weighted average number of common shares outstanding, basic
|
53,598
|
|
|
53,393
|
|
|
53,216
|
|
|||
|
Dilutive effect of securities:
|
|
|
|
|
|
||||||
|
Restricted Share Units
|
70
|
|
|
85
|
|
|
73
|
|
|||
|
Performance Share Units
|
63
|
|
|
110
|
|
|
135
|
|
|||
|
Purchase Match Units
|
18
|
|
|
23
|
|
|
24
|
|
|||
|
Weighted average number of common shares outstanding, diluted
|
53,749
|
|
|
53,611
|
|
|
53,448
|
|
|||
|
Effect of dilutive shares on earnings per share
|
$
|
—
|
|
|
$
|
(0.01
|
)
|
|
$
|
(0.01
|
)
|
|
|
Year Ended December 31, 2018
|
||||||||||||||||||||||||||
|
(In thousands)
|
Specialty P&C
|
|
Workers' Compensation Insurance
|
|
Segregated Portfolio Cell Reinsurance
|
|
Lloyd's Syndicates
|
|
Corporate
|
|
Inter-segment Eliminations
|
|
Consolidated
|
||||||||||||||
|
Net premiums earned
|
$
|
491,787
|
|
|
$
|
186,079
|
|
|
73,940
|
|
|
$
|
67,047
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
818,853
|
|
|
|
Net investment income
|
—
|
|
|
—
|
|
|
1,566
|
|
|
3,358
|
|
|
86,960
|
|
|
—
|
|
|
91,884
|
|
|||||||
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
8,948
|
|
|
—
|
|
|
8,948
|
|
|||||||
|
Net realized gains (losses)
|
—
|
|
|
—
|
|
|
(3,149
|
)
|
|
(460
|
)
|
|
(39,879
|
)
|
|
—
|
|
|
(43,488
|
)
|
|||||||
|
Other income (expense)
(1)
|
5,844
|
|
|
2,412
|
|
|
211
|
|
|
322
|
|
|
3,525
|
|
|
(2,481
|
)
|
|
9,833
|
|
|||||||
|
Net losses and loss adjustment expenses
|
(384,431
|
)
|
|
(118,483
|
)
|
|
(38,726
|
)
|
|
(51,570
|
)
|
|
—
|
|
|
—
|
|
|
(593,210
|
)
|
|||||||
|
Underwriting, policy acquisition and operating expenses
(1)
|
(112,419
|
)
|
|
(55,693
|
)
|
|
(22,426
|
)
|
|
(31,686
|
)
|
|
(18,767
|
)
|
|
2,435
|
|
|
(238,556
|
)
|
|||||||
|
Segregated portfolio cells dividend (expense) income
|
—
|
|
|
—
|
|
|
(9,122
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(9,122
|
)
|
|||||||
|
Interest expense
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(16,163
|
)
|
|
46
|
|
|
(16,117
|
)
|
|||||||
|
Income tax benefit (expense)
|
—
|
|
|
—
|
|
|
—
|
|
|
317
|
|
|
17,715
|
|
|
—
|
|
|
18,032
|
|
|||||||
|
Segment operating results
|
$
|
781
|
|
|
$
|
14,315
|
|
|
$
|
2,294
|
|
|
$
|
(12,672
|
)
|
|
$
|
42,339
|
|
|
$
|
—
|
|
|
$
|
47,057
|
|
|
Significant non-cash items:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Depreciation and amortization, net of accretion
|
$
|
7,050
|
|
|
$
|
3,850
|
|
|
$
|
441
|
|
|
$
|
(8
|
)
|
|
$
|
9,922
|
|
|
$
|
—
|
|
|
$
|
21,255
|
|
|
|
Year Ended December 31, 2017
|
||||||||||||||||||||||||||
|
(In thousands)
|
Specialty P&C
|
|
Workers' Compensation Insurance
|
|
Segregated Portfolio Cell Reinsurance
|
|
Lloyd's Syndicates
|
|
Corporate
|
|
Inter-segment Eliminations
|
|
Consolidated
|
||||||||||||||
|
Net premiums earned
|
$
|
449,823
|
|
|
$
|
163,309
|
|
|
$
|
68,197
|
|
|
$
|
57,202
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
738,531
|
|
|
Net investment income
|
—
|
|
|
—
|
|
|
1,059
|
|
|
1,736
|
|
|
92,867
|
|
|
—
|
|
|
95,662
|
|
|||||||
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
8,033
|
|
|
—
|
|
|
8,033
|
|
|||||||
|
Net realized gains (losses)
|
—
|
|
|
—
|
|
|
3,914
|
|
|
107
|
|
|
12,388
|
|
|
—
|
|
|
16,409
|
|
|||||||
|
Other income (expense)
(1)
|
5,688
|
|
|
2,096
|
|
|
115
|
|
|
(1,476
|
)
|
|
2,888
|
|
|
(1,797
|
)
|
|
7,514
|
|
|||||||
|
Net losses and loss adjustment expenses
|
(285,250
|
)
|
|
(102,233
|
)
|
|
(37,455
|
)
|
|
(44,220
|
)
|
|
—
|
|
|
—
|
|
|
(469,158
|
)
|
|||||||
|
Underwriting, policy acquisition and operating expenses
(1)
|
(107,972
|
)
|
|
(52,576
|
)
|
|
(20,764
|
)
|
|
(26,963
|
)
|
|
(29,275
|
)
|
|
1,797
|
|
|
(235,753
|
)
|
|||||||
|
Segregated portfolio cells dividend (expense) income
(2)
|
(5,181
|
)
|
|
—
|
|
|
(10,590
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(15,771
|
)
|
|||||||
|
Interest expense
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(16,844
|
)
|
|
—
|
|
|
(16,844
|
)
|
|||||||
|
Income tax benefit (expense)
(2)
|
—
|
|
|
—
|
|
|
—
|
|
|
568
|
|
|
(21,927
|
)
|
|
—
|
|
|
(21,359
|
)
|
|||||||
|
Segment operating results
|
$
|
57,108
|
|
|
$
|
10,596
|
|
|
$
|
4,476
|
|
|
$
|
(13,046
|
)
|
|
$
|
48,130
|
|
|
$
|
—
|
|
|
$
|
107,264
|
|
|
Significant non-cash items:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Depreciation and amortization, net of accretion
|
$
|
7,922
|
|
|
$
|
3,480
|
|
|
$
|
680
|
|
|
$
|
(20
|
)
|
|
$
|
16,734
|
|
|
$
|
—
|
|
|
$
|
28,796
|
|
|
|
Year Ended December 31, 2016
|
||||||||||||||||||||||||||
|
(In thousands)
|
Specialty P&C
|
|
Workers' Compensation Insurance
|
|
Segregated Portfolio Cell Reinsurance
|
|
Lloyd's Syndicates
|
|
Corporate
|
|
Inter-segment Eliminations
|
|
Consolidated
|
||||||||||||||
|
Net premiums earned
|
$
|
454,506
|
|
|
$
|
161,988
|
|
|
$
|
62,137
|
|
|
$
|
54,650
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
733,281
|
|
|
Net investment income
|
—
|
|
|
—
|
|
|
711
|
|
|
1,410
|
|
|
97,891
|
|
|
—
|
|
|
100,012
|
|
|||||||
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(5,762
|
)
|
|
—
|
|
|
(5,762
|
)
|
|||||||
|
Net realized gains (losses)
|
—
|
|
|
—
|
|
|
2,525
|
|
|
76
|
|
|
32,274
|
|
|
—
|
|
|
34,875
|
|
|||||||
|
Other income (expense)
(1)
|
5,306
|
|
|
2,218
|
|
|
18
|
|
|
1,415
|
|
|
1,069
|
|
|
(2,218
|
)
|
|
7,808
|
|
|||||||
|
Net losses and loss adjustment expenses
|
(266,090
|
)
|
|
(107,791
|
)
|
|
(35,232
|
)
|
|
(34,116
|
)
|
|
—
|
|
|
—
|
|
|
(443,229
|
)
|
|||||||
|
Underwriting, policy acquisition and operating expenses
(1)
|
(103,656
|
)
|
|
(53,597
|
)
|
|
(18,936
|
)
|
|
(22,832
|
)
|
|
(30,807
|
)
|
|
2,218
|
|
|
(227,610
|
)
|
|||||||
|
Segregated portfolio cells dividend (expense) income
|
—
|
|
|
—
|
|
|
(8,142
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(8,142
|
)
|
|||||||
|
Interest expense
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(15,032
|
)
|
|
—
|
|
|
(15,032
|
)
|
|||||||
|
Income tax benefit (expense)
|
—
|
|
|
—
|
|
|
—
|
|
|
(384
|
)
|
|
(24,736
|
)
|
|
—
|
|
|
(25,120
|
)
|
|||||||
|
Segment operating results
|
$
|
90,066
|
|
|
$
|
2,818
|
|
|
$
|
3,081
|
|
|
$
|
219
|
|
|
$
|
54,897
|
|
|
$
|
—
|
|
|
$
|
151,081
|
|
|
Significant non-cash items:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Depreciation and amortization, net of accretion
|
$
|
7,268
|
|
|
$
|
5,600
|
|
|
$
|
595
|
|
|
$
|
132
|
|
|
$
|
19,194
|
|
|
$
|
—
|
|
|
$
|
32,789
|
|
|
(1)
As a result of the third quarter 2018 segment reorganization, certain fees for services provided to the SPCs at Eastern Re and Inova Re are recorded as expenses within the Segregated Portfolio Cell Reinsurance segment and as other income within the Workers' Compensation Insurance segment. These fees are eliminated between segments in consolidation. These services primarily include SPC rental fees and were previously eliminated within the Company's Workers' Compensation segment.
|
|||||||||||||||||||||||||||
|
(2)
During 2017, ProAssurance recognized a $5.2 million pre-tax expense related to previously unrecognized SPC dividend expense for the cumulative earnings of unrelated parties that have owned segregated portfolio cells at various periods since 2003 in a Bermuda captive insurance operation managed by the Company's HCPL line of business within the Specialty P&C segment. The expense recorded in 2017 related to periods prior to the then current period and was unrelated to the Company's Cayman Islands captive operations. The $1.8 million tax impact of the expense recognized in 2017 was included in the Corporate segment's income tax benefit (expense).
|
|||||||||||||||||||||||||||
|
|
|
Year Ended December 31
|
||||||||||
|
(In thousands)
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Specialty P&C Segment
|
|
|
|
|
|
|
||||||
|
Gross premiums earned:
|
|
|
|
|
|
|
||||||
|
Healthcare professional liability
|
|
$
|
518,303
|
|
|
$
|
477,561
|
|
|
$
|
474,981
|
|
|
Legal professional liability
|
|
26,094
|
|
|
25,771
|
|
|
26,125
|
|
|||
|
Medical technology liability
|
|
35,157
|
|
|
33,836
|
|
|
34,158
|
|
|||
|
Other
|
|
468
|
|
|
415
|
|
|
667
|
|
|||
|
Ceded premiums earned
|
|
(88,235
|
)
|
|
(87,760
|
)
|
|
(81,425
|
)
|
|||
|
Segment net premiums earned
|
|
491,787
|
|
|
449,823
|
|
|
454,506
|
|
|||
|
|
|
|
|
|
|
|
||||||
|
Workers' Compensation Insurance Segment
|
|
|
|
|
|
|
||||||
|
Gross premiums earned:
|
|
|
|
|
|
|
||||||
|
Traditional business
|
|
199,466
|
|
|
173,246
|
|
|
171,434
|
|
|||
|
Alternative market business
|
|
83,508
|
|
|
80,698
|
|
|
75,658
|
|
|||
|
Ceded premiums earned
|
|
(96,895
|
)
|
|
(90,635
|
)
|
|
(85,104
|
)
|
|||
|
Segment net premiums earned
|
|
186,079
|
|
|
163,309
|
|
|
161,988
|
|
|||
|
|
|
|
|
|
|
|
||||||
|
Segregated Portfolio Cell Reinsurance Segment
|
|
|
|
|
|
|
||||||
|
Gross premiums earned:
|
|
|
|
|
|
|
||||||
|
Workers' compensation
(1)
|
|
78,255
|
|
|
72,814
|
|
|
66,899
|
|
|||
|
Healthcare professional liability
(2)
|
|
5,009
|
|
|
4,097
|
|
|
3,310
|
|
|||
|
Ceded premiums earned
|
|
(9,324
|
)
|
|
(8,714
|
)
|
|
(8,072
|
)
|
|||
|
Segment net premiums earned
|
|
73,940
|
|
|
68,197
|
|
|
62,137
|
|
|||
|
|
|
|
|
|
|
|
||||||
|
Lloyd's Syndicates Segment
|
|
|
|
|
|
|
||||||
|
Gross premiums earned:
|
|
|
|
|
|
|
||||||
|
Property and casualty
(3)
|
|
83,307
|
|
|
69,749
|
|
|
60,564
|
|
|||
|
Ceded premiums earned
|
|
(16,260
|
)
|
|
(12,547
|
)
|
|
(5,914
|
)
|
|||
|
Segment net premiums earned
|
|
67,047
|
|
|
57,202
|
|
|
54,650
|
|
|||
|
|
|
|
|
|
|
|
||||||
|
Consolidated net premiums earned
|
|
$
|
818,853
|
|
|
$
|
738,531
|
|
|
$
|
733,281
|
|
|
(In millions)
|
||||||||
|
Statutory Net Earnings
|
|
Statutory Capital and Surplus
|
||||||
|
2018
|
|
2017
|
|
2016
|
|
2018
|
|
2017
|
|
$135
|
|
$139
|
|
$163
|
|
$1,041
|
|
$1,175
|
|
|
2018*
|
||||||||||||||
|
(In thousands, except per share data)
|
1st
|
|
2nd
|
|
3rd
|
|
4th
|
||||||||
|
Net premiums earned
|
$
|
187,159
|
|
|
$
|
223,591
|
|
|
$
|
206,070
|
|
|
$
|
202,033
|
|
|
Net losses and loss adjustment expenses:
|
|
|
|
|
|
|
|
||||||||
|
Current year
|
$
|
152,572
|
|
|
$
|
184,543
|
|
|
$
|
169,154
|
|
|
$
|
179,056
|
|
|
Favorable development of reserves established in prior years, net
|
$
|
(22,786
|
)
|
|
$
|
(22,815
|
)
|
|
$
|
(21,549
|
)
|
|
$
|
(24,967
|
)
|
|
Net income (loss)
|
$
|
11,856
|
|
|
$
|
28,423
|
|
|
$
|
31,228
|
|
|
$
|
(24,450
|
)
|
|
Basic earnings per share
|
$
|
0.22
|
|
|
$
|
0.53
|
|
|
$
|
0.58
|
|
|
$
|
(0.46
|
)
|
|
Diluted earnings per share
|
$
|
0.22
|
|
|
$
|
0.53
|
|
|
$
|
0.58
|
|
|
$
|
(0.46
|
)
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
2017*
|
||||||||||||||
|
(In thousands, except per share data)
|
1st
|
|
2nd
|
|
3rd
|
|
4th
|
||||||||
|
Net premiums earned
|
$
|
182,903
|
|
|
$
|
180,353
|
|
|
$
|
192,303
|
|
|
$
|
182,972
|
|
|
Net losses and loss adjustment expenses:
|
|
|
|
|
|
|
|
||||||||
|
Current year
|
$
|
147,927
|
|
|
$
|
144,562
|
|
|
$
|
161,631
|
|
|
$
|
149,399
|
|
|
Favorable development of reserves established in prior years, net
|
$
|
(28,776
|
)
|
|
$
|
(29,012
|
)
|
|
$
|
(32,275
|
)
|
|
$
|
(44,297
|
)
|
|
Net income (loss)
|
$
|
41,455
|
|
|
$
|
19,518
|
|
|
$
|
28,949
|
|
|
$
|
17,342
|
|
|
Basic earnings per share
|
$
|
0.78
|
|
|
$
|
0.37
|
|
|
$
|
0.54
|
|
|
$
|
0.32
|
|
|
Diluted earnings per share
|
$
|
0.77
|
|
|
$
|
0.36
|
|
|
$
|
0.54
|
|
|
$
|
0.32
|
|
|
*Due to rounding, the sum of quarterly amounts may not equal the total amount for the respective year-to-date periods
|
|||||||||||||||
|
|
|
December 31, 2018
|
||||||||||
|
Type of Investment
|
|
Recorded
Cost Basis |
|
Fair
Value |
|
Amount Which is
Presented in the Balance Sheet |
||||||
|
Fixed maturities
|
|
|
|
|
|
|
||||||
|
Bonds:
|
|
|
|
|
|
|
||||||
|
U.S. Government or government agencies and authorities
|
|
$
|
171,770
|
|
|
$
|
170,154
|
|
|
$
|
170,154
|
|
|
States, municipalities and political subdivisions
|
|
289,544
|
|
|
293,772
|
|
|
293,772
|
|
|||
|
Foreign governments
|
|
30,318
|
|
|
29,892
|
|
|
29,892
|
|
|||
|
Public utilities
|
|
76,735
|
|
|
76,059
|
|
|
76,059
|
|
|||
|
All other corporate bonds
|
|
1,160,474
|
|
|
1,140,356
|
|
|
1,140,356
|
|
|||
|
Certificates of deposit
|
|
100
|
|
|
100
|
|
|
100
|
|
|||
|
Mortgage-backed securities
|
|
426,329
|
|
|
421,653
|
|
|
421,653
|
|
|||
|
Total Fixed Maturities
|
|
2,155,270
|
|
|
2,131,986
|
|
|
2,131,986
|
|
|||
|
Equity Securities
|
|
|
|
|
|
|
||||||
|
Common Stocks:
|
|
|
|
|
|
|
||||||
|
Public utilities
|
|
7,553
|
|
|
9,177
|
|
|
9,177
|
|
|||
|
Banks, trusts and insurance companies
|
|
64,148
|
|
|
62,344
|
|
|
62,344
|
|
|||
|
Industrial, miscellaneous and all other
|
|
379,230
|
|
|
371,416
|
|
|
371,416
|
|
|||
|
Total Equity Securities, trading
|
|
450,931
|
|
|
442,937
|
|
|
442,937
|
|
|||
|
Other long-term investments
|
|
352,654
|
|
|
466,140
|
|
|
466,140
|
|
|||
|
Short-term investments
|
|
308,367
|
|
|
308,319
|
|
|
308,319
|
|
|||
|
Total Investments
|
|
$
|
3,267,222
|
|
|
$
|
3,349,382
|
|
|
$
|
3,349,382
|
|
|
|
December 31,
2018 |
|
December 31,
2017 |
||||
|
Assets
|
|
|
|
||||
|
Investment in subsidiaries, at equity
|
$
|
1,599,486
|
|
|
$
|
1,713,656
|
|
|
Fixed maturities available for sale, at fair value
|
78,076
|
|
|
155,094
|
|
||
|
Short-term investments
|
76,347
|
|
|
268,181
|
|
||
|
Investment in unconsolidated subsidiaries
|
875
|
|
|
1,200
|
|
||
|
Cash and cash equivalents
|
25,757
|
|
|
81,009
|
|
||
|
Due from subsidiaries
|
—
|
|
|
2,666
|
|
||
|
Other assets
|
45,683
|
|
|
33,829
|
|
||
|
Total Assets
|
$
|
1,826,224
|
|
|
$
|
2,255,635
|
|
|
Liabilities and Shareholders’ Equity
|
|
|
|
||||
|
Liabilities:
|
|
|
|
||||
|
Due to subsidiaries
|
$
|
4,067
|
|
|
$
|
—
|
|
|
Dividends payable
|
43,446
|
|
|
267,292
|
|
||
|
Other liabilities
|
6,823
|
|
|
22,008
|
|
||
|
Debt less debt issuance costs
|
248,886
|
|
|
371,540
|
|
||
|
Total Liabilities
|
303,222
|
|
|
660,840
|
|
||
|
Shareholders’ Equity:
|
|
|
|
||||
|
Common stock
|
630
|
|
|
628
|
|
||
|
Other shareholders’ equity, including unrealized gains (losses) on securities of subsidiaries
|
1,522,372
|
|
|
1,594,167
|
|
||
|
Total Shareholders’ Equity
|
1,523,002
|
|
|
1,594,795
|
|
||
|
Total Liabilities and Shareholders’ Equity
|
$
|
1,826,224
|
|
|
$
|
2,255,635
|
|
|
|
Year Ended December 31
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Revenues
|
|
|
|
|
|
||||||
|
Net investment income
|
$
|
3,495
|
|
|
$
|
7,646
|
|
|
$
|
6,359
|
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
(325
|
)
|
|
(137
|
)
|
|
(155
|
)
|
|||
|
Net realized investment gains (losses)
|
(789
|
)
|
|
(8,606
|
)
|
|
405
|
|
|||
|
Other income (loss)
|
977
|
|
|
921
|
|
|
(960
|
)
|
|||
|
Total revenues
|
3,358
|
|
|
(176
|
)
|
|
5,649
|
|
|||
|
Expenses
|
|
|
|
|
|
||||||
|
Interest expense
|
14,844
|
|
|
16,440
|
|
|
15,030
|
|
|||
|
Other expenses
|
17,092
|
|
|
26,351
|
|
|
28,305
|
|
|||
|
Total expenses
|
31,936
|
|
|
42,791
|
|
|
43,335
|
|
|||
|
Income (loss) before income tax expense (benefit) and equity in net income of consolidated subsidiaries
|
(28,578
|
)
|
|
(42,967
|
)
|
|
(37,686
|
)
|
|||
|
Income tax expense (benefit)
|
(7,142
|
)
|
|
(13,293
|
)
|
|
(12,583
|
)
|
|||
|
Income (loss) before equity in net income of consolidated subsidiaries
|
(21,436
|
)
|
|
(29,674
|
)
|
|
(25,103
|
)
|
|||
|
Equity in net income of consolidated subsidiaries
|
68,493
|
|
|
136,938
|
|
|
176,184
|
|
|||
|
Net income
|
47,057
|
|
|
107,264
|
|
|
151,081
|
|
|||
|
Other comprehensive income (loss)
|
(35,238
|
)
|
|
(2,488
|
)
|
|
(6,456
|
)
|
|||
|
Comprehensive income
|
$
|
11,819
|
|
|
$
|
104,776
|
|
|
$
|
144,625
|
|
|
|
Year Ended December 31
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Net cash provided (used) by operating activities
|
$
|
27,981
|
|
|
$
|
67,779
|
|
|
$
|
41,356
|
|
|
Investing activities
|
|
|
|
|
|
||||||
|
(Investments in) distributions from unconsolidated subsidiaries, net:
|
|
|
|
|
|
||||||
|
Other partnership investments
|
—
|
|
|
—
|
|
|
(1,000
|
)
|
|||
|
Proceeds from sales or maturities of:
|
|
|
|
|
|
||||||
|
Fixed maturities, available for sale
|
169,822
|
|
|
295,035
|
|
|
100,240
|
|
|||
|
Net decrease (increase) in short-term investments
|
194,035
|
|
|
11,811
|
|
|
(262,169
|
)
|
|||
|
Dividends from subsidiaries
|
29,395
|
|
|
99,694
|
|
|
70,125
|
|
|||
|
Contribution of capital to subsidiaries
|
—
|
|
|
—
|
|
|
(1,983
|
)
|
|||
|
Unsettled security transactions, net of change
|
—
|
|
|
1,100
|
|
|
(1,100
|
)
|
|||
|
Funds (advanced) repaid for Lloyd's FAL deposit
|
(21,576
|
)
|
|
(25,449
|
)
|
|
—
|
|
|||
|
Funds (advanced) repaid under Syndicate Credit Agreement
|
(11,232
|
)
|
|
(6,883
|
)
|
|
1,695
|
|
|||
|
Funds (advanced) repaid under a business investment line of credit
|
—
|
|
|
(4,066
|
)
|
|
(3,090
|
)
|
|||
|
Other
|
330
|
|
|
(2,276
|
)
|
|
(2,805
|
)
|
|||
|
Net cash provided (used) by investing activities
|
360,774
|
|
|
368,966
|
|
|
(100,087
|
)
|
|||
|
Financing activities
|
|
|
|
|
|
||||||
|
Borrowings (repayments) under Revolving Credit Agreement
|
(123,000
|
)
|
|
(77,000
|
)
|
|
100,000
|
|
|||
|
Repurchase of common stock
|
—
|
|
|
—
|
|
|
(2,106
|
)
|
|||
|
Subsidiary payments for common shares and share-based compensation awarded to subsidiary employees
|
1,154
|
|
|
12,030
|
|
|
11,384
|
|
|||
|
Dividends to shareholders
|
(316,476
|
)
|
|
(315,228
|
)
|
|
(118,812
|
)
|
|||
|
Other
|
(5,685
|
)
|
|
(6,868
|
)
|
|
(3,697
|
)
|
|||
|
Net cash provided (used) by financing activities
|
(444,007
|
)
|
|
(387,066
|
)
|
|
(13,231
|
)
|
|||
|
Increase (decrease) in cash and cash equivalents
|
(55,252
|
)
|
|
49,679
|
|
|
(71,962
|
)
|
|||
|
Cash and cash equivalents at beginning of period
|
81,009
|
|
|
31,330
|
|
|
103,292
|
|
|||
|
Cash and cash equivalents at end of period
|
$
|
25,757
|
|
|
$
|
81,009
|
|
|
$
|
31,330
|
|
|
|
|
|
|
|
|
||||||
|
Supplemental disclosure of cash flow information:
|
|
|
|
|
|
||||||
|
Cash paid during the year for income taxes, net of refunds
|
$
|
4,966
|
|
|
$
|
17,193
|
|
|
$
|
(8,519
|
)
|
|
Cash paid during the year for interest
|
$
|
14,777
|
|
|
$
|
15,892
|
|
|
$
|
14,732
|
|
|
|
|
|
|
|
|
||||||
|
Significant non-cash transactions:
|
|
|
|
|
|
||||||
|
Dividends declared and not yet paid
|
$
|
43,446
|
|
|
$
|
267,292
|
|
|
$
|
265,659
|
|
|
Securities transferred at fair value as dividends from subsidiaries
|
$
|
98,292
|
|
|
$
|
190,709
|
|
|
$
|
174,270
|
|
|
|
2018
|
2017
|
2016
|
|||||||
|
Net premiums earned
|
|
|
|
|||||||
|
Specialty P&C
|
$
|
491,787
|
|
$
|
449,823
|
|
$
|
454,506
|
|
|
|
Workers' Compensation Insurance
|
186,079
|
|
163,309
|
|
161,988
|
|
||||
|
Segregated Portfolio Cell Reinsurance
|
73,940
|
|
68,197
|
|
62,137
|
|
||||
|
Lloyd's Syndicates
|
67,047
|
|
57,202
|
|
54,650
|
|
||||
|
Consolidated
|
$
|
818,853
|
|
$
|
738,531
|
|
$
|
733,281
|
|
|
|
Net investment income
(1)
|
|
|
|
|||||||
|
Segregated Portfolio Cell Reinsurance
|
$
|
1,566
|
|
$
|
1,059
|
|
$
|
711
|
|
|
|
Lloyd's Syndicates
|
3,358
|
|
1,736
|
|
1,410
|
|
||||
|
Corporate
|
86,960
|
|
92,867
|
|
97,891
|
|
||||
|
Consolidated
|
$
|
91,884
|
|
$
|
95,662
|
|
$
|
100,012
|
|
|
|
Losses and loss adjustment expenses incurred related to current year, net of reinsurance
|
|
|
|
|||||||
|
Specialty P&C
|
$
|
461,516
|
|
$
|
404,543
|
|
$
|
403,249
|
|
|
|
Workers' Compensation Insurance
|
126,534
|
|
107,975
|
|
109,342
|
|
||||
|
Segregated Portfolio Cell Reinsurance
|
47,693
|
|
45,968
|
|
39,801
|
|
||||
|
Lloyd's Syndicates
|
49,583
|
|
45,032
|
|
34,615
|
|
||||
|
Consolidated
|
$
|
685,326
|
|
$
|
603,518
|
|
$
|
587,007
|
|
|
|
Losses and loss adjustment expenses incurred related to prior year, net of reinsurance
|
|
|
|
|||||||
|
Specialty P&C
|
$
|
(77,085
|
)
|
$
|
(119,293
|
)
|
$
|
(137,159
|
)
|
|
|
Workers' Compensation Insurance
|
(8,051
|
)
|
(5,742
|
)
|
(1,551
|
)
|
||||
|
Segregated Portfolio Cell Reinsurance
|
(8,967
|
)
|
(8,513
|
)
|
(4,569
|
)
|
||||
|
Lloyd's Syndicates
|
1,987
|
|
(812
|
)
|
(499
|
)
|
||||
|
Consolidated
|
$
|
(92,116
|
)
|
$
|
(134,360
|
)
|
$
|
(143,778
|
)
|
|
|
Paid losses and loss adjustment expenses, net of reinsurance
|
|
|
|
|||||||
|
Specialty P&C
|
$
|
354,221
|
|
$
|
320,776
|
|
$
|
341,189
|
|
|
|
Workers' Compensation Insurance
|
108,742
|
|
96,734
|
|
89,418
|
|
||||
|
Segregated Portfolio Cell Reinsurance
|
29,320
|
|
28,761
|
|
27,391
|
|
||||
|
Lloyd's Syndicates
|
37,496
|
|
29,926
|
|
21,254
|
|
||||
|
Inter-segment eliminations
|
200
|
|
118
|
|
—
|
|
||||
|
Consolidated
|
$
|
529,979
|
|
$
|
476,315
|
|
$
|
479,252
|
|
|
|
Amortization of DPAC
|
|
|
|
|||||||
|
Specialty P&C
|
$
|
52,253
|
|
$
|
47,615
|
|
$
|
44,344
|
|
|
|
Workers' Compensation Insurance
|
16,864
|
|
14,551
|
|
13,273
|
|
||||
|
Segregated Portfolio Cell Reinsurance
|
21,039
|
|
19,927
|
|
18,385
|
|
||||
|
Lloyd's Syndicate
|
15,913
|
|
15,194
|
|
13,769
|
|
||||
|
Inter-segment eliminations
|
(1,568
|
)
|
(1,536
|
)
|
(1,393
|
)
|
||||
|
Consolidated
|
$
|
104,501
|
|
$
|
95,751
|
|
$
|
88,378
|
|
|
|
Other underwriting, policy acquisition and operating expenses
|
|
|
|
|||||||
|
Specialty P&C
|
$
|
60,166
|
|
$
|
60,357
|
|
$
|
59,312
|
|
|
|
Workers' Compensation Insurance
|
38,829
|
|
38,025
|
|
40,324
|
|
||||
|
Segregated Portfolio Cell Reinsurance
|
1,387
|
|
837
|
|
551
|
|
||||
|
Lloyd's Syndicates
|
15,773
|
|
11,769
|
|
9,063
|
|
||||
|
Corporate
|
18,767
|
|
29,275
|
|
30,807
|
|
||||
|
Inter-segment eliminations
|
(867
|
)
|
(261
|
)
|
(825
|
)
|
||||
|
Consolidated
|
$
|
134,055
|
|
$
|
140,002
|
|
$
|
139,232
|
|
|
|
Continued on the following page.
|
||||||||||
|
|
||||||||||
|
|
2018
|
2017
|
2016
|
||||||
|
Continued from previous page
|
|
|
|
||||||
|
Net premiums written
|
|
|
|
||||||
|
Specialty P&C
|
$
|
494,148
|
|
$
|
466,621
|
|
$
|
454,718
|
|
|
Workers' Compensation Insurance
|
195,350
|
|
173,566
|
|
163,513
|
|
|||
|
Segregated Portfolio Cell Reinsurance
|
75,547
|
|
68,862
|
|
64,028
|
|
|||
|
Lloyd's Syndicates
|
69,869
|
|
54,969
|
|
56,274
|
|
|||
|
Consolidated
|
$
|
834,914
|
|
$
|
764,018
|
|
$
|
738,533
|
|
|
Deferred policy acquisition costs
(1)
|
$
|
54,116
|
|
$
|
50,261
|
|
$
|
46,809
|
|
|
Reserve for losses and loss adjustment expenses
(1)
|
$
|
2,119,847
|
|
$
|
2,048,381
|
|
$
|
1,993,428
|
|
|
Unearned premiums
(1)
|
$
|
415,211
|
|
$
|
398,884
|
|
$
|
372,563
|
|
|
|
2018
|
2017
|
2016
|
||||||
|
Property and Liability *
|
|
|
|
||||||
|
Premiums earned
|
$
|
903,354
|
|
$
|
821,249
|
|
$
|
790,791
|
|
|
Premiums ceded
|
(126,036
|
)
|
(110,347
|
)
|
(95,315
|
)
|
|||
|
Premiums assumed
|
41,535
|
|
27,629
|
|
37,805
|
|
|||
|
Net premiums earned
|
$
|
818,853
|
|
$
|
738,531
|
|
$
|
733,281
|
|
|
Percentage of amount assumed to net
|
5.07%
|
3.74%
|
5.16%
|
||||||
|
* All of ProAssurance’s premiums are related to property and liability coverages.
|
|||||||||
|
Exhibit Number
|
|
Description
|
|
|
|
|
|
2
|
|
Schedules to the following documents are omitted; the contents of the schedules are generally described in the documents; and ProAssurance will upon request furnish to the Commission supplementally a copy of any omitted schedule
|
|
|
|
|
|
|
Agreement and Plan of Merger by and among ProAssurance Corporation, PA Merger Company and Eastern Insurance Holdings, Inc., dated September 23, 2013, filed as an Exhibit to ProAssurance's Current Report on Form 8-K for event occurring September 24, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
|
Certificate of Incorporation of ProAssurance, filed as an Exhibit to ProAssurance’s Registration Statement on Form S-4 (File No. 333-49378) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
|
Certificate of Amendment to Certificate of Incorporation of ProAssurance, filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2001 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
|
Fourth Restatement of the Bylaws of ProAssurance, effective December 2, 2015, filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2015 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
|
Indenture, dated November 21, 2013, between ProAssurance and Wilmington Trust Company, filed as an Exhibit to ProAssurance's Current Report on Form 8-K for event occurring November 21, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
|
First Supplemental Indenture, dated November 21, 2013, between ProAssurance and Wilmington Trust Company relating to the $250,000 5.30% Senior Notes due 2023, filed as an Exhibit to ProAssurance's Current Report on Form 8-K for event occurring November 21, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
|
|
ProAssurance will file with the Commission upon request pursuant to the requirements of Item 601 (b)(4) of Regulation S-K documents defining rights of holders of ProAssurance’s long-term indebtedness that has not been registered. See also the documents related to long-term indebtedness filed as material contracts under Exhibits 10.10(a), (b), (c), (d), (e) and (f) to this Form 10-K.
|
|
|
|
|
|
|
Form of Release and Severance Compensation Agreement dated as of January 1, 2008 between ProAssurance and each of the following named executive officers:*
|
|
|
|
|
Howard H. Friedman
Dana S. Hendricks
Jeffrey P. Lisenby
Frank B. O’Neil
Edward L. Rand Jr.
|
|
|
|
Filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2007 (File No. 001-16533) and incorporated herein by this reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
Employment Agreement between ProAssurance and W. Stancil Starnes dated as of May 1, 2007, filed as an Exhibit to ProAssurance’s Current Report on Form 8-K for the event occurring May 12, 2007 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
|
|
Amendment to Employment Agreement with W. Stancil Starnes (May 1, 2007), effective as of January 1, 2008, filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2007 (File No. 001-16533) and incorporated herein by this reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
|
|
Amendment to Employment Agreement with W. Stancil Starnes (May 1, 2007), effective as of June 1, 2015, filed as an Exhibit to ProAssurance's Current Report on Form 8-K dated May 27, 2015 (File No. 001-16533) and incorporated herein by this reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
|
|
Amendment to Employment Agreement with W. Stancil Starnes (May 1, 2007), effective as of June 1, 2017, filed as an Exhibit to ProAssurance's Current Report on Form 8-K dated May 31, 2017 (File No. 001-16533) and incorporated herein by this reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
|
|
Form of Release and Severance Compensation Agreement dated as of September 1, 2011 between ProAssurance and Ross E. Taubman, filed as an Exhibit to ProAssurance’s Definitive Proxy Statement (File No. 001-16533) on April 11, 2008 and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
|
|
Form of Indemnification Agreement between ProAssurance and each of the following named executive officers and directors of ProAssurance*:
|
|
|
|
|
Bruce D. Angiolillo
Michael L. Boguski
Samuel A. Di Piazza, Jr.
Robert E. Flowers
Howard H. Friedman M. James Gorrie
Ziad R. Haydar
Jeffrey P. Lisenby
John J. McMahon
Frank B. O’Neil
Katisha T. Vance
Edward L. Rand, Jr.
Frank A. Spinosa
W. Stancil Starnes
Ross E. Taubman
Thomas A. S. Wilson, Jr.
|
|
|
|
Filed as an Exhibit to ProAssurance’s Definitive Proxy Statement (File No. 001-16533) on April 11, 2008 and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
ProAssurance Group Employee Benefit Plan which includes the Executive Supplemental Life Insurance Program (Article VIII), filed as an Exhibit to ProAssurance's Annual Report on Form 10-K for the year ended December 31, 2004 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
|
|
Amendment and Restatement of the Executive Non-Qualified Excess Plan and Trust effective January 1, 2008, filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2007 (File No. 001-16533) and incorporated herein by this reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
|
|
Director Deferred Compensation Plan as amended and restated December 7, 2011, filed as an Exhibit to ProAssurance's Annual Report on Form 10-K for the year ended December 31, 2011 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
|
|
Amendment No. 1 to the Amended and Restated Director Deferred Compensation Plan dated May 22, 2013, filed as an Exhibit to ProAssurance's Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
|
|
Revolving Credit Agreement, dated April 15, 2011, between ProAssurance and U.S. Bank National Association, Wells Fargo Bank, National Association, Branch Banking and Trust Company, First Tennessee Bank, N.A., and JP Morgan Chase Bank N.A., filed as an Exhibit to ProAssurance’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
|
Amendment No. 1 to Revolving Credit Agreement between ProAssurance and U.S. Bank National Association, Wells Fargo Bank, National Association, Branch Banking and Trust Company, First Tennessee Bank, N.A., and JP Morgan Chase Bank N.A., filed as an Exhibit to ProAssurance's Quarterly Report on Form 10-Q for the quarter ended September 30, 2012 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
|
Amendment No. 2 to Revolving Credit Agreement between ProAssurance and U.S. Bank National Association, Wells Fargo Bank, National Association, Branch Banking and Trust Company, First Tennessee Bank, N.A., and JP Morgan Chase Bank N.A., filed as an Exhibit to ProAssurance's Current Report on Form 8-K for event occurring November 8, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
|
Form of the Augmenting Lender Supplement to Revolving Credit Agreement between ProAssurance and U.S. Bank National Association, Wells Fargo Bank, National Association, Branch Banking and Trust Company, First Tennessee Bank, N.A., and JP Morgan Chase Bank N.A., filed as an Exhibit to ProAssurance's Quarterly Report on Form 10-Q for the quarter ending June 30, 2014 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
|
Copy of the Augmenting Lender Supplement to Revolving Credit Agreement between ProAssurance and U.S. Bank N.A., Wells Fargo Bank, N.A., Branch Banking and Trust Company, First Tennessee Bank, N.A., Key Bank, Cadence Bank, N.A., and Regions Bank, N.A., dated June 19, 2015, filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2015 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
|
Amendment No. 5 to Revolving Credit Agreement between ProAssurance and U.S. Bank National Association, Wells Fargo Bank, National Association, Branch Banking and Trust Company, First Tennessee Bank, N.A., and JP Morgan Chase Bank N.A., filed as an Exhibit to ProAssurance's to ProAssurance’s Annual Report on Form 10-K for the Year ended December 31, 2017 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
|
Pledge and Security Agreement between ProAssurance and U.S. Bank National Association, filed as an Exhibit to ProAssurance’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
|
ProAssurance Corporation Amended and Restated 2014 Equity Incentive Plan, filed as an Exhibit to ProAssurance’s Current Report on Form 8-K for event occurring May 14, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
|
|
ProAssurance Corporation 2014 Annual Incentive Plan, filed as an Exhibit to ProAssurance’s Definitive Proxy Statement (File No. 001-16533) filed on May 22, 2013 and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
|
|
Facility Agreement between ProAssurance and the Premiums Trust Fund of Syndicate 1729, filed as an Exhibit to ProAssurance's Annual Report on Form 10-K for the year ended December 31, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
|
Amendment to Facility Agreement effective April 6, 2016, between ProAssurance and the Premiums Trust Fund of Syndicate 1729 filed as an Exhibit to ProAssurance's Quarterly Report on Form 10-Q for the quarter ended June 30, 2016 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
|
Retention and Severance Compensation Agreement effective January 1, 2014, between ProAssurance and Michael L. Boguski, filed as an Exhibit to ProAssurance's Annual Report on Form 10-K for the year ended December 31, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
|
|
Mortgage Agreement, dated December 11, 2017, between ProAssurance Indemnity Company, Inc. and First Tennessee Bank National Association, filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2017 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
|
Mortgage Agreement, dated December 11, 2017, between Podiatry Insurance Company of America and First Tennessee Bank National Association, filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the Year ended December 31, 2017 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
|
Interest Rate Cap Agreement, dated October 23, 2017, between Podiatry Insurance Company of America and First Tennessee Bank National Association, filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the Year ended December 31, 2017 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
|
Subsidiaries of ProAssurance Corporation
|
|
|
|
|
|
|
|
Consent of Ernst & Young LLP
|
|
|
|
|
|
|
|
Certification of Principal Executive Officer of ProAssurance as required under SEC Rule 13a-14(a)
|
|
|
|
|
|
|
|
Certification of Principal Financial Officer of ProAssurance as required under SEC Rule 13a-14(a)
|
|
|
|
|
|
|
|
Certification of Principal Executive Officer of ProAssurance as required under SEC Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code, as amended (18 U.S.C. 1350)
|
|
|
|
|
|
|
|
Certification of Principal Financial Officer of ProAssurance as required under SEC Rule 13a-14(b) and 18 U.S.C. 1350
|
|
|
|
|
|
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
|
|
|
|
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
* Denotes a management contract or compensatory plan, contract or arrangement required to be filed as an Exhibit to this report.
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|